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ABSTRACT OF THE DISSERTATION 
Synthesis and Characterization of Amphiphiles for Mammalian Cell 
Transfection and Antimicrobial Activity  
 
by 
 
Joseph W. Meisel 
 
Doctor of Philosophy in Chemistry 
University of Missouri-St. Louis, 2016 
Dr. George W. Gokel, Advisor 
 
Amphiphiles are molecules that contain both hydrophilic and hydrophobic 
components. The dual nature of these molecules engenders remarkable properties 
including the ability to self-assemble into ordered structures. Cell membranes are 
composed of amphiphilic phospholipids that organize into a bilayer motif. Synthetic 
amphiphiles can interact with natural membranes and influence the transport of 
molecules across the cell membrane. The work elaborated in this report employs 
amphiphiles to co-assemble with DNA and transport the genetic material across cell 
membranes.  
First, a simplified method for interacting DNA with amphiphiles was developed. 
Typically, a liposome containing cationic lipids and often helper lipids is prepared in 
a multistep process. Then, the liposome is mixed with DNA to spontaneously form a 
lipid-DNA complex. An abbreviated method was developed by dissolving lipids in an 
aqueous-miscible organic solvent and mixing directly with DNA. The lipid-DNA 
complexes formed by this method had similar properties as assessed by agarose gel 
electrophoresis, dynamic light scattering, and electron microscopy. The complexes 
were compared against the standard procedure in the transfection of two different 
mammalian epithelial cell lines with plasmid DNA encoding a green fluorescent 
protein. The different methods yielded comparable results. This direct-mixing 
method obviates a liposomal intermediate thereby broadening the range of 
chemical structures that can be tested in transfection. 
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Second, a series of known ion-transporting compounds were assayed for their 
interaction with DNA. Hydraphile and lariat ethers are ionophoric compounds 
consisting of diaza-18-crown-6 subunits. The former act as ion channels in lipid 
membranes and the latter are putative ion carriers. Utilizing the direct-mixing 
method established herein, the effects of hydrocarbon chain length, DNA counter-
cation, and buffer pH were assessed by agarose gel electrophoresis. The results 
support a model wherein protonated diazacrown ethers interact with the negatively 
charged phosphate backbone of DNA. The hydrophobic aliphatic chains then self-
associate resulting in a condensed DNA nanoparticle. 
Third, a new class of DNA-binding molecules was designed and characterized. The 
molecules consist of two amino acids coupled via their carboxy-termini to a diamine 
linker. The remaining amino termini are exposed and are protonated at 
physiological pH. Arylene and alkylene linkers were investigated, as were various 
amino acids. Bis(aminoamide) compounds containing the hydrophobic amino acid 
tryptophan and the cationic amino acid lysine were the most efficient in binding and 
condensing DNA. Studies at varying pH indicated different mechanisms for DNA 
interactions with the tryptophan- and lysine-based compounds. The resultant 
complexes with plasmid DNA were examined by electron microscopy. A 
bis(tryptophan) compound begat nanoparticles markedly different from lipid-DNA 
complexes. Results obtained from the aforementioned three DNA-focused studies 
have application in biological research and potentially in gene therapy to cure 
disease.  
In addition to DNA binding, some of the bis(tryptophan) molecules described in this 
work were found to have antimicrobial properties. The compounds were shown to 
reverse antimicrobial resistance when co-administered with another antibiotic. The 
compounds were found to be non-toxic at low and antimicrobially active 
concentrations to three mammalian epithelial cell lines. Confocal microscopy 
studies suggest that the compounds are membrane-active, which implies a more 
general strategy for combating antibiotic resistance.  
Both the DNA and antimicrobial studies employed a uniquely supramolecular 
perspective in the design of methods and compounds that are biologically functional 
and aim to treat disease. Together, this work represents a structure-based approach 
to the understanding of how amphiphilic small molecules interact within 
biologically relevant systems. 
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Chapter 1 
Introduction and background. 
1.1. Amphiphiles and membranes. Amphiphiles are molecules with both hydrophilic 
(water-loving) and hydrophobic (water-hating—sometimes called lipophilic or 
lipid-loving) components. These molecules were first termed amphipathic (from the 
Greek amphi, meaning both) by G. S. Hartley in 1936 when describing the 
aggregation properties of paraffin-chain salts in water.1 The term amphiphilic 
became popular about 20 years later, employing the philic suffix for continuity.2 
Figure 1.1 clearly shows an escalating interest in amphiphiles demonstrated by the 
number of publications per year on the subject.3 
 
Figure 1.1. Publications per year indexed in SciFinder® containing 
the term amphiphilic, amphipathic, or derivatives thereof. 
 
Much of the early work on amphiphilic molecules describes their ability to form 
aggregates in aqueous solutions.1,2,4 Amphiphiles that consist of a relatively small 
hydrophilic head group and a longer hydrophobic tail will undergo self-assembly to 
exclude water from the hydrophobic portion of the molecule. Figure 1.2 shows the 
chemical structure (left panel) and aggregation/self-assembly behavior (right 
panel) of two common amphiphiles.5 The particle that is formed from the assembly 
of amphiphiles in water depends on the geometry of the amphiphile.6 The 
hydrophilic head group is hydrated in aqueous solution, making it wider than an 
aliphatic chain. This results in a conical geometry for single-chained amphiphiles. 
The cones assemble into a sphere with the hydrophobic tails pointing toward the 
center and the head groups facing outward to the solution. This maximizes the 
interaction of hydrophilic groups with water and minimizes the contacts between 
hydrophobic tails and the solvent.  The resulting structure is called a micelle. Twin-
chained amphiphiles have a cylindrical geometry and typically aggregate into 
bilayers (lamellae). Micellar and bilayer structures are just two examples of the 
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different amphiphile polymorphisms in aqueous solution. Additional liquid 
crystalline phases are accessible to amphiphiles of varying composition and under 
different solution conditions. 
 
 
Figure 1.2. The left panel shows chemical structures and cartoon 
‘lollipop’ representations of representative single- (left) and twin-
chained (right) amphiphiles. The right panel shows the geometry of 
hydrated single-chained (top) amphiphiles and micellar aggregates. 
Twin-chained amphiphiles (bottom) are shown forming a bilayer 
structure.5 
 
Phospholipids comprise a class of amphiphiles that typically consist of 
phosphorylated diacylglyerols. They are ubiquitous in living organisms and as twin-
chained amphiphiles, they form bilayer structures. Synthetic spherical bilayer 
structures can be formed from phospholipids. The resulting structure is called a 
liposome or a vesicle and can contain a single bilayer (unilamellar) or many bilayers 
(multilamellar). The key difference between micelles and liposomes is that the latter 
contains an aqueous interior compartment. Liposomes can therefore transport 
hydrophilic cargo in their interior as well as hydrophobic molecules embedded in 
the lipid bilayer. Liposomes may be considered the simplest representation of the 
membranes of living cells; however, the latter is considerably more complex in both 
composition and structure. 
 
Cellular membranes are two-dimensional fluids of various lipids interspersed with 
proteins. This perspective of membrane structure was elaborated in 1972 by Singer 
and Nicolson as the fluid-mosaic model of cell membranes.7 While nonpolar small 
molecules such as O2 and CO2 can diffuse through the membrane, ions and larger 
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hydrophilic compounds cannot. Hydrophobic compounds of low molecular weight 
can diffuse through the membrane. Water diffusion through the membrane is 
assisted by transmembrane proteins called aquaporins.8 Passive and active 
transport of ions and other compounds is often achieved by highly specific protein 
channels. 
 
1.2 Nucleic acids and genetic transformation. Nucleic acids consist of planar 
heteroaromatic rings fused to a ribose-phosphate backbone. DNA and RNA differ in 
that the former does not contain the 2’-hydroxyl group on the ribose subunit. Both 
are polyanionic, arising from the acidic phosphate groups on the backbone. Neither 
is capable of simple diffusion through a phospholipid bilayer. As the carrier of 
genetic information, nucleic acids have been studied for their ability to carry their 
encoded protein-making instructions between organisms. This transforming 
principle was observed in bacteria before the structure and function of nucleic acids 
was even discovered.9,10 The ability to transfer genetic material into eukaryotes in 
general and mammalian cells in particular was first observed with viral nucleic 
acids and was called transfection.11 Soon thereafter, it was discovered that various 
cationic polymers12 and calcium aggregates13 enhanced the transfection efficiency of 
nucleic acids.  
 
Viral transfection methods are highly efficient. However, the safety of the method is 
of concern. The use of certain viral vectors to transport genetic material results in 
the random insertion of the exogenous DNA into the host genome. In a 2002 gene 
therapy clinical trial this resulted in the alteration of oncogenes and caused 
leukemia in four patients, one of whom did not survive.14 Certain viral vectors, such 
as adeno-associated viral vectors, are safer because their genome insertion is non-
random.15 Nevertheless, the immune response to viral vectors can still pose a threat, 
as was the case in the tragic death of 18 year old Jesse Gelsinger in 1999.14  
 
In response to the safety concerns of viral vectors in gene therapy, non-viral 
methods have been developed. Perhaps the more promising of these methods is the 
use of cationic lipids for transfection. This technique was pioneered by Felgner and 
coworkers, who called it lipofection.16 The process involves preparing a liposome 
containing cationic lipids. Neutral helper lipids are often included to manipulate the 
lipid packing, a commonly used example is dioleoylphosphatidylethanolamine 
(DOPE). Once formed, the liposomes are then mixed with DNA, which causes 
spontaneous assembly into lipid-DNA complex called a lipoplex. The aim of the 
experiments in Chapter 2 was to assess a simplified method for preparing the 
lipoplex. The results elaborated in Chapter 3 utilized the method elaborated in the 
preceding chapter to characterize complexes formed from azacrown ethers and 
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plasmid DNA. In Chapter 4, amino acid-based compounds were synthesized and 
assessed for DNA binding ability. 
 
A long-term goal of the effort to design novel DNA binding compounds is to 
engender sequence-specificity into the structures. The ability to target a particular 
DNA or RNA sequence has tremendous potential for research and clinical 
applications. New technologies in RNA interference (RNAi)17 and gene editing 
(CRISPR)18 are especially promising. Both techniques require the transport of 
nucleic acids across a cellular membrane. Synthetic chemicals are also being studied 
for their ability to bind DNA in a sequence-specific manner19 and have recently 
shown promise20 in curing infectious diseases.  
 
1.3 Antimicrobial resistance. The necessity for developing new classes of 
antimicrobial chemotherapies can hardly be overstated. Resistance to current 
antibiotics continues to increase while the approval of new antibiotics is in 
decline.21 The results elaborated in Chapter 5 show that new amino acid-based 
small molecules show broad-spectrum antimicrobial activity. Even more interesting 
was the discovery that these molecules are capable of recovering antibiotic potency 
in a tetracycline-resistant strain of E. coli. The membrane activity of these molecules 
is implicated in these observations, suggesting a more general strategy for 
combating a particular class of antibiotic resistance. 
 
Whether DNA-binding and transport or antimicrobial activity was investigated, the 
unifying theme of the work reported in this document is the structure and function 
of amphiphiles in biologically relevant systems. This work represents a uniquely 
supramolecular perspective as it applies to binding, aggregation, and transport 
phenomena influenced by chemical structure. 
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Chapter 2 
A Simplified Direct Lipid Mixing Lipoplex Preparation: Comparison of 
Liposomal-, Dimethylsulfoxide-, and Ethanol-Based Methods 
 
2.1. Introduction. 
The tetravalent polyamine spermine was among the first reagents successfully 
employed in the transfection of mammalian cells over fifty years ago.1 Shortly 
thereafter, DEAE-dextran, protamine, and other cationic polymers were found to 
increase the genetic transforming activity of viral DNA and RNA on bacterial and 
mammalian cells.2,3,4,5 A technique utilizing the co-precipitation of calcium 
phosphate with DNA marked one of the first chemical transfection methods not 
using polyamines.6 
 
Since these earliest studies, numerous procedures have been developed for non-
viral mammalian cell transfection. Several physical techniques for transfection have 
been explored. These include gene gun,7 electrospray,8 electroporation,9 
sonoporation,10 and magnetofection.11 Chemical approaches typically involve the 
use of cationic polymers,12 calcium phosphate,6 inorganic nanoparticles,13 and 
lipids.14,15  
 
The formation of stable and condensed particles containing DNA is the most 
common strategy used for in vitro transfection. When such a complex is formed 
using a cationic polymer it is called a polyplex, whereas cationic lipids beget a 
lipoplex. While cationic polymers are typically water soluble, cationic lipids are not. 
The latter must therefore be pre-formed into liposomes.16 The lipoplex is then 
generated by the addition of an aqueous solution of cationic liposomes to an 
aqueous solution of DNA. The spontaneously formed lipoplex transfects cells in the 
process known as lipofection.15 
 
The lipoplex structure does not resemble that of the small unilamellar liposomes 
from which they derive. Instead, the lipoplex is a multilamellar liquid crystal 
consisting of hydrated DNA layers alternating with cationic lipid bilayers.17 A 
structural variant consists of a columnar hexagonal phase in which the DNA helix 
comprises the axis. Cationic lipid head groups face the DNA and the hydrophobic 
tails interdigitate between the hexagonally packed columns excluding water.18 The 
dynamics of lipoplex assembly are poorly understood, but it has been shown that  
lipid packing parameters19 dictate the structure’s organization.  
 
In most reports involving transfection, lipoplex formation was predominantly 
achieved by mixing plasmid DNA with cationic liposomes formed by the well-
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established lipid film hydration method.20 Small unilamellar vesicles are achieved by 
sonication and/or extrusion21 of the hydrated lipid. An ethanol-injection method has 
also been reported for liposome formation22 and used in transfection.23 These and 
other lipoplex preparation methods based on a liposomal intermediate require the 
use of lipids or lipid mixtures that form stable liposomes. Unless an amphiphile can 
form liposomes, it cannot be tested for DNA interaction or transfection using these 
methods.  
 
Lipoplex preparation methods have been developed that eliminate the liposomal 
intermediate. One method requires the use of a T-shaped mixing chamber to add an 
ethanolic solution of lipids to aqueous DNA.24 Another method utilizes 50% aqueous 
ethanol to dissolve both lipids and DNA and the resulting particles have been called 
GenospheresTM.25 Both methods require rotary evaporation or dialysis to remove 
ethanol before the lipoplex is delivered to cells. 
 
The results presented here demonstrate that lipids dissolved in dimethylsulfoxide 
(DMSO) or ethanol (EtOH) may be added directly to aqueous DNA to form a lipoplex. 
We call this technique direct lipid mixing (DLM) and denote the solvent by subscript, 
i.e. DLMDMSO or DLMEtOH. This method is fast, simple, and requires neither specialized 
equipment nor removal of the organic solvent. The method enables facile 
optimization of multi-lipid mixtures and lipid-DNA ratios. The absence of a 
liposomal intermediate enables the investigation of a greater diversity of chemical 
structures for transfection ability. 
 
2.2. Results and Discussion. 
2.2.1. Model cationic lipid transfection agent. The studies presented here use the 
cationic lipid 1,2-dioleoyl-3-trimethylammoniumpropyl chloride (DOTAP, see 
Figure 1). This lipid is widely used as an in vitro transfection agent,26,27 its lipoplex 
with DNA has been characterized,18,28 and it is commercially available. Liposomes 
can easily be prepared from DOTAP alone without the need for a helper lipid (such 
as dioleoylphosphatidylethanolamine, DOPE). DOTAP is also soluble in the water-
miscible organic solvents DMSO and ethanol. This property makes it possible to 
assess if DOTAP functions differently in lipoplex formation depending on whether 
the lipid is initially isotropically dispersed in a solvent (DLM) or the lipid is in the 
form of aqueous liposomes. Such differences in lipoplex formation could affect 
DOTAP’s activity as a transfection agent. It is this question that is addressed herein. 
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Figure 2.1. Chemical structure of model cationic lipid transfection 
reagent 1,2-dioleoyl-3-trimethylammoniumpropyl chloride (DOTAP) 
 
2.2.2. Introduction to agarose gel electrophoresis. DNA migrates through an agarose 
gel matrix by the action of an electric field according to its charge, length, and 
morphology. Successful transfection reagents, whether polymers or lipids, inhibit 
the migration of plasmid DNA through the gel. This retardation may result from 
aggregate formation, which cannot pass through the pores in the gel, and/or by 
screening the charge on the DNA phosphates from the influence of the electric field.  
 
A typical agarose gel electrophoresis experiment is run with a gel prepared from 
0.5-1.0% agarose in tris-acetate buffer. The gel is cast into a slab measuring 
approximately 1 x 12 x 13 cm for our apparatus. A comb is used to create regularly 
spaced and sized holes in the gel. These holes are termed wells and upon removal of 
the comb they are used to load samples into the gel. The comb may be placed at one 
end of the gel or in the middle. The gel is submerged under aqueous running buffer, 
which is typically the same composition as the buffer used to cast the gel. Figure 2.2 
shows an image of our gel apparatus in panel A, a side-view schematic of the 
apparatus in panel B, and the chemical structures of agarose polymer, tris-acetate 
(TA), and ethylenediaminetetraacetic acid (EDTA) in panel C. The metal ion 
chelating agent EDTA is often included in the buffer. EDTA prevents DNA damage 
from metal-dependent nuclease enzymes by binding the divalent metals (calcium, 
magnesium) necessary for the function of the enzyme. We have omitted EDTA from 
our buffer preparations in order to avoid any interaction between the polyanionic 
EDTA and our cationic DNA-binding reagents. We do not see nuclease activity in our 
system as the buffer and DNA are highly purified. 
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Figure 2.2. A) Electrophoresis apparatus. B) Side-view schematic of 
electrophoresis chamber. C) Chemical structures of the agarose 
polymer, tris-acetate, and ethylenediaminetetraacetic acid (EDTA). 
 
The formation of a gel from the agarose polymer powder creates a porous matrix 
through which the DNA can migrate under an electric current. The pore size of the 
matrix is dependent on the concentration of the polymer used, with lesser amounts 
of agarose leading to larger pores. Under our conditions (0.5% agarose w/v) the 
pore size ranges from 200-1000 nm in diameter. A 2007 study analyzed gels formed 
from a similar material, sepharose, by using transmission electron microscopy to 
generate a computer model of the gel matrix.29 The computer-generated image of a 
gel matrix is shown in Figure 2.3. If a chemical binds DNA and condenses it into a 
nanoparticle that is too large to efficiently move through the pores of the gel, then it 
will not be observed to migrate on the gel. 
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Figure 2.3. Computer model of an agarose gel matrix. The agarose 
fibers create pores of various sizes depending on the concentration of 
agarose used. 
 
The DNA migrates as the gel is run at ~100 V for 1.5 hours. The gel is then stained to 
visualize the location of the DNA. The fluorescent dye ethidium bromide is used for 
this purpose. Ethidium bromide is known to intercalate between the base pairs of 
DNA and upon intercalation a large increase in its fluorescence intensity is 
observed.30 The gel is stained in a solution of running buffer containing the dye and 
imaged on a UV trans-illuminator. An image of a typical gel is presented with 
annotations in Figure 2.4. The external-most lanes in the gel consist of a 1 kilobase 
ladder (Promega). The 1 kb ladder is a reference that consists of linear double 
stranded DNA from 250 base pairs in length to 10,000 base pairs. The second and 
next-to-last lanes consist of control plasmid DNA. The control plasmid DNA is mixed 
with the solvent in which the experimental compound is dissolved (in most cases 
dimethyl sulfoxide). The sixteen lanes between the ladder and plasmid controls are 
the experimental lanes. Their contents are typically shown above the lane and the 
equivalent of compound to DNA phosphate is also shown. The direction of DNA 
migration through the gel is from the top of the image to the bottom. Dark 
rectangles can be seen at the top of the gel. These are the wells in which the sample 
is placed. Fluorescent material can sometimes be observed in the wells. In many 
cases this is retained DNA. However, certain aggregates of insoluble compounds can 
also create this effect, as can deformed wells. Therefore, the appearance of 
fluorescent material in the well must be assessed in conjunction with the migration 
of DNA in order to conclude whether DNA was retained. 
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Figure 2.4. A typical image of an agarose gel stained by ethidium 
bromide. The image is obtained by UV trans-illumination. 
 
Plasmids are circular, double-stranded DNA. The plasmid used in electrophoresis 
experiments was a 9,988 base pair plasmid (pKLMF-FX, New England Biolabs) that 
was amplified in and extracted from the bacterium Escherichia coli. We have usually 
rounded the plasmid size to 10 kilobase pairs (10 kb) in this document. Often, more 
than one band is observed for a single plasmid on a gel. The multiple bands arise 
from the different topological isomers (topoisomers) plasmids can form. The most 
prevalent bands observed are, in order of fastest migration, supercoiled, linear, and 
open-circular (nicked) plasmid DNA. The different topoisomers of plasmid DNA are 
shown in Figure 2.5. The supercoiled DNA is more compressed than the other forms 
and therefore migrates the fastest. The linear DNA is a plasmid that has been cut 
through both strands. The pKLMF-FX plasmid shown in the Figure was cut with the 
BamHI enzyme to form a linear strand. The linear DNA migrates slightly slower than 
the supercoiled DNA and is seen to co-migrate with the 10,000 bp linear reference 
ladder DNA. Open-circular DNA is a plasmid that has been cut only though one 
strand of the double-helix. This allows the supercoiled DNA to relax by winding 
about the other intact strand to form an open circle. The nicked DNA migrates 
slower than supercoiled and linear DNA.  
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Figure 2.5. The topological isomers of DNA are shown and identified 
on an agarose gel. The enzyme BamHI was used to make a double-
strand cut in the DNA. 
 
2.2.3. Assessment of DOTAP-DNA interaction by agarose gel electrophoresis. We 
compared the effects of concentration and the physical state of DOTAP on the 
migration of plasmid DNA in an agarose gel in order to assess whether DLM or 
liposomal methods influence the DNA-lipid interaction. Lipoplex solutions were 
formed either by the addition of aqueous liposomal DOTAP or DMSO-dissolved 
DOTAP (DLMDMSO) to an aqueous solution of 10 kilobase-pair (10 kb) plasmid DNA. 
Aqueous liposomes were prepared by two methods: by sonication or sonication-
extrusion (hereafter referred to only as “extrusion”). Lipoplex solutions of 
DOTAP:DNA phosphate (+/- charge) ratios from 0.25 to 4 were prepared and added 
to the wells of an agarose gel. We were unable to test ethanol-dissolved DOTAP 
(DLMEtOH) because the mixture is less dense than water. This precludes the loading 
of the mixture into the wells. The electrophoretic mobility of the DNA was observed 
by ethidium bromide staining. 
 
We found that the DNA-lipid interaction as assessed by electrophoretic mobility was 
independent of the initial lipid physical state. The gel image in Figure 2.6A shows 
that both liposomal and DLMDMSO DOTAP interact with DNA to the same extent. At 
DOTAP:DNA phosphate ratios of 1-2, nearly all of the DNA was retained 
independent of the initial lipid physical state. Substoichiometric amounts of cationic 
lipid resulted in some DNA retention. The absence of significant streaking suggested 
the presence of minor amounts of intermediate structures, i.e. partially formed 
lipoplexes. The latter result suggested that lipoplex formation may be cooperative.  
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The graph in Figure 2.6B confirms that the concentration-retention profile for each 
lipid form is nearly identical. Together, these data suggest that the primary function 
of preparing a liposomal form of lipofection reagents is to make the lipids water-
soluble. Once the liposomes and DNA interact, the liposomal structure collapses and 
the lipids and DNA co-assemble into a distinct lipoplex structure. By dissolving the 
lipid in DMSO or ethanol, the liposome preparation step can be eliminated.  
 
Figure 2.6. (A) Agarose gel electrophoresis of 10 kb plasmid DNA-
DOTAP lipoplexes formed with liposomes (sonicated or extruded) or 
by DLMDMSO. The image represents a single gel; the gap in the image 
omits a control plasmid lane for clarity. (B) Percent retention of DNA 
by DOTAP as a function of +/- charge ratio and initial lipid form 
calculated by densitometric transformation of agarose gel images. 
Error bars represent the standard deviation of three trials. 
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The stability of transfection reagents is an important consideration when assessing 
the convenience of methods. Liposomes are often stored at 4 °C with a shelf life from 
weeks to months with many factors contributing to their stability.31 The chemical 
degradation of phospholipids by oxidation or hydrolysis and the physical stability of 
liposomes in suspension can be responsible for lower transfection efficiency or 
higher toxicity. The DLM method possesses major advantages relevant to stability. 
First, DLM lipid solutions may be prepared immediately prior to use much more 
rapidly than liposome solutions. Second, because DLM lipid solutions are 
isotropically dispersed they are not susceptible to the physical stability (i.e. 
aggregation) issues encountered with liposomes. Finally, DLMDMSO solutions may be 
particularly stable as DMSO readily freezes at 4 °C. In order to assess stability, the 
DNA retention of sonicated, extruded, and DLMDMSO solutions stored at 4 °C for 6 
months was tested by electrophoresis and found no difference in DNA mobility was 
apparent when compared to fresh solutions.  
 
2.2.4. Lipoplex characterization by dynamic light scattering (DLS). Both liposomes 
and lipoplex particles were studied in aqueous solution by dynamic light scattering. 
DOTAP liposomes were prepared by sonication or extrusion and diluted to a 
concentration of 30 µM in water. DLS showed that the average particle size was 
350 nm for the sonicated lipid, whereas extrusion resulted in 180 nm particles 
(corresponding well to the 0.2 µm (200 nm) membrane filter pore). The size 
distribution for liposomes formed by sonication alone was broader than for 
liposomes formed by extrusion. When DMSO-dissolved lipids were diluted with 
water to 30 µM, 90 nm particles were observed and fewer particles were apparent 
than was recorded for either liposomal method. In the latter case, some lipids may 
be dispersed as monomers or aggregates that were too small to be detected.  
 
A so-called “simple injection” technique for liposome formation that was reported 
some years ago involves ethanol-dissolved lipids.23 A DLS analysis of particle sizes 
obtained by using this technique found too few particles to measure. Presumably, 
the lipids were mostly dispersed as monomers or perhaps as aggregates too small to 
be detected. Based on the specifications of the instrument used in our analyses, the 
former seems more likely. The simple-injection procedure requires rapid injection 
of ethanol-dispersed lipids into water with simultaneous vortexing to form 
liposomes. Notwithstanding its potential convenience, this method has been used 
only occasionally in transfection studies during the past two decades. 
  
The charge affinity between the cationic lipids and the DNA phosphate groups 
drives the self-assembly. It is also likely that solvent exclusion from the complex 
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also fosters its formation. DLS showed that directly mixing DMSO-dissolved lipids 
with DNA (DLMDMSO) resulted in monodisperse lipoplex structures. 
 
Figure 2.7 shows particle size (DLS) data for lipoplexes formed by each of the four 
methods discussed here. They are (1) sonication, (2) extrusion, and the present 
method using (3) DMSO or (4) ethanol as the lipid solvent. Lipoplexes were formed 
using DOTAP and 6.2 kb or 10 kb plasmid DNA. The results demonstrate that 
methods 2-4 afford lipoplex particles that are similar in size. However, aqueous 
lipids that were sonicated formed larger liposomes. Comparing the results of similar 
experiments conducted with 6.2 kb and 10 kb plasmids show that the lipoplex 
reflects the initial liposome size rather than the length of the DNA included within it. 
 
 
Figure 2.7. Assessment of particle size variations for 30 µM DOTAP 
with varying amounts of plasmid DNA. Sonicated and extruded DOTAP 
are liposomal methods. EtOH and DMSO DOTAP are direct lipid mixing 
methods. Data shown represent the average of 10 measurements. 
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The size range of lipoplexes measured was relatively monodisperse across all 
preparation methods. The polydispersity index (PDI) was less than 0.25 for all 
methods with sonication giving the widest size distribution (PDI ~0.25). DLM 
methods had a typical PDI of 0.15. Unsurprisingly, extruded liposomes produced the 
most uniform lipoplexes, which had a PDI of ~0.1. Under our preparation 
conditions, both the size and polydispersity of lipoplexes were reproducible in 
repeated trials. 
 
2.2.5. Transmission electron microscopy of DOTAP-DNA lipoplex. The size and 
morphology of DOTAP-DNA lipoplexes prepared by extrusion or by DLMDMSO were 
examined by using transmission electron microscopy. Lipoplexes were adhered to 
formvar/carbon-coated copper grids and negatively stained with uranyl acetate. 
Both extrusion and DLMDMSO methods resulted in multilamellar structures. Lamellar 
spacings in extrusion samples were 4.7 ± 1.2 nm. A similar lamellar spacing (4.6 ± 
0.5 nm) was observed in samples prepared by the DLMDMSO method. These spacings 
correspond to lamellae consisting of DNA alternating with DOTAP bilayers.  
 
We clearly observe lamellar structures for the lipoplexes formed by using the 
DLMDMSO method. The lamellar spacing is approximately 5 nm (50 Å). Lamellar 
spacings recorded in other lipoplex formation reports are larger than this, but 
reflect different experimental conditions. Talmon and coworkers reported a spacing 
of 4.9 nm for DOTAP with single-stranded oligonucleotides measured by cryo-TEM 
and by small angle X-ray scattering (SAXS).32 Safinya and coworkers reported 
lamellar spacings of 3.72 nm (37.2 Å) for DOTAP in the absence of DNA.33 This 
finding implies lipid tail interdigitation, as our estimation of the length of a DOTAP 
monomer is 2.6 nm (26 Å). In the present case, the lipoplexes are supported 
(formvar backing) and are neither in solution nor suspension. If we estimate the 
DNA cylindrical diameter to be 2 nm (20 Å), the lipids must occupy ~3 nm (30 Å). 
The repeating unit must therefore include 20 Å + 15 Å + 15 Å to account for the 
spacing of 50 Å. This seems possible only if the lipids are interdigitated. Such 
compression seems reasonable because the solid TEM sample is unlikely to be 
hydrated. 
  
Despite the similarity in lamellar spacing, extrusion lipoplexes maintain a concentric 
lamellar structure (see Figure 2.8A), whereas DLMDMSO lipoplexes have a stacked 
lamellar arrangement (Figure 2.8B). It is unclear whether the lipoplex preparation 
method or the TEM grid preparation accounts for the difference in morphology. We 
speculate that lipoplex formation from liposomes may be templated by the 
liposome, resulting in the curvature observed in the concentric lamellae. However, 
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lipoplex formation from dissolved lipids may be templated by the DNA or by small 
lipid assemblies. The latter could result in a lipoplex lamellar structure that is 
influenced by the lipid packing parameters. This comports with DOTAP (a low-
curvature lamellae-forming lipid) forming the stacked lamellar structure. 
Interestingly, Lehn and coworkers observed stacked lamellar structures for 
lipoplexes derived from a water-soluble guanidinium-cholesterol reagent (BGTC) by 
cryo-TEM.34 However, when BGTC was formulated with DOPE as a liposome, 
concentric lamellar structures were observed for the corresponding lipoplex. This 
comports with our speculation above on liposome-templation versus DNA-
templation or small lipid assembly-templation. 
 
 
Figure 2.8. (A) Aggregated lipoplex particles formed from extruded 
DOTAP liposomes (B) Aggregated and partially-fused lipoplex 
particles formed from DMSO-dissolved DOTAP.  The lamellar spacing 
is approximately 5 nm (50 Å) and is shown in the magnified inset. 
Scale bars represent 50 nm, inset scale bars represent 10 nm. 
 
2.2.6. Transfection using DMSO-dissolved lipids. An application study was undertaken 
to determine if the similarities in lipoplex structures on electrophoretic, light 
scattering, and electron microscopic evidence were reflected in cells. Transfection 
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studies were conducted on HEK-293 human embryonic kidney cells. The 6.2 kb 
plasmid pCDNA3-EGFP encoding the enhanced green fluorescent protein (EGFP) 
was used to visually identify transfected cells. Confocal microscopy was used to 
assay transfection efficiency.  Transfection studies were run in triplicate and data 
was derived from representative confocal micrographs. Micrographs were analyzed 
using ImageJ software for cell counting (~2,500 cells per sample). Hand counting 
and computer analysis agreed within ±7%, represented by error bars in Figures 
2.9B and 2.10B.  
 
Both the DLMDMSO and liposomal methods resulted in transfected cells. The first 
transfection study used 1000 ng of DNA per well and lipoplexes were formed from a 
1:1 +/- ratio of DOTAP to DNA phosphate. The amount of DNA and DOTAP lipid used 
in each experiment was identical and is unoptimized for this cell line. 
Figure 2.10 shows the results of this study, which compared both liposomal 
methods and the DLMDMSO transfection method. The micrographs shown 
qualitatively demonstrate comparable transfection rates between methods. 
Quantitative analysis by cell-counting corrects for variable cell density and confirms 
that transfection efficiencies are similar.  
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Figure 2.9. (A) Confocal micrographs of DOTAP-transfected HEK-293 
cells using DMSO-solvated DOTAP (left), aqueous extruded liposomal 
DOTAP (middle), and aqueous sonicated liposomal DOTAP (right). 
The top darkfield images show EGFP fluorescence alone, bottom 
images are of the same cells with the fluorescence channel overlayed 
with brightfield to show cell density. (B) Transfection efficiency as 
determined by cell counting, expressed as a percentage of transfected 
cells. Error bars represent a ±7% error associated with cell counting.  
 
In order to confirm that similar transfection efficiency was observed under different 
conditions, we performed an additional transfection at a lower DNA concentration 
(250 ng per well) and a greater DOTAP:DNA ratio (4:1). The amount of DOTAP per 
well was the same as in the previous experiment. Lipoplexes in this experiment 
were prepared by DLMEtOH as well as the previously studied DLMDMSO and sonicated 
liposome methods. The results from this study are shown in Figure 2.10. 
Transfected cells were observed for each lipoplex preparation method. The rates of 
transfection for this DNA and DOTAP concentration regime were uniformly higher 
than in the previous transfection. The transfection efficiency was similar across all 
lipid formulation methods. These data suggest that DLM methods and liposomal 
methods give comparable transfection results under varied transfection conditions. 
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Figure 2.10. (A) Confocal micrographs of DOTAP-transfected HEK-
293 cells using DMSO-solvated DOTAP (left), ethanol-solvated DOTAP 
(middle), and aqueous sonicated liposomal DOTAP (right). The top 
darkfield images show EGFP fluorescence alone, bottom images are of 
the same cells with the fluorescence channel overlayed with 
brightfield to show cell density. (B) Transfection efficiency as 
determined by cell counting, expressed as a percentage of transfected 
cells. Error bars represent a ±7% error associated with cell counting. 
 
After obtaining transfection results for the direct-mixing lipoplex formation method 
with model lipid DOTAP, we examined its applicability to commercial lipofection 
reagents. The LipofectamineTM reagents have been used to transfect a variety of cell 
lines. ViafectTM is a relatively new formulation that claims low cell toxicity. The exact 
formulations of the reagents are proprietary, but both are aqueous lipid-based 
solutions. A known volume of the commercial transfection reagent was dried by 
lyophilization and reconstituted in the same volume of DMSO. This dissolves the 
liposome assembly, leading to an isotropic solution. The DMSO-dissolved lipids 
were then mixed with DNA in the same ratio as the aqueous solutions and the 
resulting lipoplexes were used to transfect HEK-293 cells. Confocal micrographs of 
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the transfected cells are displayed in Figure 2.11. A quantitative determination of 
transfection efficiency or fluorescence intensity was not possible in this study due to 
high cell density. The DNA amount and lipid ratio have not been optimized for this 
cell line, but in each case both the aqueous and DLMDMSO reagents successfully 
transfected the cells. 
 
Figure 2.11. Confocal microscopy images of EGFP transfected cells. 
Top row is darkfield and bottom is brightfield image. Transfection 
was performed using the commercial reagent ViafectTM as an aqueous 
liposomal solution (far left) and as a DMSO solution (middle left) and 
the commercial transfection reagent Lipofectamine LTXTM as an 
aqueous liposomal solution (middle right) and as a DMSO solution (far 
right). 
 
2.2.7. Transfection and toxicity assessed by flow cytometry. In order to demonstrate 
the utility and versatility of the direct lipid mixing method we performed additional 
transfection experiments using flow cytometry to determine transfection efficiency 
and toxicity. Transfection efficiency was assessed by EGFP fluorescence and toxicity 
was determined using the cell impermeant dye propidium iodide (PI).35 For the 
widespread applicability of this method, it must be useful with multicomponent 
lipid mixtures in addition to single lipid formulations. The top panel of Figure 2.13 
shows the results of the transfection of HEK-293 cells with lipoplexes derived from 
DOTAP (left) or from 1:1 DOTAP:DOPE (right). In each case the molar ratio of total 
lipid to DNA phosphate was 4:1. Three DNA concentrations were tested: 1.0, 2.5, and 
5.0 µg/mL. The associated toxicities of these methods are represented in the bottom 
panel of Figure 2.12. In each case, the toxicity of the DLM methods is similar to or 
less than that observed by using the liposomal methods. The transfection efficiency 
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of DLM methods with DOTAP were similar to liposomal methods at 2.5 µg/mL DNA, 
but slightly lower at 5.0 µg/mL. The toxicity of DLM methods was less than the 
liposomal methods when cationic lipids were combined with a helper lipid DOPE. In 
transfection with the binary lipid system, DLMEtOH was less toxic under these 
conditions but resulted in low transfection efficiency at 5 µg/mL DNA. DLMDMSO 
performed significantly better than all other methods having both the highest 
transfection efficiency and lowest toxicity.  
 
 
Figure 2.12. Transfection (top) and toxicity (bottom) of DLM and 
liposomal methods in human embryonic kidney cells. Single-lipid 
(left) and binary lipid (right) mixtures were assayed. 
 
In addition to assessing transfection efficiency and toxicity for DLM and liposomal 
methods with different lipid mixtures and various DNA concentrations, the 
application of DLM in a different cell line was also tested. The COS-7 cell line was 
chosen because of its widespread use in transfection for the preparation of 
recombinant proteins.36 The transfection was carried out at 5.0 µg/mL DNA, 4:1 
total lipid to DNA phosphate, and with DOTAP or DOTAP:DOPE lipid mixtures. The 
results are shown in Figure 2.13. 
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Figure 2.13. Transfection (bars) and toxicity (lines) of DLM and 
liposomal methods in COS-7 monkey kidney cells. Single-lipid (left) 
and binary lipid (right) mixtures were assayed. 
 
The transfection of COS-7 (monkey kidney) cells by DLM or liposomal methods with 
DOTAP or DOTAP:DOPE lipoplexes at 5.0 µg/mL DNA showed generally lower 
toxicity than the same transfection conditions in HEK-293 cells. When DOTAP was 
used alone, DLM and liposomal methods transfected COS-7 cells with similar 
efficiency and toxicity. For the binary lipid system the transfection results were 
similar to those found with HEK cells. DLMDMSO was the most efficient, liposomal 
methods were intermediate, and DLMEtOH was the least effective. The appearance of 
this trend across two cell lines suggests that DMSO is the preferred solvent for direct 
lipid mixing for multi-lipid systems at higher DNA concentrations. 
 
The use of DMSO in this procedure deserves comment. Since this solvent’s 
introduction into biological studies, the reports of its effects have varied from 
extremely favorable in certain applications to those uses where its presence was 
inimical to the desired outcome. We recently showed that the application of DMSO 
in a series of related systems showed some variation in outcome under similar 
conditions.37 Notwithstanding, the studies presented here show that when used as 
prescribed, the transfection outcomes are reproducible and comparable to 
procedures that require greater manipulation.  
 
The primary utility of this method, and indeed the conditions under which it has 
been tested, is for in vitro transfection with plasmid DNA. The application of the 
method to in vitro oligonucleotide delivery is under investigation. While not 
currently being tested, the extension of this method to in vivo transfection studies is 
not precluded. Organic solvents have long been used safely to solubilize drugs for 
parenteral applications and as embolic liquids themselves.38 While the initial mixing 
of lipid and DNA in the DLM method results in a solution of 15-50% by volume of 
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organic solvent, the solution delivered to cells consisted of only 1% organic solvent 
or less and was effective in media with or without serum. DMSO is listed as an 
inactive ingredient in approved drugs in the United States for topical administration 
in three FDA applications and for a single intravenous application (lyophilized 
powder, DMSO content not specified).39 Ethanol is listed as an inactive ingredient in 
many topical applications and at least 15 intravenous or intramuscular applications 
with intravenous injection concentrations as high as 92%.  
 
2.3. Conclusion. 
The present approach is a simplification of established methodology. It uses known 
lipids to form lipoplexes that are successfully transfected into mammalian cells. The 
studies presented here are side-by-side comparisons of two previous methods with 
the present approach. The key advantages of the method described here are 
convenience, cost, and efficiency. The comparative data confirm that the present 
approach affords transfection results that are comparable to those obtained by 
using methods that are in more common use. A summary diagram comparing the 
known and present methods is shown as Figure 2.14.  
  
 
Figure 2.14. Flow chart demonstrating lipoplex methods compared 
herein. Depicted are the liposomal methods of standard lipid film 
hydration-sonication-extrusion (left), simple-injection method 
(middle), and the non-liposomal direct lipid mixing (DLM) method 
featured in this work (right). 
 
Taken together, the results reported in this work demonstrate that the liposomal 
structure itself is not a necessary prerequisite to lipoplex formation. Liposome 
formation can be bypassed by dissolving lipids in an aqueous-miscible organic 
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solvent and mixing directly with an aqueous solution of DNA. The resulting 
lipoplexes transfected HEK-293 and COS-7 mammalian cells with efficiencies 
comparable to the standard protocol. This was demonstrated with the model lipid 
DOTAP dissolved either in dimethylsulfoxide or in ethanol. Our results suggest that 
the DLMDMSO method is advantageous in binary or multi-lipid systems. We also 
provide evidence that the DLMDMSO method works with the commercial lipid 
formulations Lipofectamine LTXTM and ViafectTM. 
By obviating the necessity for liposome-forming lipids, this work greatly expands 
the range of chemical structures that can be tested for transfection ability. 
Furthermore, the process of optimizing lipid formulations to a particular cell line is 
simplified. Of course, the choice of solubilizing solvent is an important 
consideration. While DMSO and ethanol were the solvents tested in this study, other 
solvents might be used. Minimally, the solvent must dissolve the transfection 
reagents and be miscible with water. The biological effects of such solvents on their 
own should also be examined and controlled for, with our results indicating that 
DMSO and ethanol have no observable effect on toxicity at the concentrations used. 
We anticipate that the development of the DLM method, while modest, may 
potentiate the pursuit of higher efficiency, more selective transfection reagents for 
biological research and gene therapy. 
 
2.4. Experimental. 
LipofectamineTM and ViafectTM were obtained from commercial sources as aqueous 
suspensions. DOTAP was obtained from Avanti Polar Lipids (Alabaster, AL, USA) in 
solid form as the chloride salt. Plasmid DNA (pKLMF-FX, 9.988 kb, New England 
Biolabs or pCDNA3-EGFP, 6.160 kb, Addgene # 13031) was amplified in E. coli, 
extracted using ZyppyTM Maxiprep spin columns, purified by NaCl/ethanol 
precipitation, and dissolved in 18.2 MΩ purified water. 
 
2.4.1. Lipid preparations.  
Sonicated and extruded DOTAP liposomes. A 1.0 mL solution of 6.06 mM (or 24.24 
mM for transfection) DOTAP-Cl in chloroform was prepared in a clean glass vial. 
Chloroform was removed by rotary evaporation to leave a thin film of lipid. The lipid 
film was hydrated with 1.0 mL 18.2 MΩ purified water, vortexed, and sonicated to 
homogeneity. Extruded liposomes were prepared from sonicated lipids by passing 
the solution through a 0.2 μm Whatman filter membrane 11 times. 
 
DMSO (or ethanol)-dissolved DOTAP lipid. A 1.0 mL solution of 6.06 mM (24.24 mM 
for transfection) DOTAP-Cl in dimethyl sulfoxide (or ethanol) was prepared in a 
clean glass vial. The solution was incubated at 37 °C on an orbital shaker at 50 rpm 
and vortexed to ensure complete dissolution. 
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DMSO-Dissolved commercial transfection solutions. A 100 μL solution of 
Lipofectamine LTXTM or ViafectTM formulation was lyophilized on a Labconco Lyph 
Lock 6 freeze dryer. The residue was then dissolved in 100 μL DMSO and used as 
directed. 
 
2.4.2. Transfection procedure. Transfection was carried out on HEK-293 cells in 
antibiotic-free media on black NuncTM 96-well optical-bottom plates (Thermo 
Scientific). Plates were seeded with 20,000 cells/well in antibiotic-free Dulbecco’s 
modified Eagle’s medium (DMEM), 10% fetal bovine serum (FBS) and grown to 
approximately 70% confluency before transfection. DOTAP-pCDNA3-EGFP 
lipoplexes of 1:1 +/- ratio were prepared by mixing 5 μL 6.06 mM DOTAP 
(sonicated, extruded, DMSO-dissolved, or EtOH-dissolved) with 100 μL of 100 ng/μL 
plasmid DNA. Lipoplex-containing media was prepared by adding 42 μL lipoplex 
solution to 400 μL DMEM (FBS-free). Lipoplexes of 4:1 +/- ratio were formed by the 
same procedure using 24.24 μM lipid and diluted 4-fold with 18.2 MΩ H2O, 
controlling for DMSO or ethanol content for DLM methods. Cell media was removed 
and 110.5 μL lipoplex media was added to cells and incubated 90 min, 37 °C, 5% CO2 
before 200 μL DMEM (containing blasticidin and 10% FBS) was added. Cells 
received either 1000 ng DNA at 1:1 +/- ratio or 250 ng DNA at 4:1 +/- ratio. The 
final concentration of DMSO or ethanol was less than 0.5%. After 36 h, cell media 
was replaced with phosphate-buffered saline and cells were imaged on a Zeiss LSM 
700 confocal microscope. 
 
2.4.3. Flow Cytometry. Transfection for flow cytometry experiments was performed 
in 24-well plates treated for cell culture. Cells were seeded in 1 mL aliquots at 
50,000 cells per well in DMEM with 10% FBS and grown to about 70% confluency 
overnight. Lipoplexes were prepared as described above for a 4:1 total lipid to DNA 
phosphate molar ratio. DOTAP trials were performed in triplicate and DOTAP:DOPE 
trials were performed in duplicate. Transfection was performed in 0.5 mL DMEM 
(FBS-free) containing the lipoplex for 90 min, 37 °C, 5% CO2 before 0.5 mL DMEM 
(10% FBS) was added. The DNA concentration before the DMEM+FBS supplement 
for HEK-293 transfection was 1.0, 2.5, or 5.0 µg/mL; COS-7 cells were transfected in 
an identical manner at 5.0 µg/mL DNA. After 24 h, the cell media was removed and 
centrifuged at 100 x g for 5 min to collect dead cells (for toxicity assay) and the 
supernatant was removed. Adherent cells were collected by washing with 0.3 mL 
PBS, adding 0.3 mL 0.25% trypsin-EDTA solution and incubating 5 min at 37 °C, 
then 0.7 mL DMEM+FBS was added and the cells were combined with dead cells and 
centrifuged at 100 x g for 10 min. The supernatant was removed and cells were 
resuspended in 300 µL DMEM+FBS. To stain dead cells 0.5 µL 0.5 mg/mL propidium 
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iodide (PI) solution was added. Cells were analyzed on a BD Biosciences FACSCanto 
II. EGFP was detected by excitation at 488 nm using a 530/30 nm filter, 520 LP 
mirror; PI was detected by excitation at 488 nm using a 670 nm filter, 655 LP 
mirror. Toxicity and transfection efficiency were determined by gating out cell 
debris and establishing a quadrant analysis based on PI +/- and EGFP +/-. Toxicity is 
reported as %survival = (PI-/EGFP- + PI-/EGFP+)/total cells. Transfection efficiency 
is reported as %transfection = (PI-/EGFP+)/total cells. After gating out debris each 
analysis contained about 30,000 cells on average. 
 
2.4.4. Agarose Gel Electrophoresis. Agarose powder was obtained from Sigma Aldrich. 
Purified water with 18.2 MΩ resistivity (Milli-Q) was used in all cases. Gels were cast 
by heating a 0.5% w/v solution of agarose in 40 mM tris-acetate buffer (pH 7.2) 
until fully dissolved, then cast by cooling the solution to room temperature in an 
Owl B2 horizontal electrophoresis chamber with a centrally placed 20-well comb. 
The gel was submerged under 40 mM tris-acetate (pH 7.2) running buffer, samples 
were added to the wells, and the gel was run 90 minutes at 105 ± 3 volts. Gels were 
stained in 2.5 μg/mL ethidium bromide for 15 minutes at 37 °C, 50 rpm, and 
destained in Milli-Q water for 5 minutes at 37 °C, 50 rpm. Ethidium bromide-stained 
DNA was visualized using a UV trans-illuminator. 
Gel images were analyzed by densitometry using ImageJ software.40 Lane profile 
plots were generated and integrated (data not shown). Using manual baselines, the 
control plasmid was set as 100% DNA migration. The inverse of the DNA migration 
in experimental wells relative to control DNA migration gave a measure of percent 
DNA retention. Results presented are the average of three gels. 
 
2.4.5. Dynamic Light Scattering. Measurements were performed on a Brookhaven 
Instruments Corp. ZetaPALS instrument at 37 °C using a 660 nm laser and 
correlating scattering at 90°. Samples were prepared by adding 10 μL 6.06 mM lipid 
solution to 200 μL of 25, 50, or 100 ng/μL pKLMF-FX or pCDNA3-EGFP in a pre-
cleaned glass vial. The mixture was vortexed and incubated at room temperature for 
5 minutes then diluted to 2.0 mL with 37 °C 18.2 MΩ H2O, transferred to a clean 
glass cuvette and equilibrated in the instrument for 5 min at 37 °C. Ten 
measurements consisting of two-minute runs were made on each sample. The 
average effective diameter was calculated with the standard deviation reported as 
the error. 
 
2.4.6. Transmission Electron Microscopy. The samples from dynamic light scattering 
measurements were also used for TEM. A 10 μL sample was applied to lacey 
formvar/carbon 300 mesh copper TEM grids (Ted Pella, Inc.) for 60 seconds and the 
grid was washed with 18.2 MΩ H2O (30 s), stained with 2 % uranyl acetate (30 s), 
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and washed twice with H2O (15 s each). The above solutions were applied at a 
volume of 10 μL, wicked away between each application, and the grid was finally 
dried with a gentle N2 stream. Specimens were examined on a JEOL JEM-2000 FX 
transmission electron microscope operated at 300 keV. Lamellae measurements 
were performed by ImageJ analysis of electron micrographs. Briefly, density profiles 
perpendicular to lamellae were generated from a minimum of 6 lipoplex structures 
per sample. Lamellar spacings were obtained by taking the first derivative of the 
density profile function. 
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Chapter 3 
Condensation of Plasmid DNA by Benzyl Hydraphiles and Lariat Ethers: 
Dependence on pH and Chain Length 
 
3.1. Introduction. 
Deoxyribonucleic acids are vast stacks of planar heterocycles linked by a sugar 
phosphate backbone. The large size of DNA, coupled with the ionized phosphates, 
comprises a barrier that prevents passage of these molecules through phospholipid 
membranes. The emergence of gene therapy has engendered the search for agents 
that can overcome these impediments and permit DNA to enter cells. The obvious 
goal is to find inexpensive, non-toxic, and efficient transformation and transfection 
agents.1 Viruses,2 polyamines,3 and even mechanical devices (gene gun)4 have been 
used to facilitate DNA transport into cells. A standard methodology for delivering 
DNA in transfection experiments is to form a lipoplex in which DNA is within a 
complex consisting of at least lipid monomers.5 Liposomal delivery methods are 
increasingly common, especially those utilizing such commercial reagents as 
Lipofectamine.® 
 
We have long been interested in binding6 and transporting both cations7 and 
anions.8 We surmised that the lariat ether9 and hydraphile10 amphiphiles that we 
had previously developed might be applicable in this context. In particular, we 
sought to characterize DNA complexation by either lariats or hydraphiles by using 
gel electrophoresis. The metric for this experiment would be to determine how 
much of the amphiphile was required to condense DNA. Complexing or neutralizing 
the surface phosphates would diminish the DNA plasmid’s response to an electric 
field and reduce or prevent its mobility on agarose gel.  
 
A recent report11 describes the incorporation of steroidal lariat ethers12 into 
liposomes prepared from 3β[N-(N’,N’-dimethylaminopropyl)carbamoyl]cholesterol 
and dioleoylphosphatidylethanolamine (DOPE). These liposomes included plasmid 
DNA within them and the lipoplexes were used to transfect human embryonic 
kidney (HEK-293) cells. We were intrigued by this report for three reasons. First, we 
originally reported the two steroidal carbamate lariat ethers chosen for the study.13 
Second, we have recently reported a new and simplified direct mixing lipoplex 
preparation method.14 Third, we have a long-standing interest in the complexation 
and transport properties of various lariat ethers and pore-forming hydraphiles.15 
The compounds used in the Sewbalas et al. study11 are shown in the upper left of 
Figure 3.1. The amphiphilic lariat ether family that we have extensively studied16 is 
shown in the upper right of the Figure and the pore-forming hydraphiles that are the 
subject of the present report are illustrated in the bottom panel.  
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Figure 3.1. 15- and 18-membered ring cholesteryl lariat ethers 
reported as transfection agents in reference 11 (upper left). Dialkyl 
lariat ethers previously studied whose binding constants are noted 
herein (upper right). Lower structure shows hydraphiles studied for 
the present report.  
 
The lariats in the above cited report11 were chosen for a transfection application 
because they are amphiphiles and they insert in membranes.17 The cholesteryl 
residue obviously imparts membrane solubility to the mixture and likely enhances 
the stability of the liposomes in this three-component mixture. A significant 
difference between the carbamoylated lariat ethers and either dialkyl lariats or 
hydraphiles is that the latter two compounds can be protonated at nitrogen. Amidic 
and carbamoyl lariat ethers cannot be readily protonated and the amidic links to the 
macroring rigidifies them. Moreover, amidic and carbamoyl lariat ethers are 
typically poor cation binders.18 Notwithstanding, the macrocyclic ring is polar 
enough to comprise an amphiphilic head group whether or not its polarity is 
augmented by binding a cation.19 
 
The compounds that we call hydraphiles are synthetic amphiphiles that insert into 
phospholipid bilayer membranes and mediate the passage of cations by pore 
formation.20 Moreover, they are multiple cation binders.21 We envisioned that 
hydraphiles and amphiphilic, alkyl side-chained lariat ethers could interact with 
DNA in either or both of two possible ways. The DNA polyphosphate ladder is 
negatively charged, but associated with cations. Both lariat ethers and hydraphiles 
could form complexes with cations that are further associated with DNA. Alternately, 
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the amine nitrogen atoms present in either type of structure could undergo 
protonation at physiological pH and the di- or polyammonium salts could associate 
with DNA. In either case, DNA mobility across a phospholipid bilayer—and 
ultimately the potential to transfect mammalian cells—might be enhanced.  
 
In the work reported here, we have found that alkyl side armed lariat ethers and 
hydraphiles do, indeed, form assemblies with DNA that lead to diminished mobility 
under electrophoretic conditions on agarose gels. We report below the effects of 
compound structure, variations in cations, and changes in pH on DNA mobility and 
present evidence from electron microscopy that complexes of significant size form 
between the amphiphiles and DNA. 
 
3.2. Results and Discussion.   
3.2.1. Compounds studied. Plasmid DNA (pKLMF-FX, 10 kilobase)22 was obtained 
from New England Biosciences and amplified in E. coli and extracted by using 
standard protocols (see Experimental Section). This plasmid was used in all studies 
reported herein. Two types of closely related compounds that we anticipated would 
interact with this plasmid are the lariat ether23 derivatives based on 4,13-diaza-18-
crown-6 derivatives in which each macroring nitrogen is substituted by an alkyl 
group: n-butyl, n-hexyl, n-octyl, n-decyl, n-dodecyl, n-tetradecyl, n-hexadecyl, and n-
octadecyl. The hydraphiles are tris(macrocycle)s that form cation-conducting pores 
in phospholipid bilayer membranes.10 Four hydraphiles were prepared and studied 
for the present report.24 Figure 3.1 shows both lariat ethers and hydraphiles. The 
latter have benzyl side arms on the distal macrocycles and the internal spacer chains 
are octylene, decylene, dodecylene, or tetradecylene. 
 
3.2.2. Assay of DNA complex gel mobility (gel retardation). DNA polymers are 
rich in phosphate anions and accompanying cations. Both lariat ethers25 and 
hydraphiles21 bind cations. Moreover, both are membrane active, albeit by different 
mechanisms.4,19 The lariat ethers are typically carriers26 whereas hydraphiles of 
appropriate length form ion-conducting pores.27 The lariat ethers and the 
hydraphiles that are the subject of this study not only bind and transport cations, 
they have protonatable nitrogen atoms. Any ammonium salt is expected to interact 
with phosphate anions present in DNA chains. 
 
One means by which the interaction of DNA with another compound can be assayed 
is a change in electrophoretic mobility. In this study, the mobility of the 
amphiphile•DNA complex on an agarose gel was compared to migration of DNA 
alone. DNA migration was visualized by using ethidium bromide.28 This dye 
intercalates in DNA, which enhances its fluorescence. Typically, the macrocyclic 
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complexing agent will not interact with ethidium bromide to enhance fluorescence 
and no signal will be observed absent the dye’s interaction with DNA. In control 
experiments, no fluorescent enhancement was observed when ethidium bromide 
was present in solutions containing either lariat ethers or hydraphiles at 
concentrations similar to those used with gels.  
 
The presence of either benzyl C8 or benzyl C14 hydraphile admixed with the DNA 
plasmid was found to inhibit DNA plasmid mobility. The study was conducted on an 
agarose gel in the presence of tris-acetate (TA) buffer. The divalent cation chelating 
agent ethylenediaminetetraacetic acid (EDTA) was omitted without affecting DNA 
stability. Figure 3.2 shows an image of the stained gel obtained by UV 
transillumination. The compound mixture was placed in wells which are clearly 
illuminated upon staining after the gel was run. This suggested that the 
amphiphile•DNA complexes were either too large to move through the pores in the 
gel or the surface charge of the complex was too low to respond to the applied 
potential. The effect on mobility is dependent on the amount of hydraphile used and 
on the length of the hydraphile spacer chain. Benzyl C8 hydraphile prevented the 
migration of plasmid DNA at a ratio of 5.0 equivalents of amphiphile to DNA 
phosphate. The longer chained benzyl C14 hydraphile retained DNA more effectively, 
requiring a ratio of 3.5 equivalents. Better retention by hydraphiles having longer 
spacer chains implies at least some hydrophobic effect in DNA complexation by 
these compounds.  
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Figure 3.2. Electrophoretic mobility assay for increasing 
concentrations of benzyl C8 hydraphile and benzyl C14 hydraphile 
mixed with 10 kb plasmid DNA at pH 8.5 in tris-acetate buffer. 
 
It is interesting to note that the shift in DNA mobility is observed as complete 
immobility of DNA. In other words, the DNA either migrates normally or is retained 
in the well. The absence of major bands of DNA between the plasmid control and the 
well suggests that complexation is cooperative. 
 
Based on our experience in crown ether29 and cation complexation6 chemistry as 
well as ion transport, we envisaged a tripartite crown-sodium cation-DNA 
phosphate sandwich complex. Figure 3.3 shows two 4,13-diaza-18-crown-6 
structures complexed in different ways to a DNA fragment. Typically, a crown ether 
will complex an alkali metal cation such as K+ within the macroring and the four 
oxygen and two nitrogen atoms will contact the ion, disperse the charge, and 
stabilize the assembly.30 Thus, we anticipated that complexation would be cation 
dependent. To test this hypothesis, we performed agarose gel electrophoresis31 with 
the DNA plasmid described above by varying both the hydraphile:phosphate ratios 
and the alkali metal cations.  
 
Figure 3.3. Left: A tripartite sandwich complex in which both crown 
and phosphate anion bind Na+. Right: Alternate complexation mode in 
which protonated crown serves as an H-bond donor for phosphate 
anion. The anion could also be closer to the positive charge than 
represented schematically. 
 
We first obtained the required cation-DNA salt by precipitation from aqueous 
ethanol in the presence of NaCl, LiCl, or KCl. It seemed possible that the tris 
ammonium cation in the gel running buffer would exchange with the alkali metal 
cation so a metal cation-borate system was used.32 Borate buffers were prepared by 
dissolving the appropriate alkali metal hydroxide in pure water and then adjusting 
the pH with boric acid followed by sterile filtering. The final buffer pH was 8.2. 
 
 
38 
 
Either benzyl C8 or benzyl C14 hydraphile was mixed with DNA in concentration 
ratios (hydraphile:DNA phosphate) ranging from 0.1 to 17 equivalents. Identical 
results were obtained whether the gel was run in lithium, sodium, or potassium 
borate buffer. In each case, the DNA remained in the well at ratios as high as 5 
equivalents of benzyl C14 hydraphile or 17 equivalents of benzyl C8 hydraphile. We 
concluded that there was no differential alkali metal cation participation in the 
hydraphile-DNA binding. 
 
An alternate hypothesis was that the nitrogen atoms within the diazacrown ethers 
were protonated in the running buffer and the resulting ammonium cations interact 
with the DNA phosphate residues. This hypothesis was addressed experimentally by 
varying buffer solution pH. At lower pH values, the macroring nitrogen atoms 
protonate to form a diammonium salt as shown at the right Figure 3.3. A bis(cation) 
is unlikely to bind a third cation, but it may interact with an anion by hydrogen 
bonding or by simple charge-charge stabilization. To the extent that cations are 
solvent separated from the DNA phosphates, the diprotonated macrocycle can form 
the type of diammonium phosphate complex shown.  
 
The protonated diazacrown hypothesis was tested by mixing varying equivalents of 
benzyl C8 or benzyl C14 hydraphile with DNA, then running tris-acetate buffered gels 
at pH values of 7.4, 8.5, and 9.4 (Figure 3.4). We expect no appreciable change in the 
protonation state of DNA phosphates over this range, as the pKA of the phosphate 
residues is ~0-2. Greater DNA retention in the wells at lower equivalents of benzyl 
C8 hydraphile was observed as pH decreased. The results were similar, but less 
pronounced, for benzyl C14 hydraphile. The pH dependence confirms the interaction 
of protonated hydraphiles with DNA. These results suggest a pH-dependent release 
mechanism that might be used to protect DNA from acid hydrolysis. 
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Figure 3.4: Graph showing the number of equivalents of benzyl 
hydraphiles having the indicated spacer chain lengths required for 
50% retention of 10 kb plasmid DNA in the agarose gel wells. BH 
represents benzyl hydraphile and Cn indicates the spacer chain length. 
 
The dependence on pH and chain length implied that both electrostatic and 
hydrophobic interactions drive complex formation. In order to further probe the 
forces that comprise the hydraphile-DNA interaction, a variety of compounds were 
tested for their ability to prevent complex formation. The anionic amphiphiles 
sodium dodecyl sulfate (SDS) and sodium dodecanoate are surfactants and they 
could form complexes with protonated hydraphiles in preference to DNA. They could 
also compete in binding DNA with hydraphiles that have formed sodium complexes. 
Crown-cation complexes are typically weak in water but increase in strength in 
lower dielectric media such as the nonpolar environment of a lipid membrane. The 
anionic surfactants, the hydraphiles, or assemblies formed from either or both could 
therefore inhibit aggregation.  
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Figure 3.5. Structures of benzyltrimethylammonium chloride (upper 
left), dodecyltrimethylammonium chloride (upper right), Triton X-100 
(center) and the polyamines spermine and spermidine. 
 
It was speculated that the cationic amphiphiles benzyltrimethylammonium chloride 
and dodecyltrimethylammonium chloride and the nonionic amphiphile Triton X-100 
would compete for phosphate ion pairs or would solvate the hydraphile and prevent 
complexation (Figure 3.5). The known DNA binding polyamines spermine and 
spermidine (used as hydrochloride salts) were also tested. The prevention agents 
were added to DNA before the addition of hydraphile. Benzyl C14 hydraphile was 
used at 1 equivalent and the prevention agents were tested at 1 equivalent and 25 
equivalents both in the presence and absence of hydraphile. No prevention of 
hydraphile-DNA complex formation was observed at 1 equivalent; the DNA 
remained in the well. However at 25 equivalents sodium dodecyl sulfate was 
successful in preventing complex formation and the DNA migrated normally. The 
ratio of 25 equivalents corresponds to a concentration of ~750 μM, over an order of 
magnitude below the critical micelle concentration of SDS.33 Spermine 
tetrahydrochloride also reduced complex formation, but the control experiment 
conducted in the absence of hydraphile showed an increase in the open circular 
band. The nicked plasmid likely resulted from acid catalyzed single-strand 
hydrolysis. The results of the prevention experiment are shown in Figure 3.6, left 
panel. 
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Figure 3.6. Left: Prevention experiment. DNA and the indicated 
prevention agent were mixed with (+) or without (-) 1.0 equivalent of 
benzyl C14 hydraphile. Normal DNA migration was observed with 
sodium dodecyl sulfate (SDS). Partial DNA migration was observed 
with spermine. Right: Disruption experiment. 10 kb plasmid DNA and 
hydraphile were run for 30 minutes then SDS was added to the well 
and the gel was run an additional 1 hour. Partial liberation of the 
hydraphile•DNA complex was observed. 
 
Sodium dodecyl sulfate prevented DNA-hydraphile formation, but it was unknown if 
this detergent could disrupt the complex after formation. A disruption experiment 
was conducted in which DNA and benzyl C14 hydraphile were allowed to react and 
then the gel was run for 30 minutes. Because the hydraphile-DNA complex was 
known to remain in the well, adding a reagent that disrupts the complex should 
release DNA, which can then migrate normally. SDS was added to the well (25 eq) 
and plasmid DNA was placed in another well as a control. After an additional hour of 
electrophoresis, the gel was stained and the image showed that some DNA was 
released upon addition of SDS. Therefore while 25 eq SDS can prevent the formation 
the hydraphile-DNA complex, the same amount is insufficient to fully release the 
DNA once the complex is formed. This may be due either to complex stability or to 
the inability of the surfactant to access (penetrate) the complex, or both.  
 
Agarose gel electrophoresis was also used to evaluate the effect, if any, of lariat 
ethers (LEs) on plasmid DNA. The dependence on alkyl chain length was 
investigated using lariat ethers having n-alkyl chains ranging in length from C4 to C18 
(even numbers). Each experiment was conducted at lariat ether concentrations of 17 
and 50 equivalents. Figure 3.7 shows that when the lariat side arms were C4, C6, or 
C8, DNA migrated normally at both concentrations. Lariat ethers having C10-C18 side 
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chains retained DNA in the well at 50 equivalents, while only C12 and C14 LEs fully 
inhibited migration at 17 equivalents. At the lower concentration, C10, C16, and C18 
but not C12 or C14 lariat ethers showed streaking, suggesting there is both a lower 
limit and upper limit on chain length for optimum complex formation. It is unclear 
why there appears to be a mid-range discontinuity. Lariat ether amides, whose alkyl 
chains connect to the diazacrown through amide bonds were also tested. The side 
arms were equivalent in length to the saturated compounds. None showed any 
activity in the gel experiments (data not shown). This result supports the need for 
amine protonation in complex formation. 
 
Figure 3.7. Top: Gel retardation assay for 17 or 50 equivalents of 
lariat ethers of varying side chain lengths with 10 kb plasmid DNA. 
Bottom: Graph showing the number of equivalents of lariat ether of 
varying chain length required for 50% plasmid DNA retention.  
 
Condensation of DNA by cationic lipids is known to generate lyotropic liquid 
crystalline phases. Lamellar or inverted columnar hexagonal assemblies are the 
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predominant morphologies that are observed.34 The lamellar phase consists of 
hydrated DNA layers alternating with cationic lipid bilayers.35 In the columnar 
hexagonal phase, the DNA helix comprises the axis and cationic lipid head groups 
contact the DNA. The lipid tails interdigitate between the hexagonally packed 
columns to exclude water. We have previously reported the solid state structure of a 
sodium iodide complex of the C12 lariat ether determined by X-ray diffraction.30 The 
lariat ether is organized in a bilayer structure with interdigitated alkyl chains. This 
provides evidence that these compounds are capable of forming assemblies similar 
to those formed by DNA and cationic lipids. Models of lamellar and columnar 
hexagonal phases were generated from C12 lariat ether (CSD: HUTGUY) and B-form 
DNA (PDB: 1BNA) structures (Figure 3.8). The ability to efficiently complex DNA 
may rely on the interdigitation of the alkyl chains. The shortest C4 and C6 chains 
offer little hydrophobic surface area for bilayer formation. The longest C16 and C18 
chains may possess too much conformational flexibility to efficiently pack or they 
may preferentially form assemblies excluding DNA through rapid aggregation.  
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Figure 3.8. Proposed models of lamellar (top) and inverted columnar 
hexagonal (bottom) assemblies of DNA with C12 lariat ether. 
 
3.2.3. Electron microscopy of a benzyl C14 hydraphile•DNA complex. 
An electron microscopy study was performed in order to probe the morphology of 
the benzyl hydraphile•DNA complex. Benzyl C14 hydraphile and plasmid DNA were 
mixed, the complex was diluted with dH2O, and adsorbed to a formvar-coated lacey 
carbon copper grid. Uranyl acetate was used as the counter-stain. Figure 3.9 shows a 
representative image.  Semi-spherical particles were observed by a transmission 
electron microscopy; the particles appeared to reside predominantly at the edges of 
the lacey carbon support. The particles showed a similar morphology and diameters 
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of ~100-150 nm. The density of the particles appeared to be constant. These results 
suggest that the particles are aggregates of hydraphile and DNA rather than having a 
vesicular structure. 
 
Figure 3.9. Transmission electron micrograph of benzyl C14 
hydraphile•plasmid DNA particles. The particles are semispherical 
in morphology, ~100-150 nm diameter, and reside at the edges of 
the web-like lacey carbon support. 
 
3.3. Conclusion. 
The use of gel electrophoresis has permitted an evaluation of lariat ether and 
hydraphile binding of DNA. This work shows that the complexation of plasmid DNA 
by benzyl hydraphiles and lariat ethers is dependent on both the protonation state 
and the hydrophobic character of the amphiphiles. Large aggregates form as shown 
by electron microscopy, which revealed spherical particles of fairly uniform size 
(~1,000-1,500 A ) and density. The complex could be deaggregated as shown by 
disruption experiments using the anionic surfactant sodium dodecyl sulfate. An 
additional electrophoretic mobility study demonstrated that the same surfactant can 
inhibit complex formation as can the presence of competing polyamines such as 
spermine. Further studies are underway to characterize the dynamics of complex 
formation with an eye toward the transport of genetic material into viable cells. 
 
3.4. Experimental. 
3.4.1. Compounds used. Sodium dodecyl sulfate, sodium dodecanoate, Triton X-100, 
benzyltrimethylammonium chloride, dodecyltrimethylammonium chloride, 
spermine, and spermidine were purchased from Sigma-Aldrich and used as received. 
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The C4-C18 lariat ethers were prepared as previously reported (36). Benzyl C8-C14 
hydraphile compounds were prepared as previously reported (24). 
 
3.4.2. Plasmid DNA. pKLMF-FX (10 kb) was obtained from New England Biosciences 
and amplified in JM109 E. coli (Promega cat. #2005). The plasmid was extracted 
using a ZyppyTM Plasmid Maxiprep Kit (cat. #D4027) and then further purified by 
ethanol precipitation in the presence of NaCl, LiCl, or KCl and dissolved in 18.2 MΩ 
water. The sodium DNA salt was used in nearly every case. 
 
3.4.3. Agarose gel electrophoresis. Gel retardation assays were carried out in 0.5% 
agarose gels and run in various buffers. Gels were run at 105 ± 4 V for 2.5 h in borate 
buffers and 1.5 h in tris buffers unless noted otherwise. In each experimental sample 
20 ng/μL aqueous plasmid DNA (no buffer) was mixed with an equal volume of the 
compound of interest in DMSO and incubated for 15 min at room temperature 
before being transferred to the well. These samples did not receive loading dye. Each 
gel included 1 kb DNA ladder (Promega) controls that included loading dye. Gels 
were stained with 2 μg/mL ethidium bromide for 15 m and destained in running 
buffer without dye for 5 m before visualization on a UV transilluminator. 
 
3.4.4. Transmission electron microscopy (TEM). Amphiphile•DNA complexes were 
prepared as described for agarose gel electrophoresis and then diluted 10-fold with 
pure water. A 10 μL sample was applied to lacey formvar/carbon 300 mesh copper 
TEM grids (Ted Pella, Inc.) for 60 seconds and the grid was washed with 18.2 MΩ 
H2O (30 s), stained with 2 % uranyl acetate (30 s), and washed twice with H2O (15 s 
each). The above solutions were applied at a volume of 10 μL, wicked away between 
each application, and the grid was finally dried with a gentle N2 stream. Specimens 
were examined on a JEOL JEM-2000 FX transmission electron microscope operated 
at 300 keV.  
 
3.5. References.
 
1 Micklos, D.A.; Freyer, G.A.; Crotty, D.A. DNA Science; 2 ed.; Cold Spring Harbor 
Laboratory Press: Cold Spring Harbor, NY, 2003. 
2 Yelle, J.; Dion, M.; Hamelin, C. Efficient transfection of mammalian cells with 
viral DNA in optimal culture conditions. J. Virol. Methods 1983, 7, 321-326. 
3 (a) Zabner, J.; Fasbender, A.J.; Moninger, T.; Poellinger, K.A.; Welsh, M.J. 
Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. 
Chem. 1995, 270, 18997-19007. (b) Dalby, B.; Cates, S.; Harris, A.; Ohki, E. C.; 
Tilkins, M.L.; Price, P.J.; Ciccarone, V.C. Advanced transfection with 
 
 
47 
 
 
Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput 
applications. Methods 2004, 33, 95-103. 
4 Karasev, A.V.; Foulke, S.; Wellens, C.; Rich, A.; Shon, K.J.; Zwierzynski, I.; Hone, 
D.; Koprowski, H.; Reitz, M. Plant based HIV-1 vaccine candidate: Tat protein 
produced in spinach. Vaccine 2005, 23, 1875-1880. 
5  Felgner, P.L.; Gadek, T.R.; Holm, M.; Roman, R.; Chan, H.W.; Wenz, M.; 
Northrop, J.P.; Ringold, G.M.; Danielsen, M. Lipofection: a highly efficient, 
lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U S A 1987, 
84, 7413-7417. 
6  Inoue, Y., Gokel, G.W., Eds.; Cation Binding by Macrocycles; Marcel Dekker: 
New York, 1990. 
7  Xie, Q.; Gokel, G.W.; Hernandez, J. C.; Echegoyen, L. Efficient Sodium Cation 
Transport Across Liposome Membranes Using Synthetic Carriers. J. Am. 
Chem. Soc. 1994, 116, 690-696. 
8  (a) Pajewski, R.; Ferdani, R.; Schlesinger, P.H.; Gokel, G.W. Chloride 
complexation by heptapeptides: influence of C- and N-terminal sidechains 
and counterion. Chem. Commun. 2004, 160-161. (b) You, L.; Ferdani, R.; 
Gokel, G.W. Chloride Ion Efflux from Liposomes is Controlled by Sidechains in 
a Channel-forming Heptapeptide. Chem. Commun. 2006, 603-605. 
9  (a) Gokel, G.W.; Dishong, D.M.; Diamond, C.J. Lariat Ethers. Synthesis and 
Cation Binding Properties of Macrocyclic Polyethers Possessing Axially 
Disposed Secondary Donor Groups. J. C. S. Chem. Commun. 1980, 1053-1054. 
(b) Leevy, W.M.; Weber, M.E.; Gokel, M.R.; Hughes-Strange, G.B.; Daranciang, 
D.D.; Ferdani, R.; Gokel, G.W. Correlation of bilayer membrane cation 
transport and biological activity in alkyl-substituted lariat ethers. Org. 
Biomol. Chem. 2005, 3, 1647-1652. 
10  Gokel, G.W. Hydraphiles: Design, Synthesis, and Analysis of a Family of 
Synthetic, Cation-Conducting Channels; Chem. Commun. 2000, 1-9. 
11 Sewbalas, A.; Islam, R.U.; van Otterlo, W.A.L.; de Koning, C.B.; Singh, M.; 
Arbuthnot, P.; Ariatti, M. Enhancement of transfection activity in HEK293 
cells by lipoplexes containing cholesteryl nitrogen-pivoted aza-crown ethers, 
Med. Chem. Res. 2013, 22, 2561-2569. 
12 Gokel, G.W.; Hernandez, J.C.; Viscariello, A.M.; Arnold, K.A.; Campana, C.F.; 
Echegoyen, L.; Fronczek, F.R.; Gandour, R.D.; Morgan, C.R.; Trafton, J.E.; 
Minganti, C.; Eiband, D.; Schultz, R.A.; Tamminen, M. Steroidal Lariat Ethers: A 
New Class of Macrocycles and the Crystal Structure of N-
(Cholesteryloxycarbonyl)aza-15-crown-5, J. Org. Chem. 1987, 52, 2963-2968. 
13  Echegoyen, L.E.; Hernandez, J.C.; Kaifer, A.; Gokel, G.W.; Echegoyen, L. 
Aggregation of Steroidal Lariat Ethers: The First Example of Nonionic 
 
 
48 
 
 
Liposomes (Niosomes) formed from Neutral Crown Ether Compounds, Chem. 
Commun. 1988, 1988, 836-837. 
14  Meisel, J.W.; Gokel, G.W. A Simplified Direct Lipid Mixing Lipoplex 
Preparation: Comparison of Liposomal-, Dimethyl Sulfoxide-, and Ethanol-
Based Methods. Scientific Reports, 2016, In Press.  
15 (a) Murillo, O.; Watanabe, S.; Nakano, A.; Gokel, G.W. Synthetic models for 
transmembrane channels: Structural variations that alter cation flux. J. Am. 
Chem. Soc. 1995, 117, 7665-7679. (b) Gokel, G.W.; Murillo, O. Synthetic 
organic chemical models for transmembrane channels. Acc. Chem. Res. 1996, 
29, 425-432. 
16  (a) Gokel, G.W.; Barbour, L.J.; Ferdani, R.; Hu, J. Lariat ether receptor systems 
show experimental evidence for alkali metal cation-pi interactions. Acc. 
Chem. Res. 2002, 35, 878-886. (b) Elliott, E.K.; Hu, J.; Gokel, G.W. The 
Fluorescence Properties of Free and Cation-complexed Lariat Ethers having 
Sidearms Terminated by a Benzene Ring. Supramol. Chem. 2007, 19, 175-
183. 
17 Muñoz, S.; Mallén, J.V.; Nakano, A.; Chen, Z.; Echegoyen, L.; Gay, I.; Gokel, G.W. 
Lariat ether bola-amphiphiles: formation of crown ether based bola-
amphisomes. Chem. Commun. 1992, 520-522. 
18  Gokel, G.W.; Trafton, J.E., Cation Binding by Lariat Ethers. In Cation Binding by 
Macrocycles; Gokel, G. W.; Inoue, Y., Eds. Marcel Dekker, Inc.: New York, 1990; 
pp. 253-310. 
19  Gokel, G.W.; Echegoyen, L., Lariat Ethers in Membranes and as Membranes. In 
Advances in Bio-organic Frontiers; Dugas, H., Ed. Springer Verlag: Berlin, 
1990; pp. 116-141. 
20 Weber, M.E.; Schlesinger, P.H.; Gokel, G.W. Dynamic Assessment of Bilayer 
Thickness by Varying Phospholipid and Hydraphile Synthetic Channel Chain 
Lengths. J. Am. Chem. Soc. 2005, 126, 636-642. 
21  Shabany, H.; Murray, C.L.; Gloeckner, C.A.; Grayson, M.A.; Gross, M.L.; Gokel, 
G.W. Evidence for multiple alkali metal cation complexation in membrane-
spanning ion transporters. Chem. Commun. 2000, 2375-2376. 
22 UniProt: The Universal Protein Resource. 
http://www.uniprot.org/taxonomy/568094. (accessed March 31, 2016). 
23 Gokel, G.W. Lariat Ethers: From Simple Sidearms to Supramolecular System; 
Chem. Soc. Rev. 1992, 21, 39-47. 
24  Curvey, N.S.; Luderer, S.E.; Walker, J.K.; Gokel, G.W. Improved Syntheses of 
Benzyl Hydraphile Synthetic Cation-conducting Channels. Synthesis 2014, 46, 
2771-2779. 
 
 
49 
 
 
25 Arnold, K.A.; Hernandez, J.C.; Li, C.; Mallen, J.V.; Nakano, A.; Schall, O.F.; 
Trafton, J.E.; Tsesarskaja, M.; White, B.D.; Gokel, G.W. Analysis of sodium, 
potassium, calcium, and ammonium cation binding selectivity in one- and 
two-armed nitrogen-pivot lariat ethers. Supramol. Chem. 1995, 5, 45-60. 
26 Hernandez, J.C.; Trafton, J.E.; Gokel, G.W. A Direct Comparison of Extraction 
and Homogeneous Binding Constants as Predictors of Efficacy in Alkali Metal 
Cation Transport. Tetrahedron Lett. 1991, 6269-6272. 
27 Murray, C.L.; Gokel, G.W. Cation flux dependence on carbon chain length in 
tris(macrocycle) channels as assessed by dynamic 23Na NMR studies in 
phospholipid bilayers, Chem. Commun. 1998, 2477-2478. 
28 LePecq, J.B.; Paoletti, C., A fluorescent complex between ethidium bromide 
and nucleic acids. Physical-chemical characterization, J. Mol. Biol. 1967, 27, 
87-106. 
29 Gokel, G.W. Crown Ethers and Cryptands; The Royal Society of Chemistry: 
London, England, 1991; Vol. 3. 
30  De Wall, S.L.; Barbour, L.J.; Gokel, G.W. Solid state bilayer formation from a 
dialkyl-substituted lariat ether that forms stable vesicles in aqueous 
suspension. J. Phys. Org. Chem. 2001, 14, 383-391. 
31 Martin, R. Gel Electrophoresis: Nucleic Acids; Bios Scientific Publishers: 
Oxford, 1996, 175 pp. 
32  Zhang, J.; Wang, F.; Wang, T. A simple and effective SuperBuffer for DNA 
agarose electrophoresis, Gene 2011, 487, 72-74. 
33  Evans, H.C. Alkyl sulfates. I. Critical micelle concentrations of the sodium 
salts. J. Chem. Soc. 1956, 579-586. 
34  Safinya, C. Structures of lipid–DNA complexes: supramolecular assembly and 
gene delivery. Curr. Opin. Struct. Biol. 2001, 11, 440-448. 
35  Rädler, J.O., Koltover, I., Salditt, T.; Safinya, C.R. Structure of DNA–cationic 
liposome complexes: DNA intercalation in multilamellar membranes in 
distinct interhelical packing regimes. Science 1997, 275, 810-814. 
36 Gatto, V.J.; Arnold, K.A.; Viscariello, A.M.; Miller, S.R.; Morgan, C.R.; Gokel, G.W. 
Synthesis and binding properties of bibracchial lariat ethers (BiBLEs): survey 
of synthetic methods and cation selectivities; J. Org. Chem. 1986, 51, 5373-
5384. 
 
 
  50 
Chapter 4  
De Novo Design, Synthesis, and Biophysical Characterization of 
Bis(aminoamides) that Bind and Condense Plasmid DNA 
 
4.1. Introduction. 
Since the report by Crabtree and his collaborators1 that relatively simple tris-arene 
compounds such as isophthalic acid dianilide can bind chloride and bromide ions, a 
vast literature has emerged in the area of anion receptors.2 Sessler, Anslyn, and their 
coworkers reported hundreds of compounds limited to binding phosphorylated 
molecules.3 Two monographs have recently dealt with the enormous interest in 
anion complexation.4,5  
 
The initial interest in halides in the Gokel laboratory was their transport through 
bilayers. A family of synthetic anion transporters (SATs)6 was developed that 
selectively transported Cl¯ through both liposomal7 and vital cellular membranes.8 
Computational studies by Burkhardt, Skelton, and Fried9 confirmed the dimer10 
nature of the functional channel. Detailed NMR studies showed that two of the seven 
amino acid amide NH residues were key as H-bond donors to chloride in solution.11 
This piqued interest in assessing whether relatively simple peptides could function 
as Cl¯ complexing agents. Indeed, the SATs having Gly3-Pro-Gly3 peptide sequences 
were competitive with the Crabtree tris-arenes in binding strength,12 although the 
nature of the countercation clearly played a role as well.13 
 
Since the binding of the heptapeptide SATs and the Crabtree tris-arenes was similar 
in strength, previous colleagues in the Gokel laboratory attempted unsuccessfully to 
develop Cl¯-selective channels based on that module. Instead, it was found that 
appropriately-substituted tris-arenes could form pores that showed the open-close 
behavior characteristic of channels.14 It was observed in a spectroscopic study 
designed primarily to assess halide ion complexation by dipicolinamides and 
isophthalamides that binding of H2PO4¯ was visible to the eye.15 The success with 
peptides and phosphates suggested that amino acid derivatives mimicking some 
features of the Crabtree tris-arenes might bind the phosphates of DNA. The notion 
was that complexation between anion-selective binders might surround and 
condense DNA. This is an important prerequisite for both transformation of bacteria 
or transfection of higher cells.  
 
Lessons from the burgeoning field of anion supramolecular chemistry provided a 
framework for the investigation of novel structures capable of binding and 
condensing DNA. Previous work elaborated in Chapter 2 of this thesis showed that 
known liposomal-based transfection reagents could be brought to interact with DNA 
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and transfect cells without forming the liposome intermediate. The new procedure 
provided the means to test chemicals that do not readily form liposomes and that 
may not be water soluble. This method was utilized to characterize the interaction 
of diaza-18-crown-6-based amphiphiles with DNA, reported in Chapter 3. A 2002 
report by Bloomfield and coworkers showed that protonated simple primary 
amines with normal alkyl chains can bind and condense DNA.16 This served as the 
inspiration for the work described in this chapter: a determination of the minimal 
structural features required for DNA binding and condensation and the 
development of a new class of DNA binding small molecules. The primary goal of 
this work was to address whether a more diverse range of chemical structures, 
outside the canonical cationic lipids and cationic polymers, are suitable for more 
efficient and less toxic in vitro transfection. Better transfection reagents for cultured 
cells may then progress to in vivo applications and ultimately gene therapy in 
humans to treat disease.  
 
4.2. Results and Discussion. 
4.2.1. DNA binding and condensation by simple amines measured by agarose gel 
electrophoresis. Preliminary to the design of novel DNA-condensing molecules, 
several DNA binding studies were undertaken with the goal of identifying the 
minimal structural characteristics required for DNA binding. Primary and secondary 
linear-chained amines were tested as were α,ω-diamino-n-alkanes and 
phenylenediamines (Figure 4.1). All compounds were tested as the hydrochloride or 
dihydrochloride salts. Our model plasmid was pKLMF-FX (9.988 kb, New England 
Biolabs) and was purified as the sodium salt by ethanol precipitation. While 
oligonucleotides have seen increasingly widespread use in biological research and 
as a therapeutic strategy,17 the binding and transport of oligonucleotides is beyond 
the scope of these studies.   
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Figure 4.1. Simple amines tested for DNA binding and condensation. 
 
The simple amines were tested by using agarose gel electrophoresis. Amines of 
varying chain lengths were screened at two concentrations: 50 and 17 molar 
equivalents of molecule to DNA phosphate. Based on findings described in Chapter 1 
electrophoretic studies, it was observed that the cationic lipid DOTAP condensed 
DNA and fully retained it in the well at 1-2 equivalents. Because we are screening for 
DNA interaction, we chose 50 equivalents as the maximum amount of compound 
where DNA retention on the gel can be considered a specific interaction with DNA 
rather than non-specific aggregation. The results can be seen in Figure 4.2. The 
shortest C6 n-alkyl primary amine did not retain DNA to any appreciable extent. The 
intermediate length C12 chain retained some DNA, but streaking was observed at 50 
equivalents. The longest C18 chain fully retained DNA at both concentrations. That 
these simple compounds could bind and condense DNA suggests minimally two 
structural requirements for DNA condensation: a positively charged group that 
confers affinity to the negatively charged DNA phosphates, and a self-associative 
moiety to drive reagent-reagent interactions. In this case the self-association is 
through the exclusion of solvent from the hydrophobic tails. The dependence on 
chain length demonstrates that there is a certain degree of self-association 
necessary to form the condensed DNA-reagent particle. This may manifest in the 
thermodynamic contribution of entropy by the release of solvent from the 
hydrophobic surface. However, it may also be related to the geometry of how the 
reagent packs with DNA to form an organized particle. To the extent that either of 
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these is true, we are unable to form any specific conclusions from electrophoretic 
experiments alone. 
 
Secondary amines possessing two n-alkyl chains of identical length showed a similar 
trend in electrophoretic DNA retention. As was the case with single-chained primary 
amines, the shortest C6-chained secondary amines were also unsuccessful at 
retaining DNA in the well. However, some streaking of the DNA was observed, which 
indicates that an interaction between the reagent and the DNA did occur. Unlike the 
primary C12 amines, the secondary C12 amine did retain DNA in the well. The 
increase in DNA interaction is likely due to the increase in hydrophobic surface area 
of the twin chains compared to the single chained primary amine, and therefore the 
entropic contribution to DNA condensation was increased. We could also say that 
the self-association of the twin chains is higher than amines of the same length less 
one chain. Once again, we cannot eliminate the contribution of the geometry of the 
reagent. The twin-chained analog is more conical with a wider hydrophobic area 
compared to the more cylindrical primary amine. 
 
 
Figure 4.2. Agarose gel electrophoresis of primary and secondary 
amines with 10 kb plasmid DNA. The breaks in the gel arose from the 
accidental inversion of two samples during loading; the results are 
from a single gel, the lanes were switched back to their intended 
positions for clarity. 
 
We identified two requirements for small molecule reagents that bind and condense 
DNA: positive charge and self-association. The self-associative nature of aliphatic 
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carbon chains can be increased or decreased by changing the number of carbons in 
the chain. With this information in hand, we wondered whether other structural 
motifs were sufficiently self-associative to condense DNA. Our first consideration 
was inspired by the base pairs in DNA. DNA uses planar aromatic heterocycles—the 
nitrogenous bases adenine, thymine, guanine, and cytosine—to promote the 
assembly of the two helical strands. This is driven by hydrogen bonding, pi-pi 
stacking, and the exclusion of water from hydrophobic surfaces. All of these forces 
are individually weak, but collectively strong. Therefore, we tested aromatic 
structures that contained amino groups that could be protonated. The two 
structures on the right of Figure 4.2 are the hydrochloride salts of benzylamine and 
tryptamine. These compounds did not strongly interact with DNA, however, 
tryptamine did show streaking at 50 equivalents, suggesting that it has some 
interaction with DNA and that perhaps the indole functional group is more efficient 
at self-association than the phenyl group. 
 
Aromatic diamines were tested for their interaction with plasmid DNA. 
Phenylenediamines with the amino groups ortho, meta, or para were tested as the 
dihydrochloride salts. The results are shown on the left of Figure 4.3. While the DNA 
was not retained in the well, the migration of the DNA has changed. For each 
compound a slower-moving band appears. We had previously shown (Chapter 1) 
using a DNA-nicking enzyme that the slower-moving band represents an open-
circular form of the DNA. This is typically caused by enzymatic or chemical 
hydrolysis of the phosphate backbone in one strand of the DNA. In the case of the 
phenylenediamine dihydrochlorides the DNA nicking is caused by acid catalyzed 
hydrolysis. The pK1 and pK2 respectively for the diprotonated phenylenediamines 
are ortho = 0.80, 4.57; meta = 2.50, 5.11; para = 2.97, 6.31.18 Clearly these are quite 
acidic compounds. From these results we can conclude that protonated arylamines 
are unsuitable as DNA binding agents on their own because they are not sufficiently 
charged at a pH compatible with DNA stability.  
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Figure 4.3. Agarose gel electrophoresis of aryl and alkyl diamines 
with 10 kb plasmid DNA. 
 
In addition to primary and secondary n-alkyl amines, we tested α,ω-diaminoalkanes. 
While the former examples are typical amphiphiles with a polar head group and 
hydrophobic tail, the latter is an example of a simple bolaamphiphile. 
Bolaamphiphiles consist of two polar headgroups separated by a hydrophobic 
connecter.19 The name originates from the South American throwing weapon—the 
bola—that consists of two weights on opposing ends of a rope. The length (CH2)n of 
the carbon chain tested included n = 3, 4, 6, 9, and 12. All of the compounds were 
soluble in water and none of them showed an interaction with DNA. Furthermore, 
none of these compounds showed DNA nicking or hydrolysis. This confirms that the 
diaminoalkanes, with a higher pKa than the phenylenediamines, do not increase the 
acidity of the DNA-reagent solution and do not hydrolyze the phosphate backbone. 
 
In summary, several classes of simple amines were tested for binding and 
condensation of DNA by agarose gel electrophoresis. All amines were tested in their 
protonated state as hydrochloride salts. Monoamines of sufficient n-alkyl carbon 
chain length were capable of retarding the migration of DNA in electrophoresis. 
Twin-chained amines were better than single-chained amines of the same chain 
length. Amines with aromatic groups (benzylamine and tryptamine) did not interact 
significantly with DNA. Aromatic diamines did not interact with DNA, but did give 
up their protons in solution to result in acid-catalyzed phosphate backbone 
hydrolysis. Aliphatic diamines with up to 12 carbons were unsuccessful at 
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condensing DNA but did not catalyze DNA strand hydrolysis. The results from this 
study emphasize the importance of charge and reagent self-association in DNA 
binding and condensation. The amphiphilic linear amines can be considered simple 
approximations of the cationic lipids already known to bind, condense, and transfect 
cells with plasmid DNA. 
 
4.2.2. Structure-based design of novel DNA binding agents using molecular modeling. 
With a general plan for developing DNA binding small molecules, a structural 
analysis of the DNA helix was performed. This was done primarily using molecular 
modelling software (Mercury, CCDC) and a crystal structure of B-form DNA (PDB: 
1BNA20), which is one of the dominant forms of DNA alone and in lipoplexes.21 
Figure 4.4 shows the canonical antiparallel DNA double helix. Highlighted in green 
are the distances between phosphates across the major groove (16.112 Å), minor 
groove (9.133 Å) and between neighboring phosphates on the same strand (6.340 
Å). These values represent precise distances measured in the crystal. Of course, 
solution-phase DNA is expected to be much more flexible. The average of the major 
and minor groove interphosphate distances is 12.6 Å, roughly twice the distance 
between adjacent phosphates on the backbone. We aimed to incorporate these 
distances into our DNA binding molecules. 
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Figure 4.4. Crystal structure of a 12 base pair B-form DNA double 
helix (PDB: 1BNA). Interphosphate distances for the major groove 
(16.112 Å), minor groove (9.133 Å) and neighboring intrastrand 
phosphates (6.340 Å) are shown. 
 
The DNA-binding and transfection literature is replete with many examples of 
cationic lipid and lipid-like molecules. In the previous section we demonstrated that 
only a positively charged head group and a hydrophobic chain is necessary to 
efficiently bind and condense DNA. Therefore, we sought to identify different modes 
of DNA binding and condensation. We surmised that a doubly charged molecule of 
appropriate positive charge spacing could bridge inter- or intrastrand phosphates. 
Therefore, we proposed a general structure of N+—spacer—N+. While the 
phenylenediamine molecules did not bind DNA, we chose to use these as the spacer 
for four main reasons: 1) they are inexpensive and commercially available, 2) they 
are rigid compared to aliphatic spacers, 3) they are aromatic and hydrophobic, so 
self-association may occur by stacking and solvent exclusion mechanisms, and 4) 
ortho, meta, and para spacers can be used to vary the spacer length and charged 
group orientation. 
 
 
 
  58 
With a spacer in mind, we then had to choose an appropriate cationic group. Amino 
acids were the immediate choice for a number of reasons. Amino acids are 
commercially available, with a wide variety of chemical functionalities, and with a 
vast history of protecting group22 and synthetic23 strategies. We envisioned 
connecting the carboxy terminus of the amino acid to the phenylene diamine by 
amide bond formation. This would require a protected amino terminus to prevent 
polymerization. We would then deprotect the amino terminus to form the free 
amine, which can be protonated to form a positively charged ammonium group. The 
formation of an amide was desirable because they are generally stable under 
physiological conditions and they offer additional hydrogen bond donor (N-H) and 
acceptor (C=O) moieties. In order to understand the expected orientation of the 
aminoamide structure, a CCDC Crystal Structure Database survey of molecules 
containing the -NHC(O)CH2NH3+ group was performed. Over 150 structures were 
identified and every structure had the same three-dimensional orientation: the 
amide was always the trans isomer (nearly always the case for secondary amides) 
and the ammonium group was always syn-periplanar to the carbonyl oxygen despite 
its ability to freely rotate (see Figure 4.5). 
 
 
Figure 4.5. Possible conformations of protonated aminoamides. All of 
the 158 matching structures in the CCDC CSD survey were syn-amino, 
trans-amides (far left).  
 
We quickly realized that even if our design was limited to symmetrical structures 
using the 20 common L-amino acids and the three regioisomers of 
phenylenediamine, the 60 possible compounds (not including protected 
intermediates) was a daunting synthetic challenge. So we decided to first narrow 
our linker to a single isomer of phenylendiamine.  
 
First, the ortho, meta, and para bis(glycylamido)benzene structures were built using 
CPK models (Harvard Apparatus) and the N+—N+ spacing was compared to a 4 base 
pair DNA double helix. While this may seem rather crude, the models are designed 
with the appropriate Van der Waals distances, bond lengths, and bond angles. 
Manual manipulation of the three isomers against the DNA model suggested that the 
meta isomer may be the most favorable. Perhaps the most useful observation with 
the models was the ortho structure is likely to form a cyclic hydrogen bond 
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(NH⋅⋅⋅O=C) between the amides. This eliminates the symmetry of the structure and 
more notably, reduces the N+—N+ spacing. 
 
Second, the protonated ortho-, meta-, and para-bis(glycylamido)benzene structures 
were modeled and minimized using molecular mechanics simulations (MM2, 
ChemBio3D Ultra 12.0) and N+—N+ spacing was compared. The major conformers 
are shown in Figure 4.6. Symmetric orientations of the meta isomer with amide 
protons syn,syn relative to the phenyl H2 (top left) and anti,anti (top right) show 
N+—N+ spacings (measured from proton to proton) of 13.1 Å and 11.8 Å, 
respectively. These distances are slightly above or below the average interstrand 
DNA phosphate spacing of 12.6 Å. The hydrogen bonded ortho isomer is shown in 
the bottom left of the Figure and has a shorter spacing of 9.2 Å. The para isomer is 
represented in the bottom right and has a longer spacing of 14.3 Å. These results 
seem to favor adoption of the meta isomer for preliminary investigations. 
 
 
Figure 4.6. Minimized structures of ortho, meta, and para-
bis(glycylamido)benzene isomers and measurements of the 
ammonium proton separation distance. 
 
Finally, a survey of the CCDC Crystal Structure Database for ortho-, meta-, and para-
bis(amido)benzene compounds was performed to identify the orientation and 
packing of amide bonds within these structures. The structures identified did not 
contain cationic residues. Most ortho isomers adopted the cyclic hydrogen bonded 
conformation shown in Figure 4.6 (bottom left). Most para isomers were also found 
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in the orientation shown in the Figure (bottom right) and formed hydrogen bonded 
planar sheets. The meta isomers were found in a variety of conformations, with the 
amides both as syn,syn and anti,anti (Figure 4.6, top left and right, respectively). The 
syn,anti conformation was also observed. The hydrogen bonding motifs also showed 
greater variation than the para isomers. Four examples of meta-bis(amido)benzene 
structures are shown in Figure 4.7. It should be noted that all of these structures are 
bis(benzamido)benzenes, which may contribute to different stacking than may be 
observed with bis(aminoamide)benzene. Intermolecular hydrogen bonding was 
observed between co-planar molecules (CSD: ATIQOJ) and between molecules in 
adjacent planes (CSD: ATIQID, VUXVIU). Non-traditional hydrogen bonding was also 
observed as aryl CH⋅⋅⋅O=C motifs (CSD: HITWEN) in anti,anti conformations. Our 
hope was that the various modes of supramolecular interactions observed would 
allow for additional contributions to the self-associative characteristic necessary for 
these compounds to condense DNA. In summary, manual molecular modeling, 
molecular mechanics simulations, and CCDC Crystal Structure Database survey 
results all suggested that the meta-phenylenediamine spacer ought to be chosen as 
our preliminary focus. 
 
 
Figure 4.7. Results of a CCDC CSD structural search for meta-
bis(amido)benzene structures. Syn,syn (far left) anti,anti (middle left 
and far right) and syn,anti (middle left) rotamers were observed with 
varying hydrogen bonding and stacking motifs. 
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Structural studies pointed to meta-phenylenediamine as the most suitable spacer 
for preliminary investigations. We then selected amino acids with different side 
chains to use in the synthesis of a small library of symmetrical receptors.   
 
4.2.3. Synthesis of bis(aminoamide)benzene DNA binding and condensing reagents. 
Amino acid side chains can be organized into 5 categories: polar negatively charged, 
polar positively charged, polar neutral, hydrophobic aromatic, and hydrophobic 
aliphatic. The 20 genetically encoded amino acids are shown in Figure 4.8. 
 
Our initial strategy was to choose and prepare compounds using at least one amino 
acid from each group. We chose not to prepare any structures with negatively 
charged side chains, as this would result in an overall neutral molecule that is 
unlikely to interact with DNA. Bis(aminoamides) of m-phenylenediamine were 
prepared using glycine, alanine, serine, threonine, proline, lysine, tryptophan, 
leucine, phenylalanine, and tyrosine. In most cases the α-amino group was protected 
by tertiary-butyl carbamate (Boc) groups.  
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Figure 4.8. The twenty genetically encoded amino acids at physiological pH. 
 
The Boc-protected amino acids were coupled to the diamine using N,N,N′,N′-
tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate (HBTU) and 
diisopropylethylamine in DMF. After workup and isolation of the desired Boc-
protected bis(aminoamido)benzene product, deprotection was carried out using 
either HCl or trifluoroacetic acid. Certain amino acid side chains required additional 
protecting groups as indicated in the experimental section. The various protection 
and deprotection reactions are described therein. The compounds prepared for the 
study are presented in Table 1. Regioisomers ortho-, meta-, and para-
bis(glycylamido)benzene, compounds 11, 12, and 13 respectively, were prepared 
for comparison to 1. 
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Compound Amino Acid R = Anion (A-) 
1 Gly -H Cl- 
2 L-Ala -CH3 Cl- 
3 L-Ser -CH2OH Cl- 
4 L-Thr -CH(OH)CH3 CF3COO- 
5 L-Pro -CH(CH2)3NH* CF3COO- 
6 L-Lys -(CH2)4NH2 2 CF3COO- 
7 L-Trp -CH2-1H-indol-3-yl Cl- 
8 L-Leu -CH2CH(CH3)2 Cl- 
9 L-Phe -CH2Ph Cl- 
10 L-Tyr -CH2Ph-4-OH Cl- 
11 Gly (ortho) H CF3COO- 
12 Gly (meta) H CF3COO- 
13 Gly (para) H CF3COO- 
 
Table 4.1. Chemical structures of synthesized compounds 1-13. 
*Proline contains a cyclic side chain.  
 
A shorthand nomenclature was developed in order to facilitate the identification of 
different structures. For example, compound 1 is abbreviated mPh-(Gly-HCl)2 and 
compound 6 is abbreviated mPh-(L-Lys-2TFA)2. 
 
4.2.4. Solid state structures. Three solid state structures were obtained for 
compounds 11 and 13 with different anions. The compounds were crystallized from 
different solvent compositions in the presence of different anions (see Experimental 
Section). The structures illustrate different conformational possibilities for this 
simplest of the compounds synthesized. In all three structures, the 
bis(glycylamido)benzene compound is essentially planar irrespective of its 
conformation or interaction with other molecules or with ions. Panel A of Figure 4.9 
shows two molecules of 11, which are present as the bromide salt. The two 
molecules, both in the anti,anti-conformation are separated by a molecule of 
methanol (solvent). An investigation of the packing showed that one of the 
ammonium groups forms hydrogen bonds with the amide oxygen lone pairs of the 
adjacent molecule. The other ammonium interacts with the bromide anion. 
 
Panel B shows 11 in the diamide anti,syn conformation. The counter anion in this 
case is trifluoroacetate, two of which are proximate to 11. In addition, a molecule 
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each of water and of acetonitrile are present in the crystal. In addition to 
ammonium-trifluoroacetate interactions, CH2NH3⋅⋅⋅O=C hydrogen bonds similar to 
the structure in Panel A are observed. Panel C shows a crystal structure of 13 in the 
anti,anti conformation with a H2PO4¯ anion and a molecule of water present in the 
crystal. It is interesting that in each crystal structure the ammonium interacts with 
both the amide oxygen and with the anion.  
 
Figure 4.9. Solid state structures of 9 crystallized from different solvent systems 
and in the presence of different anions. 
 
In each of these conformations, either amide NH bonds or ammonium cations (and 
NH bonds) are available to interact with DNA phosphates. In A, the distance 
between the distal ammonium proton atoms is 10 Å. In B, there are two potential 
interactions. The first is the ammonium to ammonium distance of 12 Å. The second 
is the syn NH and the more distant ammonium cation. This distance is 7 Å. In 
conformation C, the ammonium-ammonium distance is 14 Å and the ammonium to 
amide NH is 9 Å. These values are slightly lower than those predicted above (Figure 
4.6).   
 
4.2.5. Assessment of bis(aminoamide)-DNA binding by gel electrophoresis. Our key 
interest in the present study was to determine if these compounds could interact 
with DNA. If they bound to one or preferably two phosphates, they could screen the 
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charge. Self-association of the compound through hydrogen bonding or stacking 
could, in turn, lead to condensation and potentially to a vehicle for transfection. As a 
screening method, we again used agarose gel electrophoresis. In this experiment, 20 
ng/µL (60.6 µM DNA phosphates) 10 kb DNA plasmid (pKLMF-FX, New England 
Biolabs) is mixed with a specified amount of 1-13 in an equal volume of DMSO and 
pipetted into a well on the gel plate. A current is applied and the degree of DNA 
migration from the well is determined. To the extent the DNA charge is masked or 
compensated, migration will be minimized or prevented. A typical gel is shown in 
Figure 4.10 for compound 2 and the data obtained from the electrophoresis analysis 
is presented in Table 2. DNA-binding ability is assessed in two ways: 1) visual 
observation of the minimum concentration (expressed as equivalents) to retain DNA 
in the well (effective concentration of retention, ECret), and 2) denistometric analysis 
of the gel image by using ImageJ software (available from NIH) to determine the 
concentration (expressed as equivalents) at which DNA was 50% retained in the 
well (effective concentration for 50% retention, EC50).24 Serial dilutions are 
employed in the screening method starting from 50 equivalents and progressing 
with a dilution factor of ½. Therefore, the resolution for an ECret of x is typically 
+2x/-0.5x. The value for EC50 is extracted quantitatively from the binding curve 
generated by ImageJ analysis and therefore represents a more precise value. While 
up to 800 equivalents of compound to DNA phosphate was tested in the gel shown 
in Figure 4.10, we considered anything over 50 equivalents as very weak DNA 
binding agents and therefore inactive. 
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Figure 4.10. Agarose gel electrophoresis of 2 mPh-(L-Ala-HCl)2.  
 
The electrophoresis data presented in Table 4.2 demonstrate that certain 
bis(aminoamides) are capable of binding and condensing DNA. First, the role of the 
counter-anion deserves comment. The hydrochloride salt of the bis(glycylamido) 
compound 1 was found to weakly interact with DNA, retaining 50% of the DNA in 
the well at 37 molar equivalents of compound to DNA phosphate. However, the 
trifluoroacetate salt did not retain DNA under the same conditions. This may 
suggest that the compounds are better receptors for oxoanions than spherical halide 
ions. This may mean that they also have higher affinity for phosphate oxoanions. 
Initially, we suspected that the counter-anion would be solvent separated under the 
mixing conditions and therefore TFA and HCl were used interchangeably. Further 
work is underway to assess the role of the counter-anion and we have attempted to 
be cautious in our comparisons of different side-chained compounds when the 
counter-anions differ. 
 
The simple bis(glyicine) compound 1 showed minor DNA interaction. The 
bis(alanine) compound 2 has a methyl group on the amino acid α-carbon rather than 
a hydrogen. This prevented any additional interaction compared to 1. However, 
appending a hydroxyl to the methyl group increased DNA binding to an EC50 value of 
24 equivalents. We then explored the limitations of the hydrogen bond donor 
hydroxyl group by appending a methyl group to the β-carbon. This was achieved 
with the synthesis of the bis(threonine) analog 4. The additional methyl group 
inhibited DNA binding altogether. In an abundance of caution, we note that 4 is the 
trifluoroacetate salt, and the effect of the counter-anion is still being investigated. 
The bis(proline) compound is interesting in that the side chain is fused to the α-
amino group. This does not preclude rotation about the carbonyl carbon—α-carbon 
bond. A CCDC CSD survey of protonated prolinamides shows that the ammonium—
carbonyl relationship is, like protonated glycinamides, syn-perplanar. The 
bis(proline) compound 5 did not show DNA binding. A bis(lysine) compound 6 was 
prepared as well. This analog contains two additional positive charges and therefore 
ought to have greater affinity for the polyanionic DNA backbone. Compound 6 had 
moderately strong DNA binding and condensation activity, retaining 50% of DNA 
with 9.6 equivalents of the tetrakis(trifluoroacetate) salt. Compound 7, the 
bis(tryptophan) analog, was the most active of all compounds in this study, 
requiring only 4.1 equivalents to fully retain DNA. The TFA salt analog (not shown in 
the table) bound DNA with an ECret = 12.5 and EC50 = 7.2 equivalents. The difference 
caused by the counter-anion is appreciable. After obtaining these results, an effort 
was made to prepare only the hydrochloride salts.   
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Cpd. Structure ECret EC50 
1 mPh-(Gly-HCl)2 >50 37 
2 mPh-(L-Ala-HCl) 2 >50 >50 
3 mPh-(L-Ser-HCl) 2 50 24 
4 mPh-(L-Thr-TFA) 2 >50 >50 
5 mPh-(L-Pro-TFA) 2 >50 >50 
6 mPh-(L-Lys-2TFA) 2 25 9.6 
7 mPh-(L-Trp-HCl) 2 3.1 2.5 
8 mPh-(L-Leu-HCl) 2 >50 >50 
9 mPh-(L-Phe-HCl) 2 >50 >50 
10 mPh-(L-Tyr-HCl) 2 >50 >50a 
11 oPh-(Gly-TFA) 2 >50 >50 
12 mPh-(Gly-TFA) 2 >50 >50 
13 pPh-(Gly-TFA) 2 >50 >50 
 
Table 4.2. Summary of agarose gel electrophoresis results for the 
interaction of compounds 1-13 with 10 kb plasmid DNA. aMinor 
streaking resulting in ~20% DNA retention was observed for 10 at 50 
equivalents. 
 
The indole side chain in the strong DNA binding compound 7 is hydrophobic, 
aromatic, contains a N-H hydrogen bond donor, and can also participate in cation-π 
and π-π stacking interactions. In order to examine the extent to which any of these 
characteristics influence DNA binding, compounds 8-10 were prepared. The 
bis(leucine) compound 8 contains a hydrophobic side chain that is known to self-
associate in DNA-binding proteins in the canonical leucine zipper.25 If 
hydrophobicity was the primary self-associative characteristic driving strong DNA 
binding with 7, then we would expect the same from 8. However, no DNA binding 
was observed at 50 equivalents of 8. The role of a hydrophobic and aromatic side 
chain was probed with bis(phenylalanine) 9. This compound was also inactive up to 
50 equivalents. Finally, the role of a hydrophobic and aromatic side chain that also 
contains a hydrogen-bond donor was tested. It should be noted, however, that the 
location and directionality of the H-bond donor differs in tyrosine and tryptophan. 
The bis(tyrosine) compound 10 did not retain DNA at concentrations as high as 50 
equivalents. However, minor streaking resulting in approximately 20% retention 
was observed at 50 equivalents. This suggests that the phenolic-OH hydrogen bond 
donor improved DNA interaction compared to 9 but not to a great extent. A similar 
increase in DNA affinity was observed in bis(alanine) and bis(serine) compounds 2 
and 3 with the additional hydrogen bond donor –OH group in the latter structure. 
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Together, these results suggest that the indole side chain of 7 results in strong DNA 
binding for a reason other than simply being hydrophobic, aromatic, and containing 
an extra H-bond donor. 
 
A structural study of different characteristics of bis(tryptophan) 7 was undertaken 
to identify the requisite components for strong DNA interactions. Compounds 14 
and 15 are the ortho and para isomers of 7. While these compounds did interact 
with DNA, the retention was significantly lower than the meta regioisomer. This 
confirms that the modelling studies elaborated in Section 4.2.2 were informative. 
The role of stereochemistry was probed with 16, an enantiomer of 7 prepared with 
D-tryptophan rather than the naturally occurring isomer L-trp. The DNA binding 
was essentially unchanged. This suggests that the chirality of the molecule does not 
influence how it packs with the right-handed DNA double helix. Finally, mono-
tryptophan compound 18 and the uncharged deaminated compound 19 were 
synthesized and tested for DNA interaction. Compound 18 showed very weak 
interaction with DNA, however some streaking was observed at 50 equivalents. 
Compound 19 is prepared by condensation of indole-3-propionic acid (IPA) and 
meta-phenylenediamine. Absent the charged ammonium groups, 19 has low 
solubility in water and is observed to precipitate in the well. However, this 
precipitation does not affect the mobility of the DNA. This result emphasizes the 
necessity that the compound is both self-associative and has affinity for DNA, the 
latter of which is typically achieved through cationic ammonium groups.    
 
 
Cpd. Structure ECret EC50 
7 mPh-(L-Trp-HCl) 2 3.1 2.5 
14 oPh-(L-Trp-HCl) 2 50 11 
15 pPh-(L-Trp-HCl) 2 50 10 
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16 mPh-(D-Trp-HCl) 2 3.1 2.2 
17 Ph-(L-Trp-HCl)  >50 >50a 
18 mPh-(CH2CH2-1H-indol-3-yl) 2 >50b >50b 
Table 4.3. Structures and summary of agarose gel electrophoresis 
results for the interaction of compounds 14-18 with 10 kb plasmid 
DNA. aMinor streaking resulting in ~20% DNA retention was 
observed for 17 at 50 equivalents. 
 
The tryptophan compounds are intriguing for reasons in addition to the impressive 
DNA binding results. Tryptophan occurs in proteins with the lowest frequency of the 
20 genetically coded amino acids.26 Tryptophan is not found in the ubiquitous 
eukaryotic DNA-binding histone proteins.27,28 However a sequence of regularly 
spaced tryptophan residues is conserved in the myb DNA-binding proteins.29,30 The 
evolutionary persistence of the unusually high amount of tryptophan along with 
mutagenesis experiments31 demonstrates their importance to the DNA-binding 
ability of these proteins. The chemical environment of the tryptophans were shown 
to change upon DNA binding32. Interestingly, the tryptophans are flanked by 
positively charged amino acids, which are critical to the DNA binding function.33 
More recent crystallographic evidence shows that the tryptophans stabilize a helix-
turn-helix motif that organizes cationic lysine and arginine residues toward the 
DNA.34 Some tryptophan residues in the structure were shown to interact directly 
with the DNA major groove. A trp residue was also identified as crucial to the DNA 
binding mode in another well-known transcription cofactor, PC4.35 In the 2015 
report it was shown by crystallography that a trp to tyr mutation altered the DNA 
binding mode from a two-nucleotide to a single-nucleotide interaction. 
Interestingly, the tryptophan in these structures is in proximity to cationic residues, 
as was found in the myb family of DNA-binding proteins. A similar motif of 
tryptophan residues adjacent to positively charged amino acids has been employed 
in oligonucleotide-transfecting synthetic peptides.36,37 Tryptophan may also be 
capable of intercalating and stacking with DNA bases38, and at least one structural 
example of this occurs in a natural protein.39 
 
Just as important as the evidence of tryptophan’s role in DNA-binding is the well-
established observation that tryptophan is found near the polar-nonpolar interface 
of membrane-spanning proteins.40,41 NMR spectroscopic measurements suggest that 
this preference does not simply arise from the amphipathic nature of the indole side 
chain, rather more specific interactions of the aromatic π system including cation-π 
forces may also play a role.42 A 2002 report from the Gokel laboratory published in 
the Journal of the American Chemical Society demonstrated the versatility of the 
indole ring as a π-donor.43 Crown ethers with pendant indole groups were co-
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crystallized with sodium and potassium salts. Both the benzo and pyrrolo rings 
were found to form cation-π interactions. Another contribution to the tryptophan 
canon was made by the Gokel lab. Indole groups alkylated at the nitrogen or at the 
3-position were found to form vesicles in water when the aliphatic chain was of 
sufficient length.44,45 This discovery was relevant because the indole side chain of 
tryptophan was considered by most to be too hydrophobic to serve as a headgroup 
in a bilayer. When considered as a viable headgroup, the indolyl N-H was thought to 
be critical, yet the N-alkylated indoles surprisingly form stable vesicles. 
 
Before undertaking biophysical characterization of the bis(tryptophan)-DNA 
complex, we considered the toxicity and mutagenicity of the linker molecules. The 
cell possesses amidases that are capable of hydrolyzing amide bonds. Hydrolysis of 
the amino acids from the linker would result in the presence of phenylendiamine 
within the cell. A survey of toxicity studies found that 1,3-phenylenediamine is 
moderately toxic with an LD50 = 325 mg/kg in rat, and 290 mg/kg in mouse when 
administered by intraperitoneal injection.46 Other phenylenediamine isomers had 
similar toxicity. While these values do not represent an extraordinarily high risk of 
toxicity, we explored the use of other linkers. In 1,3-phenylenediamine the amino 
groups are separated by 3 carbons. However, altering the linker to 1,3-
diaminopropane would not alleviate toxicity concerns: LD50 = 177 mg/kg in rabbits 
by dermal application and LD50 = 308 mg/kg in rats by oral administration.47 In 
contrast, 1,4-diaminobutane (cadaverine) is considerably less toxic with LD50 = 
2000 mg/kg in rats administered orally.48 We therefore examined bis(aminoamide)s 
with aliphatic linkers. 
 
The DNA-binding ability of bis(tryptophan) compounds containing saturated 
hydrocarbon linkers was tested. The effect of chain length was investigated by 
preparing compounds 19-22, containing aliphatic spacers of 3, 4, 6, or 10 
methylenes. Their DNA interaction was assessed by gel electrophoresis. The gel 
image obtained by the standard process of staining with ethidium bromide and 
imaging by UV-transillumination is shown in Figure 4.11. The structures of 19-22 
and the results are summarized in Table 3, along with the DNA-binding results for 
compound 7, which bears a meta-phenylenediamine spacer. 
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Figure 4.11. Agarose gel electrophoresis image of bis(tryptophan) 
compounds with C3 (19), C4 (20), C6 (21), and C12 (22) methylene 
spacers. 
 
The C3 and C4 linked bis(trp) compounds 19 and 20 were moderate DNA-
condensation agents with similar EC50 values of about 40 equivalents. It is 
surprising that the longer-chained 21 was a worse DNA-binding molecule despite 
the potential for greater intermolecular hydrophobic interactions between C6 chains 
by the exclusion of water molecules. The longest chain tested was C12 (compound 
22), which showed dramatically stronger DNA-binding. The EC50 of 4.4 equivalents 
for 22 is on the order of the strong interactions observed with meta-
phenylenediamine-linked 7. The observation of moderate binding for shorter 
chains, poor binding for medium-length chains, and strong binding for longer chains 
suggest the existence of two modes of binding. Bis(tryptophan) compounds with 
aromatic or short aliphatic linkers may cause DNA condensation by interactions of 
proximate indole side chains. The meta-phenylene linker organizes the side chains 
into an optimal geometry for binding compared to ortho and para linkers. The short 
aliphatic linkers can access the preferred conformation, but lack the rigidity and 
additional stacking interactions conferred by the phenylene linkers. The C6 chain of 
21 is bulkier than the C3 and C4 chains and therefore inhibits the preferred 
formation accessible to 7, 20, and 21. The C6 linker is more hydrophobic than the 
shorter chains, but not to a degree sufficient to drive efficient condensation 
observed with the longest C12 linker of 22. C12-(L-Trp-HCl)2, compound 22, may be 
considered a bolaamphiphile. The tryptophan residues must play an important role 
in the DNA binding and condensation, as the linker itself did not show DNA 
condensation (see Figure 4.3 above). 
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Cpd. Structure ECret EC50 
7 mPh-(L-Trp-HCl) 2 3.1 2.5 
19 C3-(L-Trp-HCl) 2 50 38 
20 C4-(L-Trp-HCl) 2 50 37 
21 C6-(L-Trp-HCl) 2 >50 >50 
22 C12-(L-Trp-HCl) 2 6.25 4.4 
Table 4.4. Structures and summary of agarose gel electrophoresis 
results for the interaction of compounds 19-22 with 10 kb plasmid 
DNA. 
 
4.2.6. The effect of pH on the DNA-binding of a bis(tryptophan) and a bis(lysine) 
compound. An important component of our hypothesis for the DNA-binding and for 
the condensation mechanism of bis(aminoamide) compounds is the association of 
the cationic protonated α-amino group with the negatively charged DNA 
phosphates. The pKa of a typical amino group in an amino acid is around 9-10. In 
order to assay the role of protonation, agarose gel electrophoresis studies were 
performed under buffer conditions of pH 7.2 and pH 8.8. The compounds tested 
were a trifluoroacetate analog of 20 (23, C4-(L-Trp-TFA)2) and a bis(lysine) 
compound (24, C4-(L-Lys-2TFA)2). The resulting concentration-retention profiles 
are shown in Figure 4.12. 
 
Both 23, bis(trp) and 24, bis(lys) compounds are moderately strong DNA binding 
agents. The concentration-retention profile for the bivalent bis(tryptophan) 
compound is largely unchanged as pH is increased from 7.2 to 8.8. However, the 
tetravalent bis(lysine) compound is considerably affected by the increase in pH. It 
takes nearly four times as much 24 to retain DNA at pH 8.8 compared to pH 7.2. This 
suggests that protonation plays a much greater role in the mechanism of DNA 
condensation by 24 compared to compound 23. We hypothesize that the 
mechanism of DNA condensation for 24 involves binding the DNA and neutralizing 
its charge resulting in aggregation. While the protonated nitrogens are likely to play 
a large role in the condensation of DNA by 23, the compound also bears the indole 
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side chains. The data in Figure 4.12 suggest that the tryptophan residues play a 
large role in the self-association and resultant condensation of the DNA-complex. 
 
 
Figure 4.12. Concentration-retention profile for a tetramethylene 
linked bis(tryptophan) (top) and bis(lysine) (bottom) compounds 
tested at pH 7.2 and pH 8.8. 
 
4.2.7. Electron microscopy of the plasmid DNA complexes of a bis(tryptophan) and a 
bis(lysine) compound. Electron microscopy studies were undertaken to characterize 
the presumed complexes of 23, C4-(L-Trp-2TFA)2 and 24, C4-(L-Lys-2TFA)2 with 
plasmid DNA. Transmission electron microscopy (TEM) was used to assess the size 
and morphology of the particles. The compounds were mixed with plasmid DNA and 
then adsorbed to formvar-coated lacey carbon copper grids. The grids were then 
counterstained with uranyl acetate observed at 81,000X magnification. 
Representative micrographs are shown in Figures 4.13 and 4.14. 
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The bis(lysine) compound 24 with plasmid DNA formed spherical aggregates 
ranging from 50-150 nm in diameter (Figure 4.14). The particles did not have 
especially distinct borders, suggesting that their densities may vary at the particle 
surface, however the interior of the particle was regular in density. The complexes 
formed from bis(tryptophan) compound 23 were spherical and generally regular in 
size with a diameter of 150-250 nm (Figure 4.13). Unlike the particles formed from 
24, the tryptophan-derived particles varied in density throughout the structure. The 
spheres were observed to contain fibrils of denser material. These can be seen in the 
magnified insets of Figure 4.13. The width of the fibers is 4-5 nm, and they appear 
coiled and toroidal. This is consistent with supercoiled plasmid DNA in both size and 
morphology. These particles were examined in greater detail by scanning electron 
microscopy (SEM). 
 
Figure 4.13. Transmission electron micrographs of complexes of 23, 
C4-(L-Trp-2TFA)2 with 10 kb plasmid DNA counterstained with uranyl 
acetate. Black scale bars represent 100 nm, white scale bars represent 
25 nm. 
 
Figure 4.14. Transmission electron micrographs of complexes of 24, 
C4-(L-Lys-2TFA)2 with 10 kb plasmid DNA counterstained with uranyl 
acetate. Scale bars represent 100 nm. 
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The TEM grid from which the images in Figure 4.13 originated was sputter-coated 
with elemental gold and then observed by scanning electron microscopy. SEM is 
advantageous because of the greater depth of field obtained in the images than 
those from TEM. These images have three-dimensionality that makes it easier to 
examine certain structures in detail. Representative images from the SEM study are 
shown in Figure 4.15.  
 
   
Figure 4.15. Scanning electron micrographs of the of complexes of 
23, C4-(L-Trp-2TFA)2 with 10 kb plasmid DNA after gold sputter-
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coating. The top image and inset show particles on the surface of the 
copper grid. The bottom images show particles on the lacey carbon 
support. The white scale bar (top left inset) represents 200 nm. The 
scale bars in the bottom images represent 1 µm. 
 
The micrographs in Figure 4.15 show particles of the same size as the particles 
observed in the TEM study. The structures are spherical with a surface that consists 
of curvilinear articulations. In some cases these articulations appear as appendages 
protruding from the structure. It is likely that these features are the same ones 
observed as fibrils in Figure 4.13.  The fibrils are thicker than those observed by 
TEM. We attribute the thickness to a coating of the bis(tryptophan) compound. The 
bis(trp) aggregates are less dense than the DNA and therefore do not add to the 
appearance of the thickness of fibrils in TEM. The layer of gold from sputter-coating 
is likely too thin to create such a drastic increase in fibril thickness by itself. 
Together, these electron micrographs suggest that the compounds are binding DNA, 
presumably by charge interactions and cooperative exclusion of water, to form 
regularly sized nanoparticles. These nanoparticles may be too large or not 
sufficiently charged to migrate through an agarose gel. 
 
4.2.8. Circular Dichroism of a bis(lysine) compound with plasmid DNA. The influence 
of bis(aminoamide) binding on the helical structure of the plasmid DNA is unknown. 
Circular dichroism spectroscopy (CD) was used in order to determine if the helicity 
of DNA is influenced by binding and condensation with the bis(lysine) compound 
24. CD measures the differential absorption of circularly polarized light by chiral 
molecules or supramolecular systems. DNA typically exists in a right-handed helix 
(B-form) that has a characteristic CD absorption spectrum. Because CD is based on 
absorption phenomena, the spectrum is observed only over the range where the 
chromophore absorbs light. For DNA, this occurs with maximal intensity at 260 nm. 
Compound 24, C4-(L-Lys-2TFA)2, was chosen because it was shown to bind and 
condense DNA by agarose gel electrophoresis, the particles were characterized by 
TEM, and most importantly because it does not have any aromatic functional groups 
that overlap the characteristic DNA absorption signal centered at 260 nm. The 
results of a titration of plasmid DNA with 24 are shown in Figure 4.16. The addition 
of the bis(lysine) compound increases the intensity of the major absorption bands 
observed at 245 nm (negative ellipticity) and at 275 nm (positive ellipticity). 
Furthermore, a bathochromic shift of about 15-20 nm is observed for both 
absorption bands. This demonstrates that the bis(lysine) compound is interacting 
intimately with the plasmid DNA and induces a conformational change in its helical 
structure. While the binding mode for 24 may differ from other bis(aminoamide) 
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compounds, it may be inferred that those compounds could also bind and influence 
the DNA structure. 
 
 
Figure 4.16. The circular dichroism spectrum for the titration of 
plasmid DNA with 24, C4-(L-Lys-2TFA)2, from 0 equivalents 24 (bold 
green) to 10 equivalents 24 (bold blue). Addition of the bis(lysine) 
compound increased the ellipticity and induced a bathochromic shift 
in the DNA absorption bands to a negative maximum at 260 nm and 
positive maximum at 295 nm. 
 
4.2.9. Preliminary screening of bis(lysine) and bis(tryptophan) compounds for the 
transfection of human embryonic kidney (HEK-293) cells. A preliminary transfection 
experiment was conducted following the synthesis and structural and biophysical 
studies on bis(aminoamide)-DNA binding. Complexes of compounds 23 and 24 with 
plasmid DNA encoding a green fluorescent protein (EGFP) were tested by 
themselves and together with the cationic transfection lipid DOTAP (see Chapter 1) 
for transfection ability in HEK-293 cells. Only a limited concentration range was 
tested. No compounds showed transfection on their own and no observable 
enhancement of transfection with DOTAP was observed. Presently, no other 
compound described in this chapter has been tested as a transfection agent. 
 
4.3. Conclusion. 
The method described in Chapter 1 for the facile formation of a DNA-lipid complex 
was employed to examine the DNA-binding properties of simple alkyl and aryl 
amines and diamines. Two features were identified that promoted DNA-binding and 
condensation by small molecules: 1) DNA affinity by positively charged ammonium 
groups and 2) self-association of the DNA-binding agents through hydrophobic 
effects or other intermolecular forces. These concepts were applied in the design of 
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novel DNA-binding agents consisting of amino acids linked through their carboxy-
termini to a phenylenediamine spacer. The interaction of the synthesized 
bis(aminoamides) with DNA was assessed by agarose gel electrophoresis. In 
agreement with the initial design, the meta-phenylenediamine spacer provided the 
most effective geometry for DNA condensation. The amino acids lysine and 
tryptophan were identified as the most active in DNA-binding studies. A series of 
structurally related bis(tryptophan) compounds was prepared. Plasmid DNA 
complexes of bis(tryptophan) and bis(lysine) compounds linked by diaminobutane 
were characterized by electron microscopy. The resulting particles were on the 
order of 150 nm in diameter and fibrillary features exemplifying plasmid DNA were 
identified in the structure. The bis(lysine) compound was observed to influence the 
helicity of DNA by circular dichroism spectroscopy. Preliminary transfection 
experiments did not result in increased efficiencies in human embryonic kidney 
cells. Nevertheless, a novel strategy for developing non-lipidic small molecule DNA-
binding and condensation agents was elucidated. 
 
4.4. Experimental. 
4.4.1. Synthesis and characterization. The tert-butyl carbamate-protected (Boc-
protected) amino acids were coupled to the diamine using a uronium-based 
coupling reagent HBTU in DMF with diisopropylethylamine. After workup and 
isolation of the desired Boc-protected bis(aminoamide) product, deprotection was 
carried out using acid (HCl or trifluoroacetic acid) in methylene chloride. Certain 
amino acid side chains required additional protecting groups. Their deprotection 
reactions are described below. 
 
Serine. The bis(serine) compound used the benzyl carbamate (Cbz) nitrogen 
protecting group and the side chain hydroxyl was protected as the tert-butyl ether. 
The Cbz group was removed first by catalytic hydrogenation and the t-butyl group 
was removed by neat trifluoroacetic acid. The trifluoroacetate anion was exchanged 
for chloride using dowex 1 chloride exchange resin. 
 
Threonine. The bis(threonine) compound used the Boc nitrogen protecting group 
and the side chain hydroxyl was protected as the benzyl ether. The benzyl group 
was removed first by catalytic hydrogenation and the Boc group was then removed 
by trifluoroacetic acid in methylene chloride/methanol. 
 
Lysine. The bis(lysine) compounds used the Boc nitrogen protecting group on the α-
nitrogen and the side chain amine was protected with Cbz. The Cbz group was 
removed first by catalytic hydrogenation and the Boc group was removed by 
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trifluoroacetic acid in chloroform/methanol to give the tetrakis(trifluoroacetate) 
salt.  
 
General procedure A: coupling with HBTU. The tert-butyl carbamate-protected 
(Boc-protected) amino acids and HBTU (2.1 equivalents) were dissolved in 1o mL 
anhydrous DMF with diisopropylethylamine (4.0 equivalents for the neutral 
diamines; 6.0 equivalents for diaminedihydrochlorides). The reaction was stirred 
overnight at room temperature under an argon atmosphere. The mixture was taken 
up in 75 mL ethyl acetate and washed with 1 M NaHSO4 (2 x 75 mL), 5% NaHCO3 (3 
x 50 mL), and brine. The organic layer was dried by filtration through a 
MgSO4/celite plug and the solvent removed in vacuo. The Boc-protected bis(amino 
acid) was used without further purification or was crystallized/precipitated from 
CH2Cl2/hexane.   
 
General procedure B: Boc deprotection with HCl/dioxane. The Boc-protected 
bis(aminoamide) deprotection was carried out by using 10 equivalents of HCl in 
dioxane/methanol and the product was obtained by precipitation and trituration 
with cold methylene chloride. 
 
General procedure C: Boc deprotection with TFA. The Boc-protected 
bis(aminoamide) deprotection was carried out by using 10 or more equivalents of 
trifluoroacetic acid in methylene chloride or used neat. The product was obtained by 
removal of the solvent and TFA in vacuo. The product was used without further 
purification or recrystallized from methanol/chloroform/hexane. 
 
General procedure D: Cbz deprotection. The Cbz-protected amine was dissolved 
in absolute EtOH to which 0.1 molar equivalents of 10% Pd/C was added. The 
mixture was shook on a Parr shaker at 60 psi for 4h then filtered through celite and 
the solvent was removed in vacuo. 
 
General procedure E: ROtBu deprotection with TFA. See general procedure C. 
 
General procedure F: ROBn deprotection. See general procedure D. 
 
Di-tert-butyl ((1,3-phenylenebis(azanediyl))bis(2-oxoethane-2,1-
diyl))dicarbamate (1a) was prepared according to general procedure A using 1,3-
phenylenediamine (150 mg, 1.39 mmol) and Boc-Gly-OH. White powder (0.33 g, 
57% yield), mp 95°C (dec.). 1H-NMR (300 MHz, CDCl3): δ 1.44 (s, 18H, (CH3)3), 3.90 
(d, 4H, αCH2), 5.86 (m, 2H, Boc-NH), 7.12 (t, J = 7.2 Hz, 1H, phenyl H5), 7.23 (d, J = 
7.2 Hz, 2H, phenyl H4, H6), 7.64 (s, 1H, phenyl H2), 8.92 (s, 2H, PhNHCO-). 13C-NMR 
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(75 MHz, CDCl3): δ 28.27, 44.90, 80.28, 111.72, 116.02, 129.27, 138.00, 156.60, 
168.52. HRMS (FAB+): calcd for (C20H30N4O6) 422.2165, found 422.2163. 
 
2,2'-(1,3-phenylenebis(azanediyl))bis(2-oxoethanaminium) chloride (1) was 
prepared according to general procedure B using 1a (309 mg, 0.731 mmol). White 
powder (0.20 g, 94% yield), mp 310°C (dec.). 1H-NMR (300 MHz, D2O): δ 3.88 (s, 4H, 
αCH2), 7.14 (d, J = 8.1 Hz, 2H, phenyl H4, H6), 7.32 (t, J = 8.1 Hz, 1H, phenyl H5), 7.68 
(s, 1H, phenyl H2). 13C-NMR (75 MHz, D2O): δ 40.92, 113.72, 117.97, 129.92, 136.99, 
165.49. HRMS (FAB+): calcd for (C10H14N4O2Na) 245.1015, found 245.1014. 
 
Di-tert-butyl ((2S,2'S)-(1,3-phenylenebis(azanediyl))bis(1-oxopropane-2,1-
diyl))dicarbamate (2a) was prepared according to general procedure A using 1,3-
phenylenediamine (0.100 mg, 0.92 mmol) and Boc-L-Ala-OH. White powder (0.35 g, 
84% yield), mp 159-161 °C. 1H-NMR (300 MHz, CDCl3): δ 1.42 (d, J = 7.0 Hz, 6H, 
βCH3), 1.47 (s, 18H, (CH3)3), 4.37 (m, 2H, αCH), 5.31 (m, 2H, Boc-NH), 7.10 (m, 1H, 
phenyl H5), 7.19 (m, 2H, phenyl H4, H6), 7.60 (s, 1H, phenyl H2), 8.65 (s, 2H, 
PhNHCO-). 13C-NMR (75 MHz, CDCl3): δ 17.98, 28.35, 50.81, 80.46, 111.28, 115.50, 
129.16, 138.22, 156.13, 171.39, 188.71. 
 
 (2S,2'S)-1,1'-(1,3-phenylenebis(azanediyl))bis(1-oxopropan-2-aminium) 
chloride (2) was prepared according to general procedure B using 2a (105 mg, 0.23 
mmol). White powder (0.07 g, 93% yield), mp 195 °C (dec.). 1H-NMR (300 MHz, 
CD3OD): δ 1.60 (d, J = 7.0 Hz, 6H, βCH3), 4.08 (q, J = 7.0 Hz, 2H, αCH), 7.22-7.39 (m, 
3H, phenyl H4, H5, H6), 8.05 (m, 1H, phenyl H2). 13C-NMR (75 MHz, CD3OD): δ 17.89, 
51.06, 112.94, 117.34, 130.50, 139.86, 169.48. 
 
Dibenzyl ((2S,2'S)-(1,3-phenylenebis(azanediyl))bis(3-(tert-butoxy)-1-
oxopropane-2,1-diyl))dicarbamate (3a) was prepared according to general 
procedure A using 1,3-phenylenediamine (0.100 mg, 0.92 mmol) and Cbz-L-Ser-
(OtBu)-OH. White powder (0.61 g, 99% yield), mp 81-83 °C. 1H-NMR (300 MHz, 
CDCl3): δ 1.23 (s, 18H, OC(CH3)3), 3.50 (ABX, 2H, βCH2), 3.88 (ABX, 2H, βCH2),  4.44 
(ABX, 2H, αCH), 5.16 (s, 4H, OCH2Ph), 6.02 (m, 2H, Boc-NH), 7.20-7.37 (m, 13H, Cbz, 
phenyl H4-6), 7.86 (s, 1H, phenyl H2), 8.86 (s, 2H, PhNHCO-). 13C-NMR (75 MHz, 
CDCl3): δ 27.51, 54.94, 61.86, 67.27, 74.78, 111.23, 115.50, 128.26, 128.34, 128.65, 
129.81, 136.13, 138.26, 156.19, 168.56. 
 
(2S,2'S)-1,1'-(1,3-phenylenebis(azanediyl))bis(3-hydroxy-1-oxopropan-2-
aminium) 2,2,2-trifluoroacetate (3) was prepared by Cbz deprotection from 3a 
(360 mg, 0.54 mmol) according to general procedure D (0.16 g, 75% yield) followed 
by t-butyl ether deprotection by general procedure E. White powder(0.16 g, 77% 
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yield). 1H-NMR (300 MHz, CD3OD): δ 3.92-4.11 (m, 4H, βCH3), 4.22 (m, 2H, αCH), 
7.28-7.42 (m, 3H, phenyl H4, H5, H6), 8.09 (m, 1H, phenyl H2). 
 
Di-tert-butyl ((2S,2'S,3R,3'R)-(1,3-phenylenebis(azanediyl))bis(3-
(benzyloxy)-1-oxobutane-2,1-diyl))dicarbamate (4a) was prepared according to 
general procedure A using 1,3-phenylenediamine (150 mg, 1.39 mmol) and Boc-L-
Thr-(OBn)-OH. White powder (0.90 g, 94% yield). 1H-NMR (300 MHz, CDCl3): δ 1.21 
(d, J = 6.4 Hz, 6H, γCH3), 1.44 (s, 18H, (CH3)3), 4.15 (m, 2H, βCH), 4.44-4.61 (m, 6H, 
αCH, OCH2Ph), 5.83 (d, J = 6.8 Hz, 2H, Boc-NH), 7.05-7.31 (m, 13H, OBn, phenyl H4-
6), 7.74 (s, 1H, phenyl H2), 8.80 (br, 2H, PhNHCO-). 13C-NMR (75 MHz, CDCl3): δ 
15.35, 27.84, 58.16, 70.89, 74.43, 79.58, 111.07, 115.36, 127.28, 127.83, 127.98, 
128.78, 137.39, 137.69, 155.63, 168.18. 
 
(2S,2'S,3R,3'R)-1,1'-(1,3-phenylenebis(azanediyl))bis(3-hydroxy-1-oxobutan-
2-aminium) 2,2,2-trifluoroacetate (4) was prepared by benzyl deprotection from 
4a (0.9 g, 1.30 mmol) according to general procedure F (0.66 g, 99% yield) followed 
by Boc deprotection by general procedure C. Off-white solid (0.36 g, 93% yield), mp 
85 °C (dec.). 1H-NMR (300 MHz, CD3OD): δ 1.33 (d, J = 6.4 Hz, 6H, γCH3), 3.81 (d, J = 
6.2 Hz, 2H, αCH), 4.14 (m, 2H, βCH), 7.20-7.40 (m, 3H, phenyl H4-6), 8.07 (s, 1H, 
phenyl H2). 13C-NMR (75 MHz, CD3OD): δ 20.38, 60.99, 67.58, 113.04, 117.50, 
130.52, 139.65, 167.03. 
 
(2S,2'S)-di-tert-butyl 2,2'-((1,3-phenylenebis(azanediyl))bis(carbonyl))bis-
(pyrrolidine-1-carboxylate)(5a) was prepared according to general procedure A 
using 1,3-phenylenediamine (0.150 mg, 1.39 mmol) and Boc-L-Pro-OH. White 
powder (0.57 g, 81% yield), mp 121 °C (dec.). 1H-NMR (300 MHz, CDCl3): δ 1.49 (s, 
18H, (CH3)3), 1.85-2.55 (m, 8H, βCH2, γCH2), 3.31-3.67 (m, 4H, δCH2) 4.30-4.48 (m, 
2H, αCH), 7.06-7.52 (m, 3H, phenyl H4-6), 7.62 (br, 1H, phenyl H2), 9.34 (br, 2H, 
PhNHCO-). 13C-NMR (75 MHz, CDCl3): δ 24.58, 28.47, 47.28, 60.71, 80.83, 110.91, 
115.37, 129.23, 138.71, 156.32, 170.35. 
 
(2S,2'S)-2,2'-((1,3-phenylenebis(azanediyl))bis(carbonyl))bis(pyrrolidin-1-
ium) 2,2,2-trifluoroacetate (5) was prepared according to general procedure C 
using 5a (400 mg, 0.80 mmol). White powder (0.39 g, 91% yield), mp 80 °C (dec.). .). 
1H-NMR (300 MHz, DMSO-d6): δ 1.87-2.04 (m, 6H, γCH2, βCH), 2.32-2.43 (m, 2H, 
βCH), 3.30 (m, 4H, δCH2), 4.41 (m, 2H, αCH), 7.35 (m, 3H, phenyl H4-6), 8.07 (s, 1H, 
phenyl H2). 8.79 (br, 2H, NH2+), 9.90 (br, 2H, NH2+), 10.77 (s, 2H, PhNHCO-). 13C-
NMR (75 MHz, DMSO-d6): δ 23.52, 29.65, 45.69, 59.63, 110.69, 115.16, 129.35, 
138.59, 158.65, 166.93.  
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Di-tert-butyl ((2S,2'S)-(1,3-phenylenebis(azanediyl))bis(6-
benzylcarboxamido-1-oxohexane-2,1-diyl))dicarbamate (6a) was prepared 
according to general procedure A using 1,3-phenylenediamine (150 mg, 1.39 mmol) 
and Boc-L-Lys-(NεCbz)-OH. Yellow solid (1.10 g, 95% yield). 1H-NMR (300 MHz, 
CDCl3): δ 1.33-1.55 (m, 26H, (CH3)3, γCH2, δCH2), 1.58-1.86 (m, 4H, βCH2), 3.13 (m, 
4H, εCH2), 4.29 (m, 2H, αCH2), 5.06 (s, 4H, CH2Ph), 5.59 (br, 2H Cbz-NH), 5.92 (br, 
2H, Boc-NH), 7.06 (m, 1H, phenyl H5), 7.23 (m, 12H, Cbz-ArH, phenyl H4, H6), 7.99 
(s, 1H, phenyl H2), 9.18 (br, 2H PhNHCO-).  
 
(5S,5'S)-6,6'-(1,3-phenylenebis(azanediyl))bis(6-oxohexane-1,5-diaminium) 
2,2,2-trifluoroacetate (6) was prepared according to general procedure D using 6a 
(1.10 g, 1.32 mmol). Cbz deprotected product 6b (0.60 g, 81% yield) was used 
without further purification. Boc deprotection by general procedure C using 6b (600 
mg, 1.06 mmol) afforded yellow solid (0.76 g, 87% yield). 1H-NMR (300 MHz, 
CD3OD): δ 1.58 (m, 4H, γCH2), 1.75 (m, 4H, δCH2), 2.01 (m, 4H, βCH2), 2.98 (t, J = 7.6 
Hz, 4H, εCH2), 4.09 (t, J = 6.4 Hz, 2H, αCH), 7.28-7.40 (m, 3H, phenyl H4-6), 8.08 (s, 
1H, phenyl H2). 13C-NMR (75 MHz, CD3OD): δ 23.05, 28.20, 32.29, 40.35, 54.96, 
113.26, 117.62, 130.54, 139.70, 162.95, 163.49, 168.67.  
 
Di-tert-butyl ((2S,2'S)-(1,3-phenylenebis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropane-2,1-diyl))dicarbamate (7a) was prepared according to general 
procedure A using 1,3-phenylenediamine (150 mg, 1.39 mmol) and Boc-L-Trp-OH. 
White powder (0.80 g, 85% yield), mp 148 °C (dec.). 1H-NMR (300 MHz, DMSO-d6): δ 
1.34 (s, 18H, 2(CH3)3) 2.95-3.14 (ABX, 4H, 2CH2β), 4.39 (ABX, 2H, 2CHα), 6.90-7.12 
(m, 6H, indole H5, indole H6, ArNH), 7.15-7.40 (m, 7H, indole H2, phenylene H4), 
phenylene H5, indole H7), 7.68 (d, J = 7.7 Hz, 2H, indole H4), 7.99 (s, 1H, phenylene 
H2). 13C-NMR (75 MHz, DMSO-d6): δ 28.07, 30.59, 55.67, 77.94, 109.85, 111.15, 
114.34, 118.07, 118.54, 120.76, 123.71, 127.15, 131.24, 135.89, 139.16, 155.19, 
171.11.  HRMS (FAB+): calcd for (C38H44N6O6Na) 703.3220, found 703.3224. 
 
(2S,2'S)-1,1'-(1,3-phenylenebis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropan-2-aminium) chloride (7) was prepared according to general 
procedure B using 7a (313 mg, 0.46 mmol). White powder (0.24 g, 94% yield), mp 
223 °C (dec.). 1H-NMR (300 MHz, CD3OD): δ 3.33-3.53 (ABX, 4H, 2CH2β), 4.26 (ABX, 
2H, 2CHα), 7.01 (t, J = 7.4 Hz, 2H, indole H5), 7.12 (t, J = 7.0 Hz, 2H, indole H6), 7.22 
(s, 2H, indole H2), 7.26 (m, 2H, phenylene H4), 7.27 (m, 1H, phenylene H5), 7.38 (d, J 
= 8.1 Hz, 2H, indole H7), 7.67 (d, J = 7.9 Hz, 2H, indole H4), 7.93 (s, 2H, phenylene 
H2). 13C-NMR (75 MHz, CD3OD): δ 29.01, 55.68, 107.84, 112.61, 113.28, 117.54, 
119.29, 120.35, 122.93, 125.73, 128.35, 130.32, 138.32, 139.60, 168.52. HRMS 
(FAB+): calcd for (C28H29N6O2+) 481.2347, found 481.2356. 
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((2S,2'S)-(1,3-phenylenebis(azanediyl))bis(4-methyl-1-oxopentane-2,1-
diyl))dicarbamate (8a) was prepared according to general procedure A using 1,3-
phenylenediamine (0.150 mg, 1.39 mmol) and Boc-L-Leu-OH. White powder (0.66 g, 
89% yield). 1H-NMR (300 MHz, CDCl3): δ 0.94 (dd, J = 6.9, 6.7 Hz, 12H, CH(CH3)2), 
1.47 (s, 18H, (CH3)3), 1.55-1.85 (m, 6H, βCH2, γCH), 4.48 (m, 2H, αCH), 5.73 (m, 2H, 
Boc-NH), 6.85 (m, 1H, phenyl H5), 7.04 (m, 2H, phenyl H4, H6), 7.74 (s, 1H, phenyl 
H2), 9.30 (s, 2H, PhNHCO-). 13C-NMR (75 MHz, CDCl3): δ 21.42, 23.07, 24.61, 28.34, 
41.15, 53.80, 80.02, 111.34, 115.03, 128.52, 156.42, 171.73.  
 
(2S,2'S)-1,1'-(1,3-phenylenebis(azanediyl))bis(4-methyl-1-oxopentan-2-
aminium) chloride (8) was prepared according to general procedure B using 8a 
(500 mg, 0.935 mmol). White powder (0.35 g, 91% yield). 1H-NMR (300 MHz, 
CD3OD): δ 1.04 (d, J = 5.8 Hz, 12H, CH(CH3)2), 1.71-1.85 (m, 6H, βCH2, γCH), 4.06 (t, J 
= 7.0 Hz, 2H, αCH), 7.29-7.34 (m, 1H, phenyl H5), 7.39-7.42 (m, 2H, phenyl H4, H6), 
8.08 (t, J = 1.9 Hz, 1H, phenyl H2). 13C-NMR (75 MHz, CD3OD): δ 22.14, 23.28, 25.57, 
41.77, 53.76, 113.11, 117.49, 130.49, 138.32, 139.73, 169.15.  
 
Di-tert-butyl ((2S,2'S)-(1,3-phenylenebis(azanediyl))bis(1-oxo-3-
phenylpropane-2,1-diyl))dicarbamate (9a) was prepared according to general 
procedure A using 1,3-phenylenediamine (0.150 mg, 1.39 mmol) and Boc-L-Phe-OH. 
White powder (0.80 g, 96% yield). 1H-NMR (300 MHz, CDCl3): δ 1.37 (s, 18H, 
(CH3)3), 2.90-3.20 (m, 4H, βCH2), 4.73 (m, 2H, αCH), 5.74 (br, 2H, Boc-NH), 6.92 (m, 
1H, phenyl H5), 7.04 (m, 2H, phenyl H4, H6), 7.20 (m, 10H, C6H5), 7.61 (s, 1H, phenyl 
H2), 8.98 (br, 2H, PhNHCO-). 13C-NMR (75 MHz, CDCl3): δ 28.22, 38.57, 56.41, 80.14, 
111.73, 115.63, 126.63, 128.39, 128.77, 129.17, 136.62, 137.90, 156.14, 170.43.  
 
(2S,2'S)-1,1'-(1,3-phenylenebis(azanediyl))bis(1-oxo-3-phenylpropan-2-
aminium) chloride (9) was prepared according to general procedure B using 9a 
(550 mg, 0.913 mmol). White powder (0.40 g, 93% yield). 1H-NMR (300 MHz, 
CD3OD): δ 3.14-3.34 (m, 4H, βCH2), 4.26 (t, J = 7.3 Hz, 2H, αCH), 7.26-7.35 (m, 13H, 
phenyl H4-6, C6H5), 7.90 (t, J = 1.7 Hz, 1H, phenyl H2). 13C-NMR (75 MHz, CD3OD): δ 
38.76, 56.41, 113.14, 117.53, 128.88, 130.11, 130.33, 130.64, 135.53, 139.42, 
167.93.  
 
Di-tert-butyl ((2S,2'S)-(1,3-phenylenebis(azanediyl))bis(3-(4-
(benzyloxy)phenyl)-1-oxopropane-2,1-diyl))dicarbamate (10a) was prepared 
according to general procedure A using 1,3-phenylenediamine (0.150 mg, 1.39 
mmol) and Boc-L-Tyr-(OBn)-OH. White powder (1.10 g, 97% yield). 1H-NMR (300 
MHz, CDCl3): δ 1.38 (s, 18H, (CH3)3), 2.83-3.17 (m, 4H, βCH2), 4.70 (m, 2H, αCH), 4.94 
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(s, 4H, CH2Ph), 5.74 (br, 2H, Boc-NH), 6.84 (d, J = 8.4 Hz, 4H, phenolic H2, H6),  6.91 
(m, 1H, phenyl H5), 7.04 (m, 2H, phenyl H4, H6), 7.12 (d, J = 8.4 Hz, 4H, phenolic H3, 
H5), 7.20-7.37 (m, 10H, C6H5), 7.67 (s, 1H, phenyl H2), 9.06 (br, 2H, PhNHCO-). 13C-
NMR (75 MHz, CDCl3): δ 28.22, 37.69, 56.47, 69.72, 80.12, 111.61, 114.69, 115.52, 
127.29, 127.72, 128.36, 128.76, 128.84, 130.20, 136.85, 137.93, 156.18, 157.53, 
170.51.  
 
Di-tert-butyl ((2S,2'S)-(1,3-phenylenebis(azanediyl))bis(3-(4-
hydroxyphenyl)-1-oxopropane-2,1-diyl))dicarbamate (10b) was prepared 
according to general procedure F using 10a (1.00 g, 1.23 mmol). White solid (0.77 g, 
99% yield). 1H-NMR (300 MHz, 2:1 CD3OD/CDCl3): δ 1.39 (s, 18H, (CH3)3), 2.82-3.11 
(m, 4H, βCH2), 4.43 (m, 2H, αCH), 6.75 (d, J = 6.4 Hz, 4H, phenolic H2, H6),  7.05 (d, J 
= 6.5 Hz, 4H, phenolic H3, H5), 7.14-7.35 (m, 3H, phenyl H4-H6), 7.69 (s, 1H, phenyl 
H2), 9.64 (br, 2H, PhNHCO-). 13C-NMR (75 MHz, CDCl3): δ 28.68, 38.71, 57.66, 80.64, 
113.29, 116.05, 117.30, 128.37, 129.77, 131.11, 139.07, 156.59, 157.03, 172.31.  
 
(2S,2'S)-1,1'-(1,3-phenylenebis(azanediyl))bis(3-(4-hydroxyphenyl)-1-
oxopropan-2-aminium) chloride (10) was prepared according to general 
procedure B using 10b (770 mg, 1.21 mmol). Off-white solid (0.61 g, 99% yield). 1H-
NMR (300 MHz, CD3OD): δ 3.15-3.34 (m, 4H, βCH2), 3.70 (s, 2H, ArOH), 4.39 (m, 2H, 
αCH), 6.76 (m, 4H, phenolic H2, H6), 7.09-7.33 (m, 7H, phenyl H4-6, phenolic H3, 
H5), 8.09 (s, 1H, phenyl H2), 8.39 (br, 2H, PhNHCO-). 13C-NMR (75 MHz, CD3OD): δ 
37.90, 56.78, 113.56, 116.93, 117.79, 126.13, 130.41, 132.04, 139.34, 158.03, 
168.36.  
 
Di-tert-butyl ((1,2-phenylenebis(azanediyl))bis(2-oxoethane-2,1-
diyl))dicarbamate (11a) was prepared according to general procedure A using 
1,2-phenylenediamine (0.100 mg, 0.92 mmol) and Boc-Gly-OH. White powder (0.30 
g, 77% yield). 1H-NMR (300 MHz, CDCl3): δ 1.43 (s, 18H, (CH3)3), 3.82 (s, 4H, αCH2), 
5.87 (s, 2H, Boc-NH), 7.07 (m, 2H, phenyl H4, H5), 7.28 (m, 2H, phenyl H3, H6), 8.73 
(s, 2H, PhNHCO-). 13C-NMR (75 MHz, CDCl3): δ 28.37, 44.50, 80.23, 125.51, 126.49, 
130.31, 156.44, 169.41. 
 
2,2'-(1,2-phenylenebis(azanediyl))bis(2-oxoethanaminium) 2,2,2-
trifluoroacetate (11) was prepared according to general procedure C using 11a 
(260 mg, 0.62 mmol). White powder (0.27 g, 99% yield), mp 163-166 °C. 1H-NMR 
(300 MHz, DMSO-d6): δ 3.36 (s, 4H, αCH2), 7.24 (dd, J = 6.0, 3.6, 2H, phenyl H4, H5), 
7.61 (dd, J = 5.8, 3.6, 2H, phenyl H3, H6), 8.23 (br, 6H, NH3+), 9.87 (br, 2H, PhNHCO-). 
13C-NMR (75 MHz, DMSO-d6): δ 40.03, 114.90, 124.75, 125.53, 129.69, 158.69, 
165.29.  
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2,2'-(1,3-phenylenebis(azanediyl))bis(2-oxoethanaminium) trifluoroacetate 
(12) was prepared according to general procedure C using 1a. The product was 
spectroscopically identical to 1. 
 
Di-tert-butyl ((1,4-phenylenebis(azanediyl))bis(2-oxoethane-2,1-
diyl))dicarbamate (13a) was prepared according to general procedure A using 
1,4-phenylenediamine (0.150 mg, 1.39 mmol) and Boc-Gly-OH. White powder (0.27 
g, 46% yield). 1H-NMR (300 MHz, DMSO-d6): δ 1.42 (s, 18H, (CH3)3), 3.73 (d, J = 6.0 
Hz, 4H, αCH2), 7.07 (t, J = 5.9 Hz, 2H, Boc-NH), 7.54 (s, 4H, phenyl H2-3, H4-5), 10.02 
(s, 2H, PhNHCO-). 13C-NMR (75 MHz, DMSO-d6): δ 28.23, 43.71, 78.01, 119.42, 
134.39, 156.51, 167.93.  
 
2,2'-(1,4-phenylenebis(azanediyl))bis(2-oxoethanaminium) 2,2,2-
trifluoroacetate (13) was prepared according to general procedure C using 13a 
(210 mg, 0.50 mmol). White powder (0.11 g, 51% yield) mp 234 °C (dec.). 1H-NMR 
(300 MHz, DMSO-d6): δ 3.78 (s, 4H, αCH2), 7.59 (s, 4H, phenyl H3-6), 8.23 (br, 6H, 
NH3+), 10.67 (br, 2H, PhNHCO-). 13C-NMR (75 MHz, DMSO-d6): δ 40.87, 119.69, 
134.15, 160.90, 164.51. 
 
Di-tert-butyl ((2S,2'S)-(1,2-phenylenebis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropane-2,1-diyl))dicarbamate (14a) was prepared according to general 
procedure A using 1,2-phenylenediamine (150 mg, 1.39 mmol) and Boc-L-Trp-OH. 
White powder (0.76 g, 80% yield), mp 129 °C (dec.). Two hydrogen bonded 
conformations were observed spectroscopically, peaks for the major conformer are 
reported herein.  1H-NMR (300 MHz, CDCl3): δ 1.50 (s, 9H, (CH3)3), 3.05-3.33 (ABX, 
2H, βCH2), 4.21 (ABX, 1H, αCH), 5.40 (d, J = 7.3 Hz, 1H, Boc-NH), 6.55-7.62 (m, 7H, 
ArH, ArNH), 8.98 (s, 1H, indole NH). 13C-NMR (75 MHz, CDCl3): δ 28.48, 28.84, 56.01, 
80.53, 110.14, 111.55, 118.99, 119.65, 122.19, 123.45, 124.68, 126.10, 127.37, 
129.33, 136.16, 155.71, 171.35.  HRMS (FAB+): calcd for (C38H44N6O6Na) 703.3220, 
found 703.3218. 
 
(2S,2'S)-1,1'-(1,2-phenylenebis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropan-2-aminium) chloride (14) was prepared according to the general 
procedure B using 5a (600 mg, 0.88 mmol). White powder (0.21 g, 43% yield), mp 
201 °C (dec.). Two hydrogen bonded conformations were observed 
spectroscopically, peaks for the major conformer are reported herein. 1H-NMR (300 
MHz, CD3OD): δ 3.35-3.65 (ABX, 2H, βCH2), 4.58 (t, J = 6.9 Hz, 1H, αCH), 7.00-7.73 
(m, 7H, ArH, ArNH). 13C-NMR (75 MHz, CD3OD): δ 28.79, 55.74, 107.93, 112.56, 
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119.58, 120.36, 122.92, 125.81, 126.35, 127.36, 128.48, 130.99, 138.27, 169.44. 
HRMS (FAB+): calcd for (C28H29N6O2+) 481.2347, found 481.2359. 
 
Di-tert-butyl ((2S,2'S)-(1,4-phenylenebis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropane-2,1-diyl))dicarbamate (15a) was prepared according to general 
procedure A using 1,4-phenylenediamine (150 mg, 1.39 mmol) and Boc-L-Trp-OH. 
White powder (0.84 g, 89% yield), mp 167 °C (dec.). 1H-NMR (300 MHz, CD3OD): δ 
1.41 (s, 9H, (CH3)3), 3.19-3.36 (ABX, 2H, βCH2), 4.47 (ABX, 1H, αCH), 6.98-7.12 (m, 
3H, indole H5, indole H6, indole H2), 7.27-7.42 (m, 3H, indole H7, phenylene CH), 
7.61 (d, J = 7.7 Hz, 1H, indole H4), 7.78 (s, 1H, indole NH). 13C-NMR (75 MHz, 
CD3OD): δ 28.50, 29.26, 56.66, 80.52, 110.06, 111.90, 118.97, 119.50, 121.52, 
122.07, 124.15, 128.14, 134.88, 137.26, 156.85, 172.14. HRMS (FAB+): calcd for 
(C38H44N6O6Na) 703.3220, found 703.3210. 
 
(2S,2'S)-1,1'-(1,4-phenylenebis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropan-2-aminium) chloride (15) was prepared according to general 
procedure B using 15a (475 mg, 0.70 mmol). White powder (0.36 g, 93% yield), mp 
237 °C (dec.). 1H-NMR (300 MHz, CD3OD): δ 3.34-3.54 (ABX, 2H, βCH2), 4.27 (ABX, 
1H, αCH), 6.97-7.14 (m, 2 H, indole H5, indole H6), 7.24 (s, 1H, indole H7), 7.38 (d, J 
= 8.1 Hz, 1H, indole H7), 7.67 (d, J = 7.9 Hz, 1H, indole H4). 13C-NMR (75 MHz, 
CDCl3): δ 28.93, 55.69, 107.90, 112.57, 119.33, 120.29, 121.88, 122.87, 125.72, 
128.38, 135.61, 138.26, 168.33. HRMS (FAB+): calcd for (C28H28N6O2Na) 503.2171, 
found 503.2166. 
 
Di-tert-butyl ((2R,2'R)-(1,3-phenylenebis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropane-2,1-diyl))dicarbamate (16a) was prepared according to general 
procedure A using 1,3-phenylenediamine (200 mg, 1.85 mmol) and Boc-D-Trp-OH. 
White powder (1.05 g, 84% yield), mp 141 °C (dec.). 1H-NMR (300 MHz, CDCl3): δ 
1.38 (s, 18H, 2(CH3)3) 3.10-3.45 (ABX, 4H, 2CH2β), 4.62 (ABX, 2H, 2CHα), 6.90-7.23 
(m, 6H, indole H5, indole H6, ArNH), 7.29-7.40 (m, 7H, indole H2, phenylene H4), 
phenylene H5, indole H7), 7.66 (d, J = 7.0 Hz, 2H, indole H4), 8.21 (s, 1H, phenylene 
H2). 13C-NMR (75 MHz, CDCl3): δ 28.35, 28.98, 56.04, 80.49, 109.66, 111.63, 112.74, 
116.83, 118.67, 119.35, 121.90, 123.79, 127.64, 129.34, 136.64, 138.14, 156.25, 
171.58. HRMS (FAB+): calcd for (C38H44N6O6Na) 703.3220, found 703.3219. 
 
(2R,2'R)-1,1'-(1,3-phenylenebis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropan-2-aminium) chloride (16) was prepared according to general 
procedure B using 16a (440 mg, 0.65 mmol). Off-white powder (0.23 g, 64% yield), 
mp 242 °C (dec.). 1H-NMR (300 MHz, CD3OD): δ 3.33-3.53 (ABX, 4H, 2CH2β), 3.65 (s, 
6H, 2NH3), 4.26 (ABX, 2H, 2CHα), 7.01 (t, J = 7.4 Hz, 2H, indole H5), 7.12 (t, J = 7.0 Hz, 
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2H, indole H6), 7.22 (s, 2H, indole H2), 7.26 (m, 2H, phenylene H4), 7.27 (m, 1H, 
phenylene H5), 7.38 (d, J = 8.1 Hz, 2H, indole H7), 7.67 (d, J = 7.9 Hz, 2H, indole H4), 
7.93 (s, 2H, phenylene H2). 13C-NMR (75 MHz, CD3OD): δ 28.96, 55.67, 107.84, 
112.58, 113.31, 117.55, 119.33, 120.32, 122.89, 125.76, 128.37, 130.28, 138.27, 
139.56, 168.52. HRMS (FAB+): calcd for (C28H29N6O2+) 481.2347, found 481.2350. 
 
(S)-tert-butyl (3-(1H-indol-3-yl)-1-oxo-1-(phenylamino)propan-2-
yl)carbamate (17a) was prepared according to general procedure A using aniline 
(200 mg, 2.15 mmol) and Boc-L-Trp-OH. White powder (0.65 g, 80% yield). 
Compound previously reported49 and matched spectroscopically where available. 
 
(S)-3-(1H-indol-3-yl)-1-oxo-1-(phenylamino)propan-2-aminium chloride (17) 
was prepared according to general procedure B using 17a (350 mg, 0.92 mmol). 
White powder (0.17 g, 57% yield). Compound previously reported50 and matched 
spectroscopically where available. 
 
N,N'-(1,3-phenylene)bis(3-(1H-indol-3-yl)propanamide) (18) was prepared 
according to general procedure A using 1,3-phenylenediamine (70 mg, 0.65 mmol) 
and indole-3-propionic acid. White powder (0.23 g, 78% yield), mp 154-156 °C. 1H-
NMR (300 MHz, CD3OD): δ 2.76 (t, J = 7.6 Hz, 4H, 2COCH2CH2-indole), 3.18 (t, 7.6 Hz, 
4H, 2COCH2CH2-indole), 7.04-7.39 (m, 9H, indole H5, indole H6, indole H2, 
phenylene H4, phenylene H6), 7.37 (d, J = 7.9 Hz, 2H, indole H7), 7.60-7.66 (m, 3H, 
indole H4, phenylene H5). 13C-NMR (75 MHz, CD3OD): δ 21.81, 38.37, 111.71, 
114.33, 116.43, 117.53, 118.72, 119.06, 121.83, 122.40, 127.52, 137.04, 139.11, 
173.38. HRMS (FAB+): calcd for (C28H26N4O2Na) 473.1954, found 473.1945. 
 
Di-tert-butyl ((2S,2'S)-(propane-1,3-diylbis(azanediyl))bis(3-(1H-indol-3-yl)-
1-oxopropane-2,1-diyl))dicarbamate (19a) was prepared according to general 
procedure A using 1,3-diaminopropane dihydrochloride (200 mg, 1.36 mmol) and 
Boc-L-Trp-OH. White powder (0.51 g, 58% yield). Compound previously reported51 
and matched spectroscopically where available. 
 
(2S,2'S)-1,1'-(propane-1,3-diylbis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropan-2-aminium) chloride (19) was prepared according to general 
procedure B using 19a (380 mg, 0.59 mmol). White powder (0.30 g, 98% yield), mp 
234°C (dec.). 1H-NMR (300 MHz, CD3OD): δ 1.40 (m, 2H, -CH2CH2NH-), 2.98 (m, 4H, -
CH2CH2NH-), 3.22-3.65 (m, 4H, CH2β), 4.13 (ABX, 2H, CHα), 6.99-7.18 (m, 4H, indole 
H5, indole H6), 7.25 (s, 2H, indole H2), 7.39 (d, J = 6.4 Hz, 2H, indole H7), 7.69 (d, J = 
4.7 Hz, 2H, indole H4), 8.30 (br, CONH). 13C-NMR (75 MHz, CD3OD): δ 28.78, 29.39, 
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37.76, 55.27, 108.03, 112.62, 119.34, 120.22, 122.80, 125.71, 128.29, 138.02, 
170.05. HRMS (FAB+): calcd for (C25H31N6O2+) 447.2503, found 447.2503. 
 
Di-tert-butyl ((2S,2'S)-(butane-1,4-diylbis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropane-2,1-diyl))dicarbamate (20a) was prepared according to general 
procedure A using 1,4-diaminobutane dihydrochloride (210 mg, 1.30 mmol) and 
Boc-L-Trp-OH. White powder (0.79 g, 92% yield). Compound previously reported51 
and matched spectroscopically where available. 
 
(S)-1-((4-((R)-2-ammonio-3-(1H-indol-3-yl)propanamido)butyl)amino)-3-
(1H-indol-3-yl)-1-oxopropan-2-aminium chloride (20) was prepared according 
to general procedure B using 20a (650 mg, 0.98 mmol). White powder (0.51 g, 97% 
yield), mp 204 °C (dec.). 1H-NMR (300 MHz, CD3OD): δ 1.18 (m, 2H, -CH2CH2NH-), 
3.05 (m, 2H, -CH2CH2NH-), 3.22-3.41 (ABX, 2H, CH2β), 4.09 (ABX, 1H, CHα), 7.05-
7.17 (m, 2H, indole H5, indole H6), 7.23 (s, 2H, indole H2), 7.40 (d, J = 7.9 Hz, 1H, 
indole H7), 7.66 (d, J = 7.9 Hz, 2H, indole H4), 8.25 (br, 1H, CONH). 13C-NMR (75 
MHz, CD3OD): δ 27.24, 29.06, 40.28, 55.40, 68.27, 108.29, 112.73, 119.38, 120.37, 
123.00, 125.68, 128.51, 138.34, 170.13. HRMS (FAB+): calcd for (C26H33N6O2+) 
461.2660, found 461.2668. 
 
Di-tert-butyl ((2S,2'S)-(hexane-1,6-diylbis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropane-2,1-diyl))dicarbamate (21a) was prepared according to general 
procedure A using 1,6-diaminohexane dihydrochloride (250 mg, 1.32 mmol) and 
Boc-L-Trp-OH. White powder (0.90 g, 99% yield). Compound previously reported51 
and matched spectroscopically where available. 
 
(2S,2'S)-1,1'-(hexane-1,6-diylbis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropan-2-aminium) chloride (21) was prepared according to general 
procedure B using 21a (650 mg, 0.94 mmol). White powder (0.33 g, 62% yield), mp 
193 °C (dec.). 1H-NMR (300 MHz, CD3OD): δ 1.05 (m, 2H, aliphatic CH2), 1.26 (m, 2H, 
aliphatic CH2) 2.97-3.39 (m, 4H, -CH2CH2NH-, CH2β), 4.06 (ABX, 2H, CHα), 7.02-7.15 
(m, 2H, indole H5, indole H6), 7.20 (s, 1H, indole H2), 7.37 (d, J = 8.1 Hz, 1H, indole 
H7), 7.63 (d, J = 7.5 Hz, 2H, indole H4), 8.19 (br, CONH). 13C-NMR (75 MHz, CD3OD): 
δ 27.38, 28.98, 29.85, 40.61, 55.29, 108.19, 112.64, 119.22, 120.27, 122.91, 125.52, 
128.40, 138.26, 169.95. HRMS (FAB+): calcd for (C28H37N6O2+) 489.2973, found 
489.2972. 
 
Di-tert-butyl ((2R,2'S)-(dodecane-1,12-diylbis(azanediyl))bis(3-(1H-indol-3-
yl)-1-oxopropane-2,1-diyl))dicarbamate (22a) was prepared according to 
general procedure A using 1,12-diaminododecane (250 mg, 1.25 mmol) and Boc-L-
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Trp-OH. Off-white powder (0.93 g, 96% yield), mp 86 °C (dec.). 1H-NMR (300 MHz, 
CDCl3): δ 1.08-1.34 (m, 22H, aliphatic CH2), 1.41 (s, 18H, C(CH3)3), 2.99-3.32 (m, 8H, 
-CH2CH2NH-, CH2β), 4.42 (ABX, 2H, CHα), 5.36 (br, 2H, Boc-NH), 6.03 (br, 2H, CONH), 
6.95 (s, 2H, indole H2)  7.03-7.16 (m, 4H, indole H5, indole H6), 7.32 (d, J = 7.9 Hz, 
2H, indole H7), 7.60 (d, J = 7.7 Hz, 2H, indole H4). 13C-NMR (75 MHz, CDCl3): δ 26.52, 
28.16, 28.54, 28.99, 29.22, 29.28, 31.43, 39.38, 55.22, 65.72, 79.83, 110.12, 111.23, 
118.60, 119.27, 121.81, 123.22, 127.26, 136.19, 155.44, 171.68. HRMS (FAB+): calcd 
for (C44H64N6O6Na) 785.4785, found 785.4792. 
 
(S)-1-((12-((R)-2-ammonio-3-(1H-indol-3-yl)propanamido)dodecyl)amino)-3-
(1H-indol-3-yl)-1-oxopropan-2-aminium chloride (22) was prepared according 
to general procedure B using 22a (715 mg, 0.92 mmol). White powder (0.56 g, 93% 
yield), mp 158 °C (dec.). 1H-NMR (300 MHz, CD3OD): δ 1.08-1.34 (m, 22H, aliphatic 
CH2), 2.99-3.38 (m, 8H, -CH2CH2NH-, CH2β), 4.04 (ABX, 2H, CHα), 7.02-7.15 (m, 4H, 
indole H5, indole H6), 7.20 (s, 2H, indole H2), 7.37 (d, J = 7.9 Hz, 2H, indole H7), 7.62 
(d, J = 7.9 Hz, 2H, indole H4). 13C-NMR (75 MHz, CD3OD): δ 27.92, 28.98, 30.01, 
30.43, 30.69, 30.77, 40.77, 55.29, 108.18, 112.62, 119.20, 120.24, 122.88, 125.51, 
128.40, 138.25, 169.90. HRMS (FAB+): calcd for (C34H49N6O2+) 573.3912, found 
573.3929. 
 
(S)-1-((4-((R)-2-ammonio-3-(1H-indol-3-yl)propanamido)butyl)amino)-3-
(1H-indol-3-yl)-1-oxopropan-2-aminium trifluoroacetate (23) was prepared 
according to general procedure C using 20a. The product was spectroscopically 
identical to 20. 
 
1,4-bis(Nα-Boc-Nε-Cbz-L-lysylamido)butane (24a) was prepared according to 
general procedure A using 1,4-diaminobutane dihydrochloride (200 mg, 1.24 mmol) 
and Nα-Boc-Nε-Cbz-L-Lys-OH. Off-white solid (0.95 g, 94% yield). 1H-NMR (300 MHz, 
CDCl3): δ 1.28-1.71 (m, 34H, (CH3)3, βCH2, γCH2, δCH2, linker CH2CH2NHCO), 3.04-
3.29 (m, 4H, εCH2, linker CH2NHCO), 4.17 (m, 2H, αCH2), 5.06 (s, 4H, CH2Ph), 5.57 
(br, 2H Cbz-NH), 5.82 (br, 2H, Boc-NH), 7.30 (m, 12H, Cbz-ArH, linker CH2NHCO). 
13C-NMR (75 MHz, CDCl3): δ 22.38, 26.02, 28.04, 28.99, 32.17, 38.62, 40.30, 54.04, 
66.09, 79.33, 127.66, 128.10, 136.38, 155.77, 156.33, 172.58. 
 
1,4-bis(lysylamido)butane tetrakis(trifluoroacetate) (24)  was prepared in a 
two-step procedure. The Cbz-deprotected compound 24b was prepared according 
to general procedure D from 24a (840 mg, 1.03 mmol). White solid (0.52 g, 93% 
yield). Compound 24 was prepared according to general procedure C from 24b 
(0.22 g, 0.40 mmol). Off-white glassy solid (0.16 g, 50% yield). 1H-NMR (300 MHz, 
CD3OD): δ 1.44-1.69 (m, 8H, γCH2, linker CH2CH2NHCO), 1.81 (m, 4H, δCH2), 1.97 (m, 
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4H, βCH2), 3.04 (m, 4H, linker CH2NHCO), 3.33 (m, 4H, εCH2), 4.02 (m, 2H, αCH2), 
8.01(br, 6H, εNH3+), 8.41 (br, 6H, αNH3+), 8.64 (br, 2H, linker CH2NHCO). 13C-NMR 
(75 MHz, CD3OD): δ 22.98, 27.45, 27.89, 32.02, 40.19, 40.46, 54.22, 169.92.  
 
4.4.2. Agarose Gel Electrophoresis.  
Agarose powder was obtained from Sigma Aldrich. Purified water with 18.2 MΩ 
resistivity (Milli-Q) was used in all cases. Gels were cast by heating a 0.5% w/v 
solution of agarose in 40 mM tris-acetate buffer (pH 7.2) until fully dissolved, then 
cast by cooling the solution to room temperature in an Owl B2 horizontal 
electrophoresis chamber with a centrally placed 20-well comb. The gel was 
submerged under 40 mM tris-acetate (pH 7.2) running buffer, samples were added 
to the wells, and the gel was run 90 minutes at 105 ± 3 volts. Gels were stained in 
2.5 μg/mL ethidium bromide for 15 minutes at 37 °C, 50 rpm, and destained in Milli-
Q water for 5 minutes at 37 °C, 50 rpm. Ethidium bromide-stained DNA was 
visualized using a UV trans-illuminator. 
Gel images were analyzed by densitometry using ImageJ software.24 Lane profile 
plots were generated and integrated (data not shown). Using manual baselines, the 
control plasmid was set as 100% DNA migration. The inverse of the DNA migration 
in experimental wells relative to control DNA migration gave a measure of percent 
DNA retention. Results presented are the average of three gels. 
 
4.4.3. Electron Microscopy. 
Transmission Electron Microscopy. A 10 μL sample was applied to lacey 
formvar/carbon 300 mesh copper TEM grids (Ted Pella, Inc.) for 60 seconds and the 
grid was washed with 18.2 MΩ H2O (30 s), stained with 2 % uranyl acetate (30 s), 
and washed twice with H2O (15 s each). The above solutions were applied at a 
volume of 10 μL, wicked away between each application, and the grid was finally 
dried with a gentle N2 stream. Specimens were examined on a JEOL JEM-2000 FX 
transmission electron microscope operated at 300 keV. 
 
Scanning Electron Microscopy. The copper grids treated with samples for TEM were 
sputter-coated with elemental gold and imaged on a JEOL JSM-6320F field emission 
scanning electron microscope. 
 
4.4.4. Circular Dichroism. 
Samples were prepared according to agarose gel mixing procedures (Section 4.4.2) 
with the substitution of water for DMSO. Samples were placed in a 1 mm path length 
microsampling disc and examined on a JASCO 1500 circular dichroism 
spectropolarimeter. 
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Chapter 5 
Reversal of Tetracycline Resistance in Escherichia coli by Non-cytotoxic 
bis(Tryptophan)s 
 
5.1. Introduction. 
The current interest in anion binding molecules can hardly be overstated. Numerous 
reviews1 of the area have appeared including two monographs.2 Many of the anion 
binders derive from early work reported by Crabtree and coworkers3 who showed 
that arenes having meta-dicarboxylic acids, e.g. isophthalic acid, could form 
bis(amide)s that readily bound such spherical ions as chloride and bromide. The tris-
arene hydrogen bond stabilization system was incorporated into a cryptand-like 
structure along with a crown ether and the combination functioned as a heteroditopic 
salt binder.4 Multiple hydrogen bonds are available for anion stabilization in cycles 
such as those known as calixpyrroles.5 
 
In previous work, we prepared substituted bis(anilide)s of isophthalic and dipicolinic 
acid.6 These compounds were, like many tris-arenes, poorly soluble in water but 
certain of them formed channels in bilayer membranes.7 In other, unrelated work, we 
found that indole could function as an amphiphilic head group.8 Stable liposomes 
were formed from either 3- or N-substituted n-decyl- or n-octadecylindoles. The 
“head group” capability of tryptophan's indole is apparent in biology. The Leu-Trp 
repeats of gramicidin9 and the tryptophans present only at the membrane interfaces 
in the KcsA voltage gated potassium channel10 support this inference.  
 
Previous work suggested that tryptophan could function effectively as an amphiphilic 
head group.11 Our recent success with membrane active hydraphiles12 and lariat 
ethers13 as antimicrobials and as synergists for antimicrobials14 led us to explore the 
biological activity of a range of tryptophan derivatives. The antibiotic health crisis15 
encouraged us to survey the activity of the bis(tryptophan)s (BTs), which were 
originally patterned as anion binders. Surprisingly, several of these novel structures 
inhibit the growth of Gram-negative Escherichia coli K-12 and Gram-positive 
Staphylococcus aureus. Even more remarkable is that at sub-lethal concentrations, 
several BTs recover tetracycline’s activity against tetracycline resistant E. coli (TetR E. 
coli) expressing the tetA efflux pump. Tetracycline activity was recovered by 16-fold. 
Four of the molecules reported here exhibited no cytotoxicity at the minimal 
inhibitory concentrations (MICs) against three mammalian epithelial cell lines. A 
membrane disruption based activity is hypothesized based on increased permeability 
of Gram-negative TetR E. coli bacterial cells by one of the BTs. 
 
5.2. Results & Discussion. 
Tryptophan occurs in proteins with the lowest frequency of the 20 genetically coded 
 
 
96 
 
amino acids.16 It is hydrophobic, electron rich, and it has an N-H donor residue that 
can stabilize anions by hydrogen bond interactions. Tryptophan is often found in 
transmembrane proteins at the bilayer interface.17,18 The frequent use of tryptophan 
and cationic residues in antimicrobial peptides19 encouraged us to design BTs to 
assess the minimal structural elements requisite for antibacterial properties. 
 
We screened the BTs for biological activity because we anticipated that at least some 
of them could be amphiphiles and show membrane activity. We evaluated the 
antimicrobial function of BTs using Gram positive Staphylococcus aureus and two 
Gram negative E. coli strains: K-12 and tetracycline resistant E. coli.20 Although the 
antimicrobial activity observed varied according to compound structure and 
organism, both potency and selectivity of bacterial membranes over mammalian 
membranes was documented.  
 
5.2.1. Compounds studied. The compounds that are the focus of this report were 
prepared from diaminobenzenes or from α,ω-diaminoalkanes. They are shown in 
Figure 5.1. The amino acid, usually tryptophan, was N-Boc protected and the free 
carboxyl group was coupled with the appropriate diamine by using N,N,N',N'-
tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate (HBTU). Four 
meta-phenylenediamine (meta-Ph) derivatives were prepared. They are shown in 
Figure 5.1 as 1-4. Compound 1 has glycine side arms while 2 and 3 are 
bis(tryptophan) derivatives. The stereochemistry of the side arms in 2 and 3 varies: 2 
= L,L and 3 = D,D. The diamine was acylated with 3-(3-indolyl)propanoic acid (IPA, 
sold as 3-indolepropionic acid) to form 4. Compounds 5 and 6 are isomers of 2 but 
the arene is substituted ortho (5) or para (6).  
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Figure 5.1. Chemical structures of compounds 1-11. 
 
Compounds 7-11 are related to 2 but rather than using a meta-phenylenediamine as 
the spacer or connector chain, alkyl groups link the two L-tryptophans. The alkyl 
groups are propylene (7, C3), butylene (8, C4), hexylene (9, C6), and dodecylene (10, 
C12). Compound 11 comprises only a part of 2 and was intended to serve as a control. 
Note that chloride counter ions were used with all compounds except for the 
uncharged compound 4. 
 
5.2.2. Bacteria used. Three strains of bacteria were the focus of this report. Two 
different strains of E. coli (Gram negative) were used. The laboratory strain of E. coli, 
K-12 (ATCC 700926), was used for preliminary MIC determinations. The tetracycline 
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resistant strain of E. coli (TetR) was prepared by transforming competent JM109 E. 
coli (Promega) with the pBR322 plasmid (Carolina Biologicals). This plasmid contains 
two resistance genes. The tetA gene expresses the tetracycline resistance TetA efflux 
pump21 and the ampR gene expresses a β-lactamase enzyme22 that cleaves the four 
membered ring of penicillin derivatives. The resulting E. coli, which we designate TetR 
E. coli, is both tetracycline and ampicillin resistant. The TetA efflux pump belongs to 
the major facilitator superfamily (MFS), spans the cytoplasmic membrane, and 
transports tetracycline from the cell cytoplasm to the periplasmic space.23 This active 
efflux utilizes the proton gradient as an energy source.24  
 
Gram-positive S. aureus (ATCC 29213) used for MIC study expresses the MFS type 
NorA efflux pump and is methicillin sensitive. MFS type efflux pumps are clinically 
relevant for resistance in both Gram positive and negative bacteria.25 We therefore 
used these strains to determine the MIC values for BTs and to assess their ability to 
recover antimicrobial potency against resistant bacterial strains.  
 
5.2.3. Antimicrobial activity. All minimum inhibitory concentration (MIC) values for 
compounds 1-11 were determined according to the methods prescribed by the 
National Committee for Clinical Laboratory Standards.26 Essentially, the bacterium 
under study is grown to a specified optical density and added to antibiotic that is 
serially diluted by halves until the growth is inhibited by greater than 80%, detected 
spectroscopically. All the BTs were dissolved in DMSO and the solvent concentration 
was kept constant at 0.5% by volume in all experiments. We note that MIC 
concentrations are sometimes reported in µg/mL. For compound 10, 10 µM 
corresponds to 6 µg/mL. We use µM here for convenience in comparisons. The MICs 
that are recorded in Table 5.1 represent at least two replicates of three trials each. A 
value of >128 µM recorded in the Table means that no growth inhibition was 
apparent at 128 µM so the MIC could be far higher.  
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Table 5.1: Minimal Inhibitory Concentrations (MICs)a 
Cpd Link (AA)b 
E. coli K12 
(µM) 
E. coli TetR 
(µM) 
S. aureus 
(µM) 
1 meta-Ph (Gly) >128 >128 >128 
2 meta-Ph (L-Trp) 64 48±8 32 
3 meta-Ph (D-Trp) 64 28±4 32 
4 meta-Ph (IPA)c >128 >128 >128 
5 ortho-Ph (L-Trp) 64 56±8 32 
6 para-Ph (L-Trp) 128 120±14 128 
7 (CH2)3 (L-Trp) >128 >128 >128 
8 (CH2)4 (L-Trp) >128 >128 >128 
9 (CH2)6 (L-Trp) >128 128 >128 
10 (CH2)12 (L-Trp) 8 10±2 4 
11 C6H5-L-Trp-NH2 >128 >128 >128 
a. MIC resolution is in powers of 2 unless otherwise indicated by a 
range with ±. b. Structure of both amino acids c. 3-(3-
indolyl)propanioic acid. 
 
5.2.4. Comparison between K-12 E. coli and S. aureus. The data in Table 5.1 show that 5 
of the 11 compounds tested exhibited various levels of antimicrobial activity against 
E. coli and S. aureus. These compounds, 2, 3, 5, 6, and 10 are more active against 
Gram positive than Gram-negative bacteria. Indeed, the potency of 10 (MIC of 8 µM 
against K-12 E. coli) is twice that observed against S. aureus (4 µM). Most antibiotics 
are more potent against Gram-positive bacteria due to the absence of a secondary 
impermeable membrane.27 Of course, a Gram-positive specific target is also possible 
as observed for daptomycin.28 
 
5.2.5. Structural comparison. The compounds studied fall into two categories: 
compounds having arenyl or alkyl spacers. The compounds having aromatic spacers 
are 5 (ortho), 1-4 (meta), and 6 (para). The alkylene spacers range from three to 
twelve methylenes in 7-10. Compound 11 contains a single tryptophan (no spacer) 
and is intended to serve as a control.  
 
The arylene BTs are more active antimicrobials than those having alkyl spacers 
except for 10 [(CH2)12 (L-trp)], the most potent compound against the three strains of 
bacteria tested. Note that 11, the single Trp control, is essentially inactive (MIC > 128 
µM). Compounds 1 and 2 are identical except that the two amino acids are glycine in 
the former and tryptophan in the latter. Compound 2 shows modest antimicrobial 
activity and 1 shows none (MIC > 128 µM) against all three bacteria. The activity of 2 
was also lost when tryptophan was replaced by 3-(3-indolyl)propanoic acid (4). We 
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infer that both the charged ammonium moieties and the indoles in the tryptophan 
residues are critical for the activity of 2, 3, 5, 6, and 10. The disposition of the side 
chains in otherwise identical compounds 2, 5, and 6 revealed that ortho and meta 
substitution produced similar toxicities to the three subject bacteria, but no 
essentially no activity was observed for para-phenylene bis(tryptophan) 6. 
 
A further comparison can be made between 2 and 3, which differ only in the 
stereochemistry of the tryptophan residues. Both compounds showed similar activity 
against E. coli K-12 (64 µM) and S. aureus (32 µM). Compound 3, in which the 
tryptophans have the uncommon D-configuration, was nearly twice as active (28 ± 4 
µM) as the naturally occurring isomer L-tryptophan analog (2, 48 ± 8 µM) against E. 
coli TetR. Note that the MIC values in this case were narrowed from the power 
interval so that a closer comparison could be made. We speculate that although both 
2 and 3 are similarly toxic to E. coli TetR, the D-tryptophans are metabolized less 
rapidly29 and duration rather than potency is reflected in the different MICs. 
 
The alkylene derivatives that approximate the molecular spacing of the tryptophans 
also show relatively low activity against all three bacteria. Thus, 7 and 8 are inactive. 
Compound 9 has a slightly longer spacer chain but is essentially inactive to all three 
bacterial strains. It is marginally more active against E. coli TetR than it is against the 
E. coli K-12 or S. aureus, but it is generally less active than 2 or 3 against all three 
bacteria. However, the greater antimicrobial activity of (CH2)12 (L-Trp) (10) 
compared to meta-Ph (L-trp) (2) and meta-Ph (D-trp) (3) could relate to overall 
separation of the ammonium or tryptophan residues. The separation of -NH3+ groups 
in 10, the most active BT, is ~21 Å (fully extended alkyl chain). In 2 and 3, the 
separation is only ~12 Å. Of course, the phenylene BTs are more rigid than the alkyl 
BTs and the conformation of 10 in particular is currently unknown.  
 
Amphiphiles are known to enhance the permeability of bacterial boundary layers.30 
Amphiphiles are also known to form aggregates in aqueous solution. An effort to 
detect aggregates of 10 was made by using dynamic light scattering (DLS).  
Compound 10 was deemed to be the most amphiphilic (bola-amphiphilic31) of the 
structures owing to the estimated maximal spacing of the amino groups. Solutions of 
10•(HCl)2 at concentrations between 10 µM and 1 mM were prepared and examined 
by dynamic light scattering methods. At the highest concentration, it appeared that 
some aggregates formed, but the counts were low and the results were considered 
inconclusive. 
 
5.2.6. Cytotoxicity to mammalian cells. Our initial hypothesis was that antimicrobial 
activity resulted from membrane disruption. Membrane active compounds are often 
cytotoxic to mammalian cells.32 The survival of three mammalian epithelial cell lines 
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was assayed for 2, 3, 5, and 10. Inactive 6, para-Ph (L-Trp) and 7, (CH2)3 (L-Trp) were 
included as controls. The cell lines studied were human embryonic kidney (HEK-293), 
human cervix epithelial (Hela, ATCC CCL-2), and Cercopithecus aethiops kidney (Cos-
7, ATCC CRL 1651). Cells were cultured for 24 h in 96-well plates and treated with 
media containing concentrations using [MIC] and [MIC]×2 determined previously for 
TetR E. coli.. The number of surviving cells was determined using an XTT assay 
(Sigma-Aldrich); the results are represented as percent survival in Figure 5.2. Cells 
alone were used as controls and established 100% survival. The data represent two 
replicates of three trials and the error bars represent the standard deviation.  
 
 
Figure 5.2. Cytotoxicity at the MIC concentration (against TetR E. coli) 
of meta-Ph (L-trp) (2, 28 µM), meta-Ph (D-trp) (3, 48 µM), ortho-Ph (L-
trp) (5, 56 µM), para-Ph (L-trp) (6, 120 µM), (CH2)3 (L-trp) (7, 128 µM), 
and (CH2)12 (L-trp) (10, 10 µM) to HEK-293, HeLa and Cos-7 cells. Error 
bars represents the standard deviation in our results.  
 
At MIC concentrations, arene-linked BTs 2, 3, 5, and 6 showed ~100% survival 
against HEK-293, HeLa, or Cos-7 cells. Alkyl-linked 7 and 10 were minimally toxic to 
HEK-293 or Cos-7 cells, but were moderately toxic to HeLa cells. In general, the 
survival of Cos-7 cells was unaffected by the highest concentrations of all the 
compounds tested.  
 
The survival of all three cell lines was unaffected by a two-fold increase in 
concentration of meta-Ph (L-trp) (2, 56 µM) and ortho-Ph (L-trp) (5, 112 µM), (Figure 
5.3). In contrast, meta-Ph (D-trp) (3) at (96 µM) showed 62% survival for HEK-293 
and 29% for HeLa cells. The para-Ph (L-trp) (6) at 240 µM, showed 61% survival for 
HEK-293 and 29% for HeLa cells. We note that the cytotoxicities for D-tryptophan (3) 
and para-Ph L-tryptophan (6) were observed at high concentrations: 96 µM and 240 
µM respectively. 
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Figure 5.3. The graphs represents the cytotoxicity at twice the MIC 
concentration (against TetR E. coli) of meta-Ph (L-trp) (2, 56 µM), meta-
Ph (D-trp) (3, 96 µM), ortho-Ph (L-trp) (5, 112 µM), para-Ph (L-trp) (6, 
240 µM), (CH2)3 (L-trp) (7, 256 µM) and (CH2)12 (L-trp) (10, 20 µM) to 
HEK-293, HeLa and Cos-7 cells. Error bars represent the standard 
deviation in our results. 
 
Two observations can be made from the data in Figure 5.3 concerning alkyl BTs 7 and 
10. First, 7 and 10 were more cytotoxic than phenylene BTs 2, 3, 5, or 6. At the MIC 
concentrations of (CH2)3 (L-trp) (7, 128 µM) and (CH2)12 (L-trp) (10, 10 µM), 80-
100% survival was observed against HEK-293 and Cos-7 cells (Figure 5.2). At twice 
the MIC concentrations of 7 (256 µM) and 10 (20 µM), survival for HEK-293 and Cos-
7 further decreased to 50-80% (Figure 5.3). We infer that alkyl-linked BTs may find 
use as antimicrobials, although this possibility was not pursued further as part of the 
present effort.  
 
Second, the cytotoxicity of (CH2)3 (L-trp) (7) and (CH2)12 (L-trp) (10) was greater 
against HeLa cells than either HEK-293 and Cos-7 cell lines. The HeLa cells are 
adenocarcinoma involved cervical epithelial cells. The selectivity of (CH2)12 (L-trp) 
(10) at 20 µM for HeLa cells over HEK-293 and Cos-7, suggests a potential application 
in cancer chemotherapy. While this is not the focus of the present report, we note that 
a (CH2)8 (L-Trp) analog of 10 prepared by Lown and co-workers showed promising 
cytotoxicity against 60 human cancer cell lines.33 
 
5.2.7. Recovery of antimicrobial activity against a resistant strain. The cytotoxicity of 
the compounds 2, 3, 5, 6, 7 and 10 was minimal at MIC concentrations. Next, we 
determined whether these compounds could be used at concentrations of ½ MIC or 
lower to recover the activity of antibiotics against efflux pump expressing resistant 
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bacteria. At these lower concentrations there should be no cytotoxicity. In addition, at 
the half-MIC concentrations these compounds should not have any effect on bacterial 
growth. We hypothesized that if certain BTs increased membrane permeability, they 
could recover antimicrobial potency against efflux-based resistance. This hypothesis 
was tested with the TetR strain of E. coli prepared in our laboratory (see above). 
 
We determined MICs for 2, 3, 5, 6, 7, and 10 against TetR E. coli. Compounds 6 (para-
Ph) and 7 (n-C3) were also included as controls. The MICs against TetR E. coli were 
refined compared to the power series and are reported as a range in Table 5.1 
(above). The MICs of tetracycline and ampicillin against TetR E. coli were 900  100 
µM and >1000 µM, respectively. For comparison, the MIC for tetracycline against non-
resistant E. coli K-12 is ~3 µM. Ampicillin was used to maintain selective pressure for 
the expression of pBR322 plasmid. Ampicillin was omitted from experiments that 
contained tetracycline. Next, we determined the MIC of tetracycline when co-
administered with 2, 3, 5, 6, 7, or 10. The results are recorded in Table 5.2. The 
results are represented as the MIC of tetracycline in the presence of the indicated BTs. 
The fold-recovery was determined by dividing the MIC of tetracycline when used 
alone by the MIC of tetracycline determined in the presence of our compounds.  
 
Table 5.2. Recovery of tetracycline activity against TetR E. coli 
Compounds Used [Compound] 
µM 
MIC [Tet]  
µMa 
Fold 
Recovery 
FICc 
 
 
None 0 900  n.a.b n.a.  
meta-Ph (L-Trp) (2) 24 [½ MIC] 56.25 16-fold 0.56  
meta-Ph (L-Trp) (2) 12 [¼ MIC] 112.5 8-fold 0.38  
meta-Ph (L-Trp) (2) 14 112.5 8-fold 0.42  
meta-Ph (D-Trp) (3) 14 [½ MIC] 112.5 8-fold 0.63  
meta-Ph (D-Trp) (3) 7 [¼ MIC] 225 4-fold 0.50  
ortho-Ph (L-Trp) (5) 28 [½ MIC] 112.5 8-fold 0.63  
ortho-Ph (L-Trp) (5) 14 [¼ MIC] 225 4-fold 0.50  
para-Ph (L-Trp) (6) 60 [½ MIC] 112.5 8-fold 0.63  
para-Ph (L-Trp) (6) 30 [¼ MIC] 225 4-fold 0.50  
para-Ph (L-Trp) (6) 14 450 2-fold 0.62  
n-C3 (L-Trp) (7) 60 [½ MIC] 112.5 8-fold 0.63  
n-C3 (L-Trp) (7) 30 [¼ MIC] 112.5 8-fold 0.38  
n-C3 (L-Trp) (7) 5 450 2-fold 0.54  
n-C12 (L-Trp) (10) 5 [½ MIC] 225 4-fold 0.75  
n-C12 (L-Trp) (10) 2.5 [¼ MIC] 450 2-fold 0.75  
a. MIC is the observed inhibitory concentration of tetracycline in the presence of the 
indicated compound. MIC values represent two trials of two replicates each. MIC 
resolution is in powers of 2. b. ‘n.a.’ means not applicable. c. FIC is the fractional 
inhibitory concentration 
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Tetracycline activity was recovered by compounds 2, 3, 5, 6, 7 and 10 at ½ and ¼ of 
its MIC values. This recovery of tetracycline potency was based on the concentration 
and the structure of the compounds used. The highest recovery of tetracycline 
activity was observed with meta-Ph (L-trp) (2). The MIC of tetracycline was 
decreased from 900 µM to 56.25 µM in the presence of 24 µM of compound 2. At 
twice the concentration of compound 2 (48 µM), no cytotoxicity to HEK-293, HeLa, 
and Cos-7 cells was apparent (Figure 5.2). The (CH2)12 (L-trp) (10), most potent 
antimicrobial in the 1-10 group, showed only 2 to 4-fold recovery of tetracycline 
activity.  
 
The fractional inhibitory concentration (FIC) is often used as a measure of synergism 
or antagonism in comparing two or more compounds.34 The FIC is the sum of the 
fraction of the MIC for each compound used. Synergy is defined broadly as FIC < 1, or 
more conservatively as FIC ≤ 0.5. Under the broad definition, all compounds tested 
can be said to have at least moderate synergy with tetracycline. All arene-based 
compounds fit the more conservative definition of synergy with FIC values of 0.5 or 
less at the tested concentrations. Compound 2 showed particularly high synergy with 
a FIC of 0.38. The shorter alkyl-linked compound 7 also had a FIC of 0.38, whereas the 
longer n-C12 (L-trp) (10) did not show synergy below a FIC of 0.75. 
 
Since the MICs of all the compounds tested were different, we chose a single 
concentration to compare the efficacies of different compounds in the expectation 
that if any trend was apparent, it would be revealed. We compared the ability of 
compounds 2, 3, 5 and 6 to recover tetracycline activity at 14 µM, which is much 
lower than the MIC observed with any arene-spacer based compounds. The alkyl-
spacer based compounds (3 and 12) were compared at 5 µM, which is much lower 
than the MIC observed with either compound. It is apparent from the graph of Figure 
5.4, that at 14 µM meta-Ph (L-Trp), 2, is most effective at recovering tetracycline 
activity against TetR E. coli. The least effective synergists were those having para-Ph, 
6, or propylene (n-C3), 7, spacers. Clearly, regiochemistry and conformational 
mobility are contributors to the observed differences but the precise nature of the 
influence(s) is not known.  
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Figure 5.4. This graph compares the ability of meta-ph (L-trp) (2, 14 
µM), meta-ph (D-trp) (3, 14 µM), ortho-ph (L-trp) (5, 14 µM), para-ph 
(L-trp) (6, 14 µM), (CH2)3 (L-trp) (7, 5 µM) and (CH2)12 (L-trp) (10, 5 
µM) to recover tetracycline activity against TetR E. coli. MICs were 
reproduced three times and the resolution is in powers of 2.  
 
5.2.8. Membrane permeability. Based on the MIC and toxicity studies, meta-Ph (L-trp), 
2, and (CH2)12 (L-trp), 10, have emerged as compounds of interest for different 
reasons. The meta-Ph (L-trp), 2, shows synergy against tetracycline resistant E. coli, 
without any cytotoxicity to three mammalian cell lines. Dodecylene BT, 10, showed 
the greatest antimicrobial activity, but also exhibited cytotoxicity to HEK-293 and 
HeLa cells. In order for the BTs to exhibit toxicity to any of the microbes, it is essential 
for them to penetrate the bacterial membrane. In Gram-negative organisms, the 
boundary membrane consists of two layers although porins are present within them 
that could pass these relatively small molecules.  
 
Figure 5.5 shows the results of a confocal microscopy study using E. coli TetR as the 
test organism. The study was designed to assess the membrane permeability and 
viability of the E. coli in the presence of BTs 2 and 10. The three panels in Figure 5.5 
show the bright field (BF) microscopic images (top row), the result when fluorescein 
diacetate (FDA) is present (middle row), and the presence of propidium iodide (PI, 
bottom row), if any. Propidium iodide does not normally pass through boundary 
membranes into bacteria or other cells. When it does, it intercalates in DNA, which 
leads to enhanced fluorescence. Fluorescein diacetate is incorporated into the cells 
during growth, but is not fluorescent. If the organism is or remains vital, the diester 
will be hydrolyzed and fluorescein will be observed by its fluorescence emission. 
 
The membrane permeability and viability of E. coli TetR was observed for the microbe 
alone or in the presence of BTs 2 or 10. Controls for the  permeability/viability assay 
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were included for E. coli in the presence of a final concentration of 0.5% (v/v) DMSO 
(the vehicle for administration of BTs), and a final concentration of 0.1% (w/w) 
Triton X-100. We have recently demonstrated35 that while small amounts of DMSO 
(e.g. 0.5% in media) do not alter biological activity, at higher concentrations and with 
certain organisms there is an effect. Thus, we never use more than 0.5% DMSO (v/v); 
the control is shown in the second column. Triton X-100 is a potent detergent, which 
is used at 0.1% or ~1,670 µM.  
 
 
 
Figure 5.5: TetR E. coli cell membrane permeability by compounds 2 
(meta-Ph (L-Trp)) and 10 (C12-Trp) at ~½ MIC and controls. 
 
The images show that E. coli TetR alone or in the presence of 0.5% DMSO are vital. 
This is also the case when E. coli TetR is subjected to 2 at 24 µM or 10 at 6 µM. These 
concentrations were selected because each is ½ the MIC value. The lower row of 
Figure 5.5 shows that propidium iodide does not infiltrate E. coli TetR in the absence 
of Triton X-100, 2, or 10. When Triton X-100 is the adjuvant, essentially all the cells 
are killed and the presence of PI may simply be part of the cellular detritus. 
Propidium iodide fluorescence is observed when 2 or 10 is added to the cells. This 
indicates that the membrane permeability has increased, yet cells remain vital at the 
concentrations tested (cf. FDA fluorescence). 
 
A compound that inhibits bacterial growth and penetrates into the microbe’s cytosol 
may also penetrate into mammalian cells. We therefore conducted a similar 
microscopic study with the human embryonic kidney (HEK-293) cell line. In this case, 
only compound 2 was studied. Its activity (MIC) against all three microbes ranged 
from 32-64 µM. The microscopic study was therefore conducted at 20 µM, a value well 
below any inhibitory concentration, and at 80 µM, a concentration above all three MIC 
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values. The 80 µM concentration was used to confirm the cytotoxicity of 2 and to 
establish the lack of serum inhibition. The results are shown in Figure 5.6.  
 
 
 
Figure 5.6. Mammalian cell permeability in HEK-293 in the presence of 
meta-Ph (L-Trp), 2, at 20 µM and 80 µM. 
 
Propidium iodide indicates an increase of the membrane permeability of HEK-293 
cells and the FDA fluorescence and reports cellular vitality. When Triton X-100 is 
administered at 0.1% (~1670 µM), vitality is lost and a strong signal from propidium 
iodide reflects interaction of the dye with dispersed DNA. The results for 2 at 20 µM 
and 80 µM are interesting. At the lower concentration, a relatively low level of PI 
penetration is apparent and there is no loss of vitality. At 80 µM, there is considerable 
penetration of PI and some toxic effect is apparent. 
 
These data indicate that at sub-lethal concentrations, meta-Ph (L-trp), 2, increases the 
membrane permeability of E. coli cells, but shows no cytotoxicity or permeability 
alteration for HEK-293 mammalian cells. At higher concentrations, both cytotoxicity 
and membrane disruption are manifested.  
 
5.3. Conclusion. 
A series of nine bis(tryptophan) derivatives (BTs) and two control compounds was 
synthesized and tested for antimicrobial activity. The effect of arylene and alkylene 
linkers on the bacteriostatic activity of the compounds was assessed against two E. 
coli strains and a S. aureus strain. Structure-based studies revealed that in arylene-
linked BTs the meta positioning of two tryptophans and the charge of the molecules 
are all crucial components to observe antimicrobial potency. Removal of any one 
property leads to loss of the antimicrobial activity. Antibacterial activity of alkylene-
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linked BTs was observed only for the longest dodecylene spacer. The compounds 
were generally more active against Gram-positive S. aureus than Gram-negative E. 
coli. At sub-inhibitory concentrations the meta-phenylene linked BTs recovered the 
antibacterial activity of tetracycline against tetracycline-resistant E. coli. This 
apparent synergy may arise from the membrane activity of these compounds as 
revealed by confocal microscopy. Minimal cytotoxicity was observed for the arlyene-
linked BTs at MIC concentrations against three mammalian epithelial cell lines. 
Although many amphiphilic peptides have been previously reported, this study 
exemplifies a minimalist structure-based approach. The simplicity of the structures 
elaborated in this report notwithstanding, BTs effectively reversed efflux pump-
mediated resistance. With additional mechanistic and structural studies, we seek to 
establish a strategy for combating efflux-based antibiotic resistance with membrane-
active compounds. 
 
5.4. Experimental Section. 
5.4.1. Chemical synthesis and characterization.  
The tert-butyl carbamate-protected (Boc-protected) amino acids were coupled to the 
diamine using a uronium-based coupling reagent HBTU in DMF with 
diisopropylethylamine. After workup and isolation of the desired boc-protected 
bis(amino acid) product, deprotection was carried out using hydrochloric acid 
dioxane/methanol and precipitated out with methylene chloride. All 1H- and 13C-NMR 
spectra were determined at 300 and 75 MHz, respectively, in CDCl3 unless otherwise 
specified. 
 
General Procedure. The tert-butyl carbamate-protected (Boc-protected) amino 
acids and HBTU (2.1 equivalents) were dissolved in 1o mL anhydrous DMF with 
diisopropylethylamine (4.0 equivalents for the neutral diamines; 6.0 equivalents for 
diaminedihydrochlorides). The reaction was stirred overnight at room temperature 
under an argon atmosphere. The mixture was taken up in 75 mL ethyl acetate and 
washed with 1 M NaHSO4 (2 x 75 mL), 5% NaHCO3 (3 x 50 mL), and brine. The 
organic layer was dried by filtration through a MgSO4/celite plug and the solvent 
removed in vacuo. The Boc-protected bis(amino acid) was used without further 
purification or was crystallized/precipitated from CH2Cl2/hexane.  The deprotection 
was carried out by using 10 equivalents of HCl in dioxane/methanol and the product 
was obtained by precipitation and trituration with cold methylene chloride.  
 
Di-tert-butyl ((1,3-phenylenebis(azanediyl))bis(2-oxoethane-2,1-
diyl))dicarbamate (1a) was prepared according to the general procedure from 1,3-
phenylenediamine (0.154 mg, 1.42 mmol) and Boc-Gly-OH. The product was obtained 
as a white powder (0.33 g, 55% yield), mp 95 °C (dec). 1H-NMR: δ 1.44 (s, 18H, 
(CH3)3), 3.90 (d, 2H, αCH2), 5.86 (m, 2H, Boc-NH), 7.12 (t, J = 7.2 Hz, 1H, phenyl H5), 
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7.23 (d, J = 7.2 Hz, 2H, phenyl H4, H6), 7.64 (s, 1H, phenyl H2), 8.92 (s, 2H, PhNHCO-). 
13C-NMR (75 MHz, CDCl3): δ 28.27, 44.90, 80.28, 111.72, 116.02, 129.27, 138.00, 
156.60, 168.52. HRMS (FAB+): calcd for (C20H30N4O6) 422.2165, found 422.2163. 
 
2,2'-(1,3-Phenylenebis(azanediyl))bis(2-oxoethanaminium) chloride (1) was 
prepared according to the general procedure using 1a (309 mg, 0.73 mmol). The 
product was obtained as a white powder (0.20 g, 94% yield), mp 310 °C (dec.). 1H-
NMR (D2O): δ 3.88 (s, 4H, αCH2), 7.14 (d, J = 8.1 Hz, 2H, phenyl H4, H6), 7.32 (t, J = 8.1 
Hz, 1H, phenyl H5), 7.68 (s, 1H, phenyl H2). 13C-NMR (D2O): δ 40.92, 113.72, 117.97, 
129.92, 136.99, 165.49. HRMS (FAB+): calcd for (C10H14N4O2Na) 245.1015, found 
245.1014. 
 
Di-tert-butyl ((2S,2'S)-(1,3-phenylenebis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropane-2,1-diyl))dicarbamate (2a) was prepared according to the general 
procedure using 1,3-phenylenediamine (150 mg, 1.39 mmol) and Boc-L-Trp-OH. The 
product was obtained as a white powder (0.80 g, 85% yield), mp 148 °C (dec). 1H-
NMR (DMSO-d6): δ 1.34 (s, 18H, 2(CH3)3) 2.95-3.14 (ABX, 4H, 2CH2β), 4.39 (ABX, 2H, 
2CHα), 6.90-7.12 (m, 6H, indole H5, indole H6, ArNH), 7.15-7.40 (m, 7H, indole H2, 
phenylene H4), phenylene H5, indole H7), 7.68 (d, J = 7.7 Hz, 2H, indole H4), 7.99 (s, 
1H, phenylene H2). 13C-NMR (DMSO-d6): δ 28.07, 30.59, 55.67, 77.94, 109.85, 111.15, 
114.34, 118.07, 118.54, 120.76, 123.71, 127.15, 131.24, 135.89, 139.16, 155.19, 
171.11. HRMS (FAB+): calcd for (C38H44N6O6Na) 703.3220, found 703.3224. 
 
(2S,2'S)-1,1'-(1,3-Phenylenebis(azanediyl))bis(3-(1H-indol-3-yl)-1-oxopropan-
2-aminium) chloride (2) was prepared according to the general procedure using 2a 
(313 mg, 0.46 mmol). The product was obtained as a white powder (0.24 g, 94% 
yield), mp 223 °C (dec). 1H-NMR (CD3OD): δ 3.33-3.53 (ABX, 4H, 2CH2β), 4.26 (ABX, 
2H, 2CHα), 7.01 (t, J = 7.4 Hz, 2H, indole H5), 7.12 (t, J = 7.0 Hz, 2H, indole H6), 7.22 (s, 
2H, indole H2), 7.26 (m, 2H, phenylene H4), 7.27 (m, 1H, phenylene H5), 7.38 (d, J = 
8.1 Hz, 2H, indole H7), 7.67 (d, J = 7.9 Hz, 2H, indole H4), 7.93 (s, 2H, phenylene H2). 
13C-NMR (CD3OD): δ 29.01, 55.68, 107.84, 112.61, 113.28, 117.54, 119.29, 120.35, 
122.93, 125.73, 128.35, 130.32, 138.32, 139.60, 168.52. HRMS (FAB+): calcd for 
(C28H29N6O2+) 481.2347, found 481.2356. 
    
Di-tert-butyl ((2R,2'R)-(1,3-phenylenebis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropane-2,1-diyl))dicarbamate (3a) was prepared according to the general 
procedure using 1,3-phenylenediamine (200 mg, 1.85 mmol) and Boc-D-Trp-OH. The 
product was obtained as a white powder (1.05 g, 84% yield), mp 141 °C (dec). 1H-
NMR: δ 1.38 (s, 18H, 2(CH3)3) 3.10-3.45 (ABX, 4H, 2CH2β), 4.62 (ABX, 2H, 2CHα), 
6.90-7.23 (m, 6H, indole H5, indole H6, ArNH), 7.29-7.40 (m, 7H, indole H2, phenylene 
H4), phenylene H5, indole H7), 7.66 (d, J = 7.0 Hz, 2H, indole H4), 8.21 (s, 1H, 
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phenylene H2). 13C-NMR: δ 28.35, 28.98, 56.04, 80.49, 109.66, 111.63, 112.74, 116.83, 
118.67, 119.35, 121.90, 123.79, 127.64, 129.34, 136.64, 138.14, 156.25, 171.58. 
HRMS (FAB+): calcd for (C38H44N6O6Na) 703.3220, found 703.3219. 
 
(2R,2'R)-1,1'-(1,3-Phenylenebis(azanediyl))bis(3-(1H-indol-3-yl)-1-oxopropan-
2-aminium) chloride (3) was prepared according to the general procedure using 3a 
(440 mg, 0.65 mmol). The product was obtained as an off-white powder (0.23 g, 64% 
yield), mp 242 °C (dec). 1H-NMR (CD3OD): δ 3.33-3.53 (ABX, 4H, 2CH2β), 3.65 (s, 6H, 
2NH3), 4.26 (ABX, 2H, 2CHα), 7.01 (t, J = 7.4 Hz, 2H, indole H5), 7.12 (t, J = 7.0 Hz, 2H, 
indole H6), 7.22 (s, 2H, indole H2), 7.26 (m, 2H, phenylene H4), 7.27 (m, 1H, 
phenylene H5), 7.38 (d, J = 8.1 Hz, 2H, indole H7), 7.67 (d, J = 7.9 Hz, 2H, indole H4), 
7.93 (s, 2H, phenylene H2). 13C-NMR (CD3OD): δ 28.96, 55.67, 107.84, 112.58, 113.31, 
117.55, 119.33, 120.32, 122.89, 125.76, 128.37, 130.28, 138.27, 139.56, 168.52. 
HRMS (FAB+): calcd for (C28H29N6O2+) 481.2347, found 481.2350. 
 
N,N'-(1,3-Phenylene)bis(3-(1H-indol-3-yl)propanamide) (4) was prepared 
according to the general procedure using 1,3-phenylenediamine (70 mg, 0.65 mmol) 
and indole-3-propionic acid. The product was obtained as a white powder (0.23 g, 
78% yield), mp 154-156 °C. 1H-NMR (CD3OD): δ 2.76 (t, J = 7.6 Hz, 4H, 2COCH2CH2-
indole), 3.18 (t, 7.6 Hz, 4H, 2COCH2CH2-indole), 7.04-7.39 (m, 9H, indole H5, indole 
H6, indole H2, phenylene H4, phenylene H6), 7.37 (d, J = 7.9 Hz, 2H, indole H7), 7.60-
7.66 (m, 3H, indole H4, phenylene H5). 13C-NMR (CD3OD): δ 21.81, 38.37, 111.71, 
114.33, 116.43, 117.53, 118.72, 119.06, 121.83, 122.40, 127.52, 137.04, 139.11, 
173.38. HRMS (FAB+): calcd for (C28H26N4O2Na) 473.1954, found 473.1945. 
 
Di-tert-butyl ((2S,2'S)-(1,2-phenylenebis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropane-2,1-diyl))dicarbamate (5a) was prepared according to the general 
procedure using 1,2-phenylenediamine (150 mg, 1.39 mmol) and Boc-L-Trp-OH. The 
product was obtained as a white powder (0.76 g, 80% yield), mp 129 °C (dec). Two 
hydrogen bonded conformations were observed spectroscopically, peaks for the 
major conformer are reported herein. 1H-NMR: δ 1.50 (s, 9H, (CH3)3), 3.05-3.33 (ABX, 
2H, βCH2), 4.21 (ABX, 1H, αCH), 5.40 (d, J = 7.3 Hz, 1H, Boc-NH), 6.55-7.62 (m, 7H, 
ArH, ArNH), 8.98 (s, 1H, indole NH). 13C-NMR: δ 28.48, 28.84, 56.01, 80.53, 110.14, 
111.55, 118.99, 119.65, 122.19, 123.45, 124.68, 126.10, 127.37, 129.33, 136.16, 
155.71, 171.35. HRMS (FAB+): calcd for (C38H44N6O6Na) 703.3220, found 703.3218. 
 
(2S,2'S)-1,1'-(1,2-Phenylenebis(azanediyl))bis(3-(1H-indol-3-yl)-1-oxopropan-
2-aminium) chloride (5) was prepared according to the general procedure using 5a 
(600 mg, 0.88 mmol). The product was obtained as a white powder (0.21 g, 43% 
yield), mp 201 °C (dec). Two hydrogen bonded conformations were observed 
spectroscopically, peaks for the major conformer are reported herein. 1H-NMR 
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(CD3OD): δ 3.35-3.65 (ABX, 2H, βCH2), 4.58 (t, J = 6.9 Hz, 1H, αCH), 7.00-7.73 (m, 7H, 
ArH, ArNH). 13C-NMR (CD3OD): δ 28.79, 55.74, 107.93, 112.56, 119.58, 120.36, 
122.92, 125.81, 126.35, 127.36, 128.48, 130.99, 138.27, 169.44. HRMS (FAB+): calcd 
for (C28H29N6O2+) 481.2347, found 481.2359. 
 
Di-tert-butyl ((2S,2'S)-(1,4-phenylenebis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropane-2,1-diyl))dicarbamate (6a) was prepared according to the general 
procedure using 1,4-phenylenediamine (150 mg, 1.39 mmol) and Boc-L-Trp-OH. The 
product was obtained as a white powder (0.84 g, 89% yield), mp 167 °C (dec). 1H-
NMR (CD3OD): δ 1.41 (s, 9H, (CH3)3), 3.19-3.36 (ABX, 2H, βCH2), 4.47 (ABX, 1H, αCH), 
6.98-7.12 (m, 3H, indole H5, indole H6, indole H2), 7.27-7.42 (m, 3H, indole H7, 
phenylene CH), 7.61 (d, J = 7.7 Hz, 1H, indole H4), 7.78 (s, 1H, indole NH). 13C-NMR 
(CD3OD): δ 28.50, 29.26, 56.66, 80.52, 110.06, 111.90, 118.97, 119.50, 121.52, 122.07, 
124.15, 128.14, 134.88, 137.26, 156.85, 172.14. HRMS (FAB+): calcd for 
(C38H44N6O6Na) 703.3220, found 703.3210. 
 
(2S,2'S)-1,1'-(1,4-Phenylenebis(azanediyl))bis(3-(1H-indol-3-yl)-1-oxopropan-
2-aminium) chloride (6) was prepared according to the general procedure using 6a 
(475 mg, 0.70 mmol). The product was obtained as a white powder (0.36 g, 93% 
yield), mp 237 °C (dec.). 1H-NMR (CD3OD): δ 3.34-3.54 (ABX, 2H, βCH2), 4.27 (ABX, 
1H, αCH), 6.97-7.14 (m, 2 H, indole H5, indole H6), 7.24 (s, 1H, indole H7), 7.38 (d, J = 
8.1 Hz, 1H, indole H7), 7.67 (d, J = 7.9 Hz, 1H, indole H4). 13C-NMR (75 MHz, CDCl3): δ 
28.93, 55.69, 107.90, 112.57, 119.33, 120.29, 121.88, 122.87, 125.72, 128.38, 135.61, 
138.26, 168.33. HRMS (FAB+): calcd for (C28H28N6O2Na) 503.2171, found 503.2166. 
 
Di-tert-butyl ((2S,2'S)-(propane-1,3-diylbis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropane-2,1-diyl))dicarbamate (7a) was prepared according to the general 
procedure using 1,3-diaminopropane dihydrochloride (200 mg, 1.36 mmol) and Boc-
L-Trp-OH. The product was obtained as a white powder (0.51 g, 58% yield). The 
compound was previously reported33 and the spectra obtained matched those 
previously reported. 
 
(2S,2'S)-1,1'-(Propane-1,3-diylbis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropan-2-aminium) chloride (7) was prepared according to the general 
procedure using 7a (380 mg, 0.59 mmol). The product was obtained as a white 
powder (0.30 g, 98% yield), mp 234 °C (dec). 1H-NMR (CD3OD): δ 1.40 (m, 2H, -
CH2CH2NH-), 2.98 (m, 4H, -CH2CH2NH-), 3.22-3.65 (m, 4H, CH2β), 4.13 (ABX, 2H, CHα), 
6.99-7.18 (m, 4H, indole H5, indole H6), 7.25 (s, 2H, indole H2), 7.39 (d, J = 6.4 Hz, 2H, 
indole H7), 7.69 (d, J = 4.7 Hz, 2H, indole H4), 8.30 (br, CONH). 13C-NMR (CD3OD): δ 
28.78, 29.39, 37.76, 55.27, 108.03, 112.62, 119.34, 120.22, 122.80, 125.71, 128.29, 
138.02, 170.05. HRMS (FAB+): calcd for (C25H31N6O2+) 447.2503, found 447.2503. 
 
 
112 
 
 
Di-tert-butyl ((2S,2'S)-(butane-1,4-diylbis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropane-2,1-diyl))dicarbamate (8a) was prepared according to the general 
procedure using 1,4-diaminobutane dihydrochloride (210 mg, 1.30 mmol) and Boc-L-
Trp-OH. The product was obtained as a white powder (0.79 g, 92% yield). The 
compound was previously reported33 and the spectra obtained matched those 
previously reported. 
 
(S)-1-((4-((R)-2-ammonio-3-(1H-indol-3-yl)propanamido)butyl)amino)-3-(1H-
indol-3-yl)-1-oxopropan-2-aminium chloride (8) was prepared according to the 
general procedure using 8a (650 mg, 0.98 mmol). The product was obtained as a 
white powder (0.51 g, 97% yield), mp 204 °C (dec). 1H-NMR (CD3OD): δ 1.18 (m, 2H, -
CH2CH2NH-), 3.05 (m, 2H, -CH2CH2NH-), 3.22-3.41 (ABX, 2H, CH2β), 4.09 (ABX, 1H, 
CHα), 7.05-7.17 (m, 2H, indole H5, indole H6), 7.23 (s, 2H, indole H2), 7.40 (d, J = 7.9 
Hz, 1H, indole H7), 7.66 (d, J = 7.9 Hz, 2H, indole H4), 8.25 (br, 1H, CONH). 13C-NMR 
(CD3OD): δ 27.24, 29.06, 40.28, 55.40, 68.27, 108.29, 112.73, 119.38, 120.37, 123.00, 
125.68, 128.51, 138.34, 170.13. HRMS (FAB+): calcd for (C26H33N6O2+) 461.2660, 
found 461.2668. 
 
Di-tert-butyl ((2S,2'S)-(hexane-1,6-diylbis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropane-2,1-diyl))dicarbamate (9a) was prepared according to the general 
procedure using 1,6-diaminohexane dihydrochloride (250 mg, 1.32 mmol) and Boc-L-
Trp-OH. The product was obtained as a white powder (0.90 g, 99% yield). The 
compound was previously reported33 and the spectra obtained matched those 
previously reported. 
 
(2S,2'S)-1,1'-(Hexane-1,6-diylbis(azanediyl))bis(3-(1H-indol-3-yl)-1-
oxopropan-2-aminium) chloride (9) was prepared according to the general 
procedure using 9a (650 mg, 0.94 mmol). The product was obtained as a white 
powder (0.33 g, 62% yield), mp 193 °C (dec). 1H-NMR (CD3OD): δ 1.05 (m, 2H, 
aliphatic CH2), 1.26 (m, 2H, aliphatic CH2) 2.97-3.39 (m, 4H, -CH2CH2NH-, CH2β), 4.06 
(ABX, 2H, CHα), 7.02-7.15 (m, 2H, indole H5, indole H6), 7.20 (s, 1H, indole H2), 7.37 
(d, J = 8.1 Hz, 1H, indole H7), 7.63 (d, J = 7.5 Hz, 2H, indole H4), 8.19 (br, CONH). 13C-
NMR (CD3OD): δ 27.38, 28.98, 29.85, 40.61, 55.29, 108.19, 112.64, 119.22, 120.27, 
122.91, 125.52, 128.40, 138.26, 169.95. HRMS (FAB+): calcd for (C28H37N6O2+) 
489.2973, found 489.2972. 
 
Di-tert-butyl ((2R,2'S)-(dodecane-1,12-diylbis(azanediyl))bis(3-(1H-indol-3-
yl)-1-oxopropane-2,1-diyl))dicarbamate (10a) was prepared according to the 
general procedure using 1,12-diaminododecane (250 mg, 1.25 mmol) and Boc-L-Trp-
OH. The product was obtained as an off-white powder (0.93 g, 96% yield), mp 86 °C 
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(dec). 1H-NMR: δ 1.08-1.34 (m, 22H, aliphatic CH2), 1.41 (s, 18H, C(CH3)3), 2.99-3.32 
(m, 8H, -CH2CH2NH-, CH2β), 4.42 (ABX, 2H, CHα), 5.36 (br, 2H, Boc-NH), 6.03 (br, 2H, 
CONH), 6.95 (s, 2H, indole H2)  7.03-7.16 (m, 4H, indole H5, indole H6), 7.32 (d, J = 7.9 
Hz, 2H, indole H7), 7.60 (d, J = 7.7 Hz, 2H, indole H4). 13C-NMR: δ 26.52, 28.16, 28.54, 
28.99, 29.22, 29.28, 31.43, 39.38, 55.22, 65.72, 79.83, 110.12, 111.23, 118.60, 119.27, 
121.81, 123.22, 127.26, 136.19, 155.44, 171.68. HRMS (FAB+): calcd for 
(C44H64N6O6Na) 785.4785, found 785.4792. 
 
(S)-1-((12-((R)-2-Ammonio-3-(1H-indol-3-yl)propanamido)dodecyl)amino)-3-
(1H-indol-3-yl)-1-oxopropan-2-aminium chloride (10) was prepared according to 
the general procedure using 10a (715 mg, 0.92 mmol). The product was obtained as a 
white powder (0.56 g, 93% yield), mp 158 °C (dec). 1H-NMR (CD3OD): δ 1.08-1.34 (m, 
22H, aliphatic CH2), 2.99-3.38 (m, 8H, -CH2CH2NH-, CH2β), 4.04 (ABX, 2H, CHα), 7.02-
7.15 (m, 4H, indole H5, indole H6), 7.20 (s, 2H, indole H2), 7.37 (d, J = 7.9 Hz, 2H, 
indole H7), 7.62 (d, J = 7.9 Hz, 2H, indole H4). 13C-NMR (CD3OD): δ 27.92, 28.98, 30.01, 
30.43, 30.69, 30.77, 40.77, 55.29, 108.18, 112.62, 119.20, 120.24, 122.88, 125.51, 
128.40, 138.25, 169.90. HRMS (FAB+): calcd for (C34H49N6O2+) 573.3912, found 
573.3929. 
 
(S)-tert-Butyl (3-(1H-indol-3-yl)-1-oxo-1-(phenylamino)propan-2-yl)carbamate 
(11a) was prepared according to the general procedure using aniline (200 mg, 2.15 
mmol) and Boc-L-Trp-OH. The product was obtained as a white powder (0.65 g, 80% 
yield). The compound was previously reported36 and the spectra obtained matched 
those previously reported. 
 
(S)-3-(1H-Indol-3-yl)-1-oxo-1-(phenylamino)propan-2-aminium chloride (11) 
was prepared according to the general procedure using 11a (350 mg, 0.92 mmol). 
The product was obtained as a white powder (0.17 g, 57% yield). The compound was 
previously reported37 and the spectra obtained matched those previously reported. 
 
5.4.2. Bacterial strains and antibiotics used. K-12 E. coli (ATCC 700926) and S. 
aureus (ATCC 29213) were acquired from ATCC. The S. aureus strain was used in the 
BSL-2 facility. K-12 E. coli was grown in L. B. Miller media (Sigma-Aldrich) and S. 
aureus was grown in cation adjusted MHII media (Sigma-Aldrich). TetR E. coli was 
made by transforming JM109 competent E. coli (Promega) with pBR322 plasmid 
(Carolina Biological) using the manufacturers protocol. TetR E. coli was grown in L. B. 
Miller media containing the 100 µg/mL Ampicillin. Ampicillin and tetracycline were 
obtained from Sigma-Aldrich and dissolved in autoclaved milli-Q water before use.  
 
5.4.3. MICs and Synergy. MIC experiments were performed as described in the 
Clinical and Laboratory Standards Institute (CLSI) standard microdilution protocols. 
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Bacteria was grown overnight from one CFU in media without antibiotics. TetR E. coli 
was grown in media containing 100 µg/mL ampicillin. On the day of experiment, 
bacteria were knocked back to O.D. 600 nm = 0.550 in the same media. These 
exponential phase bacteria were then diluted in antibiotics free media to get 4 x 108 
CFU/mL. In a 96-well, plate either L.B. Miller or MHII media was added followed by 
serially diluted compounds 1-11, tetracycline, or ampicillin. All the tryptophan based 
compounds were dissolved in DMSO and the final concentration of DMSO in each well 
was kept constant at 0.5% (v/v). For the combination experiments, first the BT or 
control was added to the media in the well followed by the antibiotics. The contents 
of the well were mixed before adding 20 µL of bacteria to get 4 x 105 CFU/mL per 
well. The plates were incubated at 37°C, 200RPM for 24 hours before collecting 
results on the Biotek Cytation 3 plate reader. No more than three plates were stacked 
on top of each other at a time. Optical density of the wells was determined at λ=600 
nm. Cells alone were considered as 0% inhibition and media alone was considered as 
100% inhibition. Any inhibition greater than 80% was considered as the MIC. The 
results were reproduced three times before reporting.  
 
5.4.4. Cytotoxicity to mammalian cells. HeLa (ATCC CCL-2) cells were acquired from 
ATCC. Cos-7 (ATCC CRL-1651) cells were donated by Dr. C. Dupureur and HEK-293 
cells were donated by Dr. M. Nichols. Cell lines were regularly maintained in growth 
media containing DMEM (ATCC), 10% fetal bovine serum (FBS, ATCC) and 1% 
penicillin-streptomycin solution (ATCC). Adherent HEK-293, Hela and Cos-7 cells 
were trypsinized using 0.25% (w/v) trypsin-EDTA (Sigma-Aldrich), suspended in a 
fresh media and diluted to get a concentration of 3 x 105 cells/ml. Cells were seeded 
in a 96-well plate (100 µL/well) to get 3 x 104 cells/well. The plates were incubated 
for 24 hours at 5% CO2 and 37°C to reach a confluency of 80-90%.  
 
In a sterile 1.5 mL micro-centrifuge tube, compounds 2, 3, 5, 6, 7 and 10 (0.5% 
DMSO) were mixed with assay media (DMEM + 10% FBS) and serially diluted by 2-
fold each to get 2[MIC], [MIC], ½[MIC] and ¼[MIC] concentrations. A control 
containing 0.5% DMSO was also prepared. After 24 hours, the spent media in the 96-
well plate containing HEK-293, Hela and Cos-7 cells (90% confluency) was replaced 
with 100 µL media containing the compounds 2, 3, 5, 6, 7 and 10 at various 
concentrations. The cells were incubated at 37°C and 5% CO2 for 24 hours before 
performing XTT assay (Sigma-Aldrich). The XTT assay was performed according to 
the manufacturer’s protocol. After 24 hours of treatment with compounds, the media 
was replaced with PBS and 25 µL XTT was added to each well. The XTT assay works 
by the reduction of tetrazolium compound by alive cells to the colored soluble 
formazan product. The absorbance of the product was measured at 450 nm (XTT) 
and 690 nm (background). Percent survival was calculated by comparing the average 
absorbance of cells treated with compounds 2, 3, 5, 6, 7, and 10 to that of cells alone. 
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Two replicates for each treatment were determined. Average percent survival and 
standard deviation were calculated.  
 
5.4.5. Membrane permeability. To test the membrane permeability of the TetR E. 
coli, the bacteria was first grown overnight from one CFU in media containing 100 
µg/mL Ampicillin at 37°C and 200RPM. TetR E. coli was then knocked back to O.D. 600 
nm = 0.550 before use. In a sterile test, cells were added followed by either 
compounds 2 or 10 at half-MIC concentrations and incubated at 37°C and 200 RPM. 
The concentration of DMSO was kept constant at 0.5% -by volume in each case. After 
30 minutes of incubation, the cells were washed by centrifugation at 3000xg for 5 
minutes and re-suspended in sterile phosphate buffered saline (PBS). Propidium 
iodide (30 µM, Thermo-Fischer) and fluorescein diacetate (60 µM, Sigma-Aldrich) 
were added to the TetR E. coli cells in the PBS, mixed by vortexing and incubated at 
37°C and 200RPM. After 30 minutes, the cells were washed again by centrifugation at 
3000xg for 5 minutes. The pellet was suspended in a fresh PBS, loaded onto a clean 
glass slide, covered with a cover slip and observed under Zeiss LSM 700 confocal 
microscope.  
 
To test the permeability of HEK-293 cells, the cells were cultured in growth medium 
as described above. HEK-293 (90% confluent) were then seeded in a 96-well plate to 
get 30,000 cells/well. After 24 hours of incubation at 37 °C and 5% CO2, the spent 
media was replaced with media (DMEM and 10% FBS) containing compound 2 at 
either 20 µM or 80 µM. The 80 µM concentration was used to confirm the cytotoxicity 
of the compound 2 and to make sure that serum did not inhibit its activity. Triton X-
100 at 0.1%-by volume (1670 µM) and DMSO 0.5% (v/v) were also used as controls. 
After 2 hours of incubation, spent media was replaced with PBS containing propidium 
iodide (30 µM) and fluorescein diacetate (60 µM) and incubated at 37 °C and 5% CO2. 
After 2 hour of incubation, the spend media was replaced with fresh PBS and the cells 
were observed under Zeiss LSM 700 confocal microscope. The images were reported 
without any alterations. The gain and the intensity in all the images were kept 
constant.  
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